Analysis of vaccine:Structure, storage, moisture, and classification by infrared technology by Zheng, Yiwu
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 17, 2017
Analysis of vaccine
Structure, storage, moisture, and classification by infrared technology
Zheng, Yiwu; Jacobsen, Susanne
Publication date:
2006
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Zheng, Y., & Jacobsen, S. (2006). Analysis of vaccine: Structure, storage, moisture, and classification by
infrared technology.
 
Analysis of vaccine: 
Structure, storage, moisture, and classification 
by infrared technology 
 
 
Ph.D. Thesis by 
Yiwu Zheng 
2006 
 
 
 
 
 
BioCentrum-DTU 
Section of Biochemistry and Nutrition 
Technical University of Denmark 
Building 224, Sølvtofts Plads 
2800 Kgs. Lyngby 
Denmark 
  i
Preface 
 
 
This thesis has been submitted as partial fulfilment of the requirement for a Ph.D. degree at the 
Technical University of Denmark. The work has been done at Biochemistry and Nutrition Group, 
BioCentrum-DTU and ALK-Abelló A/S. I would like to thank my supervisors Susanne Jacobsen 
and Henning Løwenstein for giving me the opportunity to do this project and for all the work they 
have done for me.  
I specially wish to thank Ib Søndergaard, Henrik Ipsen, and Jørgen Nedergaard Larsen for 
enthusiastic discussions and the comments on the project and the thesis. If I were not with them, I 
would need a couple of more years to finish this Ph.D. project. I also would like to thank Charlotte 
Hejl for bridging the communication between the company and me when I worked at DTU. And 
also thank her for the helpful suggestion on the project. I want to thank Helene Henmar for the 
introduction of CD technique and the help on the experiments and data analysis. Mercedes Ferreras 
are greatly appreciated for the great discussion and references.  
I want to thank Marianne K. Pertersen, Ljljana Nesic, Gitte Nordskov Hansen, and Lotte Friberg for 
the help in the labs. Susanne Warng Bruun is greatly appreciated for discussions of the same 
interest—infrared and that we have been able to support each other. I would like to thank all the 
people in the research department, ALK-Ablleó A/S and at Biochemistry and Nutrition Group, 
BioCentrum-DTU for kind help and the beautiful working environment. And also thank all the 
Danish and Chinese friends for your help during these years.  
At last, but not the least, I would like to thank my pretty wife Xuxin and my lovely daughter Xinyi 
for all your love and supports.  
 
 
 
 
Yiwu Zheng 
June 2006, Denmark  
  ii
Summary 
 
Aims of this thesis 
The research described in this thesis is to extend our knowledge on the properties of vaccines and 
antigens using fast and cheap infrared techniques. FTIR-ATR spectroscopy is applied to elucidate 
the structural changes when antigen is adsorbed by aluminium hydroxide and when it is 
subsequently released. The structural stability during the storage and heating process is investigated 
as well. The alterations of other parameters, such as adsorption, release, and pH are also 
investigated during the storage. FT-NIR is applied as a fast and non-destructive method to 
determine the residual moisture content in lyophilized vaccines and to classify and identify different 
vaccine products.  
 
Organization of this thesis 
In Chapter I, the background of the project and the introductions to infrared spectroscopy as well 
as chemometrics are given respectively. In Chapter II, the current techniques for protein structure 
analysis have been discussed, especially the FTIR-ATR method. 
In Chapter III, the structural changes of two model antigens are investigated when they are 
adsorbed by aluminium hydroxide and the structures refold to their native state when they are 
released from adjuvant. The mechanism of the adjuvant enhancing the immune response is 
discussed in this chapter too.  
Chapter IV describes the structural stability of adsorbed model antigens in thermal and aging 
process in comparison to the antigens in solutions. The results indicate that aluminium hydroxide 
can protect the structure of antigens against aggregation at high temperature and/or after long period 
storage. It is more pronounced for BSA. Further study is required to confirm if the protection is 
protein specific.  
Chapter V gives the alterations of model vaccines during storage at two different temperatures. It 
demonstrates that the change of adsorption capacity by aluminium hydroxide during the storage is 
protein specific. The release of adsorbed protein from adjuvant decreases as a function of storing 
time. The pH and NIR absorbance also change.  The aging effects undergo faster modification at 37 
ºC than 4 ºC during the storage. The rotation effects when preparing vaccines are also discussed in 
this chapter as well.   
NIR method for determination of residual moisture content of lyophilized allergen vaccines is 
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introduced in Chapter VI. Five different allergen vaccines are analyzed. Acceptable calibration 
model (RMESEP 10.20 μg H2O / vial with 2 PLS factors) is obtained for multi-products data. The 
models based on product-specific data are slightly better (Appendix B). However, a general multi-
products model is more attractive since one model can predict all samples. The reference data which 
are measured by Karl Fischer titration are presented in Appendix A.  
NIR spectroscopy is applied to classify and identify five different allergen vaccines (the information 
of samples in Appendix C) at different concentrations of antigens and different batches in Chapter 
VII. The results show that NIR spectroscopy can be used to classify different allergen vaccines at 
highest antigen concentration (100,000 SQ) without api. The highest concentration products can be 
separated from other low concentrations. The discrimination of different batches may also be 
possible but need further experiments to confirm this. All SIMCA results are given in Appendix C 
to Appendix S.  
  iv
Resumé 
 
Hensigt med afhandlingen 
Forskningsarbejdet, beskrevet i denne afhandling, skal øge vores viden om vacciners og antigeners 
egenskaber ved hjælp af hurtige og billige infrarød-teknikker. FTIR-ATR spektroskopi benyttes til 
bestemmelse af strukturændringer, når antigen adsorberer til aluminium hydroxid, og når det 
efterfølgende frigives. Den strukturelle stabilitet under opbevaringen og under 
opvarmningsprocessen undersøges ligeledes. Desuden undersøges ændringer i andre parametre, 
såsom adsorption, frigivelse og pH, under opbevaringen. FT-NIR benyttes som en hurtig og ikke-
destruktiv metode til at bestemme resterende fugtindhold i frysetørrede vacciner og til at 
klassificere og identificere forskellige vaccineprodukter. 
 
Organisering af afhandlingen 
I kapitel I er baggrunden for projektet samt introduktion til infrarød spektroskopi og kemometri 
beskrevet. I kapitel II er de nuværende teknikker til protein-struktur-analyse, især FTIR-ATR 
metoden, blevet diskuteret.  
I kapitel III er undersøgt strukturændringer af to model antigener ved adsorption til aluminium 
hydroxid samt deres foldning tilbage til nativ tilstand ved frigivelse fra adjuvanten. Mekanismen for 
den immunfremmende effekt af adjuvanten er ligeledes diskuteret. 
Kapitel IV beskriver strukturel stabilitet af adsorberet modelantigen i termiske- og 
aldringsprocesser sammenlignet med antigener i opløsning. Resultaterne indikerer at aluminium 
hydroxid kan beskytte strukturen af antigenet mod aggregeringen ved høj temperatur og/eller lang 
tids opbevaring. Dette er mest udtalt for BSA. Yderligere studier kræves for at bekræfte om denne 
beskyttelse er protein-specifik.  
Kapitel V omhandler ændringen af modelvacciner under opbevaring ved to forskellige 
temperaturer. Det demonstrerer at ændringen i aluminium hydroxids adsorptionskapacitet under 
opbevaring er protein-specifik. Frigivelse af adsorberet protein fra adjuvanten nedsættes som 
funktion af opbevaringstid. Ligeledes ændres pH og NIR-absorbansen. Aldringseffekterne 
gennemgår hurtigere modifikationer med opbevaringstiden ved 37 oC end ved 4 oC. 
Rotationseffekter under fremstilling af vacciner diskuteres også i kapitlet. 
NIR-metoden til bestemmelse af resterende fugtindhold i frysetørrede allergenvacciner introduceres 
i kapitel VI. Fem forskellige allergenvacciner analyseres. Acceptable kalibreringsmodeller (RMSEP 
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10.20 μg H2O/ flaske med 2 PLS faktorer) er opnået for multi-produkt data. Modellerne baseret på 
produktspecifikke data er lidt bedre (Appendiks B). Imidlertid er en generel multiprodukt-model 
mere attraktiv idet en enkelt model kan forudsige alle prøverne. Referencedataene som måles ved 
Karl Fischer-titrering præsenteres i Appendiks A.  
NIR spektroskopi benyttes til at klassificere og identificere fem forskellige allergenvacciner 
(information om prøverne ses i Appendiks C) ved forskellige koncentrationer af antigener og 
forskellige batcher i kapitel VII. Resultaterne viser at NIR spektroskopi kan benyttes til at 
klassificere forskellige allergen vacciner ved højeste antigenkoncentration (100,000 SQ) uden api. 
Produkter ved den højeste koncentration kan adskilles fra produkter ved lave koncentrationer. 
Diskrimineringen af forskellige batcher kan også være mulig. Dette mangler dog at blive bekræftet. 
Alle SIMCA-resultater gives i Appendiks C til Appendiks S. 
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Chapter I: Background of the project and the introductions to infrared technology and 
chemometrics 
 
This chapter describes the background and purpose of this study, as well as infrared technology and 
chemometrics, which are the core technologies used in this work.  
1 Background  
Two public health interventions, clean water and vaccines, have had the greatest impact on the 
world’s health. Vaccines prevent disease or death for millions of individuals every year [1]. Vaccine 
manufacturers and public authorities, e.g. World Health Organization (WHO), have established 
ambitious goals for enhancing present vaccines and for developing new ones. New vaccine 
candidates have emerged over the past years against allergic, infectious, autoimmune diseases, and 
for cancer and fertility treatment as well [2]. 
 In the case of allergy, the prevalence of hypersensitivity reactions increases rapidly, especially in 
developed countries. Allergic diseases concern approximately 30% of the population, thus they 
become a serious clinical and social problem [3]. Allergic diseases such as asthma, atopic 
dermatitis, allergic rhinitis and conjunctivitis belong to inflammatory disorders, which can be 
treated using anti-inflammatory drugs. Although efficient in symptom control, this treatment is not 
a causal method and the WHO recommends combination treatment considering immunotherapy [4].  
The conventional allergen-specific immunotherapy (SIT) protocol was introduced by Noon and 
Freeman in 1911 [5], when they injected an extract of grass pollen to a person whose allergic 
symptoms coincided with the pollination of grass. Since then, controlled studies have shown that 
SIT is effective in patients with allergic diseases. SIT involves repeated administration of gradually 
increasing quantities of specific allergens to an allergic patient until a dose is reached that will raise 
the patient’s tolerance to the allergen. Among the current approaches in allergy therapy, SIT is the 
only treatment that may affect the course of allergic diseases and it also may prevent the 
development of asthma in patients with allergic rhinitis [4]. The mechanisms of SIT have been 
reviewed elsewhere [4]. A successful SIT is dependent on the use of high quality allergen vaccines 
that are properly standardized and can be manufactured consistently. 
Vaccine is produced by maximum adsorption of antigens onto adjuvants. Beginning in the early 20th 
century, researchers experimented with a wide variety of organic and inorganic compounds 
including aluminium salts, mineral oil, and killed mycobacteria to improve the immunogenicity of 
vaccines, but most of these concepts were never accepted for routine vaccination because of safety 
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concerns, e.g. acute toxicity and the possibility of delayed side effects [2]. These compounds are 
called adjuvants, which derived from the Latin verb adjuvare meaning “to help” [2, 6-8]. In brief, an 
adjuvant is a substance that, when mixed with an antigen and injected with it, enhances the 
immunogenicity of that antigen. Adjuvants are often used to boost the immune response when an 
antigen has low immunogenicity or when only small amounts of an antigen are available [9].  
Aluminium-contained adjuvants (ACA), first described in 1926 [10], are the only immunologic 
adjuvants used in human vaccines licensed in the United States, and are also present in many 
veterinary vaccines. They have been administered to hundreds of millions of people with only rare 
reports of serious local reactions [11]. Vaccines containing ACA are prepared by two principal 
methods [12, 13]: 1) Antigens are adsorbed by aluminium hydroxide or aluminium phosphate. Such 
products are termed adsorbed vaccines. The commercial products are prepared by this method. 2) 
Antigen solutions are mixed with a solution of KAl(SO4)2.12H2O. These products are termed alum 
precipitated vaccines. The alum precipitated vaccines are not applied today, because such 
preparations could be highly heterogeneous [12].  
Although adjuvants have been used for many years to enhance, accelerate and prolong the specific 
immune response towards the desired response to vaccine antigens, the mechanism by which 
adjuvant can enhance the immune response and/or exert their activities is still not clear [9]. A few 
hypotheses have been proposed elsewhere [2, 6, 9, 12, 14-18], which are briefly introduced here. 
• The first hypothesis is known as the “depot effect”. It is based on the lower solubility of 
aluminium-protein complex compared to the free protein solution. Vaccine antigen is 
released slowly after administration, which results in a sufficient time to induce a significant 
immune response [2, 6, 9, 12, 14-18].  
• The physical appearance of the antigen is defined by the adjuvants in the vaccine [2]. 
• Adjuvant may target the distribution of antigens to specific cells. And it may regulate both 
quantitatively and qualitatively aspects of the ensuing immune responses [2].  
• Adjuvant itself can stimulate immune response since it is associated with e.g. cytokine 
production [12, 14].  
• The particles of size from 5 to 10 μm are more easily phagocytosed by macrophages, 
dendritic cells, and neutrophils, than other particles. These are the size for most aluminium-
protein complexes [9, 14, 15].  
• Protein may be destabilized by adsorption of adjuvants. The adsorbed protein, once inside 
cells, would be more prone to degradation than the free protein. In this way the protein is 
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processed faster and thereby quickly reaches the outer membrane of antigen presenting cells 
[15].  
• Adjuvants can protect the antigen from degradation and elimination [2].  
Thus, adjuvants may enhance the immune response as a result of multiple factors. Individual 
antigens vary in their physical, biological and immunogenic properties and thus antigens may have 
different needs for help from an adjuvant [2]. Whatever the case, the structure of protein antigen is 
of great importance because it results in the functions of protein. It may also important to stimulate 
an immune response. There is little knowledge about the structure when protein antigen is adsorbed 
by ACA and after it is released, as well as on the stability of adsorbed protein antigens during 
storage and the effect of temperature variation. However, the stability of proteins has become 
recognized as a major problem in the past decades. Denatured and/or aggregated protein will not 
only be therapeutically inactive, but also may cause unpredictable side effects, such as acute 
toxicity [19, 20].  
1.1 Objective of the project 
In order to produce high quality vaccines and manufacture consistently and to well understand 
antigens and vaccines, the study focuses on the structures of model antigens when they are adsorbed 
by aluminium hydroxide and when they are subsequently released. The mechanism of ACA 
enhancement of immune responses is also discussed. The stability of vaccines is investigated during 
storage and temperature variation. And finally, a fast, non-destructive method is also introduced for 
the determination of the residual moisture content and classification of lyophilized allergy vaccines.   
2 Introduction to infrared spectroscopy 
The human eyes only respond to electromagnetic radiation within a range of wavelengths between 
400-700 nm, i. e. the visible spectrum. However, the electromagnetic spectrum extends from the 
extremely short wavelength of gamma radiation to the long wavelength of radio waves. Infrared 
refers to that part of the electromagnetic spectrum between the visible and the microwave regions. 
The infrared region is divided into three regions: near, mid, and far infrared. Near infrared (NIR) 
radiation is in the wavelength range of 780-2500 nm or 12,821- 4,000 cm-1, and the mid-infrared 
(MIR) radiation is in regions from 2500 nm to 25000 nm or 4000- 400 cm-1. MIR chemists prefer to 
use the wavenumber (cm-1) designation, whereas in NIR, most people use wavelength in 
nanometers (nm).  
The NIR radiation was discovered in 1800 by Herschel [21], who separated the electromagnetic 
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spectrum with a glass prism and found that the temperature increased markedly beyond the red, i.e. 
in the region that is called NIR today. Coblentz [22] recorded the first MIR spectrum in 1900, and 
the first commercial IR spectrometer emerged in the 1950s. From then on, MIR spectroscopy has 
been accepted as a research tool and structure-elucidation techniques in the industrial as well as the 
academic environment, especially from the availability of the first commercial Fourier transform 
infrared (FTIR) spectrometer in 1970 [23]. A number of NIR experiments were carried out in the 
early 1920s. The general attitude was that the NIR region was too confusing with many weak bands 
and overlapping peaks of numerous overtone and combination bands. Compared with the MIR 
absorption, NIR features were very weak and because of the overall complexity, baselines were 
hard to define. The seemingly hopeless results led to neglect of NIR. The re-birth of the NIR 
occurred in the early 1970s when Norris coupled a spectrometer to a computer and employed it to 
unravel the reflectance spectra of cereals [24]. In recent years, with the personal computers and new 
optical techniques rapidly developing, NIR spectroscopy has become an indispensable tool for 
academic research and industrial quality control in a wide field of applications ranging from 
chemistry to agriculture and from life science to environmental analysis. More detailed information 
on the applications of NIR spectroscopy in chemistry, polymers and textiles, agricultural and 
foodstuff, medical sciences, industrial process control, as well as pharmaceutical industry can be 
found elsewhere [25, 26]  
2.1 Theory  
Unless stated otherwise, the description of theory is taken from the handbooks or from personal 
experience. The detailed information also can also be found in these books [27-29]. 
NIR and MIR are closely related technologies. Both analyze functional group vibrations of organic 
molecules by monitoring their absorption of radiation as a function of frequency in the infrared 
spectrum [23]. Infrared radiation is absorbed by the sample when the frequency corresponds to its 
molecular vibrational transitions. Molecular vibrations give rise to absorption fundamental bands 
generally located in the MIR range. The NIR region contains adsorption bands corresponding to 
overtone and combinations of fundamental bands. The difference between NIR and MIR is only the 
frequency of these vibrations.  
The frequency of a bond can be approximated by Hooke’s law. In this approximation, two atoms 
and the connecting bond can be treated as a simple harmonic oscillator composed of two atoms 
joined by a spring. According to Hooke’s law, the frequency of the vibration of the spring is related 
to the mass and the force constant of the spring, by the following formula (Eq. 1.1): 
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where ν is the frequency of the vibration; k is the force constant; μ is the reduced mass and can be 
given by: 
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where m and M are masses of atoms. 
In the classical harmonic oscillator, vibrational energy can be given as follow formula: 
 νhE =                                                                               Eq. 1.3 
Where h is Planck’s constant, 6.6 × 10-34 Js.  
However, vibrational motion is quantized, and must follow the rules of quantum mechanics.  
νhnE )
2
1( +=                                                                   Eq. 1.4 
where n  is the quantum number: 0, 1, 2, 3… 
Therefore, the lowest energy level is νhE
2
1
0 = . At ambient temperature, most molecules are at this 
ground level 0E , and the most observed transition is from this level to the next level. The transitions 
with 1=Δn are called fundamental transitions, which match the energy of radiation in the MIR 
region. The occasional transitions with ,2=n  3 , or higher are observed, which are designated as 
‘hot bands’. 
However, a molecule is actually an anharmonic oscillator. Transition with 2Δ=n , 3Δ  or higher are 
possible in this anharmonic oscillator. These correspond to bands called overtones in the NIR 
region.  The vibrational energy levels become more closely spaced with increasing interatomic 
distance in the anharmonic oscillator. The allowed transitions become smaller in terms of energy. 
Thus, overtones can be lower in energy than predicted by the harmonic oscillator theory. The 
energy level can be expressed as following formula: 
,....2,1,0,)
2
1()
2
1( 2 =+−+= nnhvxnhvE                             Eq. 1.5 
where x is the anharmonicity constant, which is from 0.01 to 0.05, and it accounts for dissociation of 
atoms and repulsion between atoms.  
For most chemical bonds the frequency of overtones can be estimated from their fundamental 
vibrations with the anharmonicity constant by following equation: 
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Where xv is frequency of x overtone; 0v is frequency of fundamental vibration; x is the 
anharmonicity constant.  
Combination band appear between 1900 nm to 2500 nm in NIR region. It is the result of 
fundamental vibration interactions, i.e. when the energy of an adsorbed photon is shared by two or 
more fundamental transitions. The frequency of a fundamental band is the sum of multiples of each 
interacting frequency.  
It should be noted that bonds which do not involve hydrogen do not have absorption in NIR region. 
It is because hydrogen atom is the lightest and thus exhibits the largest vibrations and greatest 
deviations from harmonic behaviour. Another reason is that most X-H fundamentals absorb at 
wavelength < 5000 nm, which results in their first overtone appear in NIR region. Some polar 
bonds, However, such as C-O, C=O, and C-F, have intense fundamental bands in the MIR region 
resulting from their absorption at wavelength > 5000 nm. The absorption bands of these bonds in 
the NIR region are very weak and can be neglected due to the intensity loss. NIR absorption bands 
are typically broad, overlapping and 10-100 times weaker than their corresponding fundamental 
MIR absorption bands, since the probabilities of overtone and combination transitions are low. The 
low absorption coefficient in NIR, however, permits high penetration depth, which allows direct 
analysis of strongly absorbing and highly scattering samples and makes sample preparation 
unnecessary.  
Despite their common fundamental basis, the instrumentation used in the two fields has traditionally 
been quite different.  
2.2 Sample presentation 
Sample presentation is one of the important factors affecting measurements using infrared 
spectroscopy. The sample presentation methods for NIR and MIR are different due to the different 
extinction coefficients. NIR cannot be used for trace analysis as the mid-IR. However, this 
disadvantage becomes important when considering process analysis. The strong light source and 
weak absorbance allow NIR radiation to penetrate further into the sample, which make it possible to 
measure intact solid samples. An appropriate sample presentation improves the accuracy, precision 
and sensitivity of the spectroscopic measurements, especially when measuring solid sample due to 
scatter effects. Selecting the sample presentation for infrared spectroscopic analysis mainly depends 
on the physical conditions of samples and target parameters. Although there are some general 
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guidelines for sample presentation, the proper method is a case by case decision. 
2.2.1 NIR sample presentation  
A detailed description of NIR sample presentation can be found elsewhere [26, 30-32].  
Transmittance 
In this case, the light source and the detector are positioned opposite of each other and the incident 
light has to pass through the whole sample to be detected. Therefore, the light intensity should be 
high enough to penetrate the sample, which depends on the absorption coefficient of the sample and 
the sample thickness. In general, it is widely applied for the liquids, solutions, and can also be used 
for suspensions, or some solids such as tablets and capsules. Limitations are observed with very 
thick solid samples [26].  
Diffuse reflectance 
Diffuse reflectance mode is used for solid samples and requires a different spectrometer 
configuration comparing to transmittance mode. The light source and the detector are on the same 
side in an angle of 45 ºC to each other. The configuration minimizes the contribution to 
measurement of the specular reflectance, which contains little information about composition of 
samples. The incident light reaches the surface of the sample. It penetrates some millimeters 
depending on structure, particle size and other properties of the sample. Some light is absorbed by 
the sample and the rest is reflected, but only a part reaches the detector. Therefore, for low 
concentration applications, one can use a larger or multi-channel detector to increase the sensitivity.  
Transflectance 
Transflectance was originally developed by Technicon for the Infraanalyzer, which combines 
transmittance and reflectance. Incident light is transmitted through the sample and then scattered 
back from a reflector, which is normally made of ceramic or aluminium. Since the incident light has 
to pass through the sample twice, the limitations mentioned under transmittance measurements are 
especially relevant. 
Interaction 
In the case of interaction, a fibre optic probe having a concentric outer ring of illuminator and an 
inner portion of receptor is usually used. The end of the probe should be on or near (depends on the 
applications) the surface of the sample. This mode can be used for online analysis. 
2.2.2 MIR sample presentation   
The techniques of MIR sample presentation have been developed allowing the analysis of samples 
in any physical phase: solid, liquid or gas. The most common methods are transmittance 
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experiments with pressed disks; diffuse reflectance experiments with powder samples, and 
attenuated total reflectance (ATR) measurements with aqueous solutions and hydrated suspensions. 
These presentation methods are briefly discussed here focusing on structural analysis of proteins. 
Different methods may not provide the same information about protein structures. Weet and co-
workers [33] demonstrated the effect of sampling methods on the protein conformation. 
Transmittance 
This is the simplest and most common method of FTIR measurement. Solid samples are diluted to 
1-2% in a medium (usually KBr) and made into a disk with a certain pressure. The final sample is a 
thin, clear disk that is placed perpendicular to the infrared beam. Water must be removed from the 
system; thus, samples are heated to remove as must water as possible prior to dilution. Although the 
high-pressure affects the structure of proteins in aqueous solution [34, 35], the current established 
procedures for producing KBr-pellets does not induce protein structural changes [36-38]. For 
sample solution, the spectra can be measured in a special liquid cell with CaF2 windows. The 
pathlength has to be approximately 6 μm to allow for precise subtraction of the strong water band 
around 1640 cm-1 which overlaps the protein amide I bands. Experiments measured in transmission 
can provide quantitative information more easily than other sampling methods, since Beer-Lambert 
Law is directly applicable. The pathlength is known. However, heating samples during water 
removing may lead to structural changes in the sample. 
Diffuse reflectance 
This technique is only suited for powder samples. Measurements can be conducted for raw samples 
(without dilution) or diluted with non-absorbing matrix such as KBr.  Samples do not need to be 
pressed into a disk as measured in transmission, but can be packed directly onto the sample holder. 
This avoids the high-pressure during the pellet preparation. However, samples have to necessarily 
ground with a mortar and pestle to avoid large particles that may distort the spectrum. Regardless of 
the sample preparation, the diffuse reflectance spectra are different from the data which are 
collected in transmission mode experiments. Peak intensities at higher wave number are typically 
compressed, and all peaks tend to be rather rounded compared with sharp peaks from pressed disks. 
This can be solved using a mathematical correction known as the Kubelka-Munk equation, which is 
usually available from the software used to control the FTIR. One thing that has to be noted is that 
samples should be dried and may need to be diluted with a matrix if the absorption is overloaded.  
ATR 
ATR (also called internal reflection element or briefly IRE) is a versatile and powerful technique 
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for MIR sampling. Minimal or no sample preparation is usually required for rapid analysis. ATR is 
ideal for those materials which are strongly absorbing. In addition, ATR is a useful technique for 
providing information about the surface properties or conditions of the material. Materials which 
are either too thick or too strongly absorbing to be analyzed by transmission spectroscopy can be 
routinely analyzed using ATR. With the ATR technique, it is possible to measure a wide range of 
samples. Basic details of ATR are reviewed elsewhere [39, 40]. 
When using ATR, it is important to have the sample in intimate contact with the crystal. For solids, 
it is important to use a pressure device which presses the sample against the crystal. Paste or slurry 
samples are problematic, but the analysis becomes easy when measuring films by evaporating the 
solvent from the samples. The intimate contact is easily achieved with most liquids since they wet 
the surface of the ATR crystal. In addition, a clear advantage of ATR spectra of solutions is the 
reproducibility of the pathlength comparing to the transmission experiments, in which a very thin 
cell (6 μm) is applied to deal with a reasonable absorbance in transmission experiments. Such small 
pathlength is difficult to reproduce with sufficient accuracy. Liquid samples can also be analyzed as 
films by evaporating the solvent, which minimize the effect of water absorption [41].  
The FTIR-ATR spectra depend on the following parameters: wavelength of the incident radiation, 
refractive indices of the internal reflection element and the sample, angle of incidence and 
efficiency of the contact between sample and the crystal.  In particular, strongly distorted spectra 
result from an unwise choice of the incidence angle, from the nature of the internal reflection 
element and from the thickness of the sample (pathlength).   
Since the ATR spectra depend on the refractive index, the spectra may be distinctly different from 
the absorption bands. How much the band shapes and intensities are different from absorption 
spectra depend on the experimental conditions. However, these differences are due to the particular 
nature of the reflection spectrum and should not be confused with distortion of a true spectrum. 
Furthermore, it is a possibility to quantify concentrations even for components which are not 
absorbing within the spectral range of investigation [42]. A disadvantage, which should be noted, is 
that the spectrum may be affected by the adsorption by the ATR crystal [43] and the anomalous 
dispersion of sample on the surface of ATR [44, 45].  
2.3 Quantitative analysis using infrared spectroscopy 
In transmission mode, the basic theory of quantitative analysis results from the Beer-Lambert Law 
(Eq. 1.7). It says that the absorbance of a homogeneous sample (with an extinction coefficientε ) is 
proportional to the concentration c and pathlength l. The law is defined only for transmittance 
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measurements on homogeneous samples using data that has been corrected for non-absorption 
effects. 
clTA ε== )/1log(                                                                       Eq. 1.7 
The theory of reflectance is not clear, because people have not found a way to determine the 
pathlength followed by the radiation energy in the sample. In addition, we do not yet have a good 
model for the way radiation interacts with the sample at particle interfaces. What we know is that 
reflection is non-linear with respect to the constituent concentrations. However, even though the 
theory of reflectance is not clear, it is widely applied in infrared spectroscopic measurements.  
3 Introduction to Chemometics  
Infrared spectra are typically composed of broad overlapping bands, and the absorption bands 
contain both chemical and physical information of all sample components. The interesting 
information is always multivariate in nature, and thus, hardly selective [46]. The spectral data 
always contain more variables than samples and have correlated variables. The classical multiple 
linear regressions are not suitable in this case [47]. Therefore, Cheometrics (also known as 
multivariate data analysis, MVA) is required to extract useful information and reduce the irrelevant 
information. Cheometrics can be defined as the development and application of mathematical and 
statistical methods to extract useful chemical information from chemical measurements [48, 49]. 
Chemometircs was emerged in the late of 1960s and developed during 1970s and was introduced to 
spectroscopic data in this period [49]. The whole idea of chemometrics is that the data contain 
redundant information and can be reduced substantially. The reduced data are easier to understand 
and have more stability and residuals contain noise and less useful information [50]. The new latent 
variables in the reduced data set provide an overview of the main variation in the raw data. The 
outliers can be identified and the noise can be separated from the signal as well [51].  
In the following sections, the basic methods of Chemometrics and some methods for pre- treatments 
of mathematical data are briefly introduced. These methods are used throughout this work for 
analysis of NIR and MIR spectroscopic data.  
3.1 Data pre-treatment 
Visualization of data has always been very important in Chemometrics and it is impossible to 
discuss Chemometrics without showing plots of data [50].  However, raw data often need prior 
treatment to mathematically remove defects due to light scattering, path length variations and 
random noise. Careful selection of the method of pre-treatments can significantly improve the 
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robustness of the final calibration model. The most commonly used methods in this thesis are 
briefly discussed with respect to the effect they are able to correct. The detailed description is 
available in textbooks [52] and in the introduction to the Unscrambler software.  
Standard normal variate (SNV) 
SNV removes the multiplicative interference of scatter and particle size. The method removes slope 
variations for individual spectra. Each spectrum is transformed independently as the function of: 
∑ −−
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snvi                                                             Eq. 1.8 
Where, xi,snv  is the transformed spectrum; xi is the original spectral; x is the average value of the 
variable; and n is the number of the variables in the spectrum. In other words, SNV transformation 
is row centring followed by row scaling [53].  
Multiplicative scatter correction (MSC) 
MSC is used to correct for the significant light scattering problems. It is used based on the 
assumption that all samples have same scatter coefficient for all variables. A mean spectrum of the 
dataset is applied to estimate the scatter of the spectra. Other spectra are corrected to have the same 
scatter level as this mean spectrum. Each spectrum is shifted and rotated to fit as closely as possible 
to the mean spectrum. The fit for each spectrum is obtained by least squares as the following 
function:  
iiiii xbax ε++= 1                                                                        Eq. 1.9  
Where, xi is individual spectrum. ix is the mean spectrum of the dataset, and iε  is the residual 
spectrum, which ideally represents the chemical information in the spectrum. The fitted constants ai 
(offset, intercept) and bi (slope) are used to correct each value of the spectrum i (Eq. 1.10) and they 
reflects additive and multiplicative light scattering effects, respectively.  
i
ii
MSCi b
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                                                                                Eq. 1.10  
A disadvantage of MSC is that the obtained parameters may be affected by the chemical variations, 
since the mean spectrum is simply used as the ideal chemical spectrum.  
Extended multiplicative scatter correction (EMSC) 
This method is an extension to conventional MSC and is used to remove unwanted physical 
information resulting from light scattering, pathlength variations, and baseline drifts [54]. It allows 
a separation of physical light scattering effects from chemical light absorbance in the spectra. The 
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sample spectra are expressed as ideal chemical spectra modified by various physical effects. In the 
case of EMSC, Eq. 1.9 is extended with correction for linear and quadratic wavelength effects, i. e. 
the wavelength-dependent scatters. It is given in Eq. 1.11, where λ represents the wavelength range; 
chemix ,  is the ideal chemical spectrum.  
 Eq. 1.11 
 
The parameters in Eq. 1.11 are used to correct each value of the spectrum using Eq. 1.12. The 
baseline and pathlength variations as well as wavelength-dependent spectral effect will be removed, 
yielding corrected spectra with only chemical absorbance information left. 
iiiiicorrectedi bedaxx /)1(
2
, λλ −−−=                                         Eq. 1.12 
Derivatives 
Derivatives have been described in detail by Mark and Workman [55-58]. They are an approach to 
addressing two of the basic problems with infrared spectra: overlapping peaks and removing large 
baseline shifts. Derivatives are used for MIR spectra as a resolution-enhancement method (see 
Chapter II, III, and IV). The effect of derivatives is most clearly seen with the second derivative of a 
spectrum, which is able to separate overlapping absorption bands because it is slated to curvature 
and has the same sign as the curvature of a spectrum. Second derivative can be used to remove the 
baseline shifts, because the curvature of a straight line is zero, the derivative of a spectrum-plus-a-
straight-line-baseline will be the same as the derivative of the spectrum. The first derivative also has 
these two effects, but to a lesser extent, and has a geometric interpretation as the slope of the 
spectrum at each wavelength. Higher-order derivatives have the same two basic functions as second 
derivative, and will resolve overlapping adsorption bands more effectively than the lower-order 
derivatives. They will remove gently curved background as well as linear background shifts. 
However, they are more sensitive to noise and generate more artefacts than the lower-order 
derivatives. Higher-order derivatives do not easily give rise to get visual geometric interpretation 
and have not been widely applied in infrared spectra. They have not been shown to give great 
advantages in calibration or validation.  
There are three common methods to calculate derivatives: Savitzky-Golay, finite-difference, and 
Fourier transform. The Savitzky-Golay method fits the spectrum with a polynomial and then takes 
the derivative of that polynomial. It is most useful with very sharp absorption bands and with high 
noise spectra.  
The drawback of the derivative is that it amplifies noise. Therefore, sometimes, it is necessary to 
ichemiiiiii xbedax ελλ ++++= ,21
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smooth the data beforehand.  
Smoothing  
Smoothing is used to reduce the noise in the data. Savitzky-Golay is an averaging algorithm that fits 
a polynomial to the data points. The value to be averaged is then predicted from this polynomial 
equation. The number of variables or points has to be chosen in the averaging segment. If the 
variable number in the segment is large, it will give a smoother shape to the sample, but if the 
segment is too large, sharp peaks may be removed and the remaining bands are distorted [59]. It 
should be noted that after the operation the data will be slightly truncated at both ends. If n is the 
number of variables in the averaging segment, the first and last n variables will be zero. The order 
of the polynomial to be fitted is also important. Typically, a second- or third-order polynomial is 
used [58]. A second-polynomial means that a second-degree equation will be used to fit the data 
points.   
Normalization 
Normalization is used to get all data in approximately the same scaling or to get a more even 
distribution of the variances and the average values. Normalization of a sample is accomplished by 
dividing each variable by a constant. It reduces systematic variation, but normalization may remove 
important concentration information.  
It is a row-oriented transformation, that is to say the contents of a cell are likely to be influenced by 
its horizontal neighbours. There are three types of normalization: 1) mean normalization; 
2) maximum normalization; 3) range normalization. Mean normalization is the standard 
normalization. Maximum normalization is a normalization that “polarizes” the spectra. The peaks of 
all spectra with positive values touch +1, while spectra with values of both signs touch -1. Range 
normalization involves scaling all samples to a common range, for example between 0 and +1. Thus 
each axis in a plot of range-scaled data is adjusted such that the data fill the region of the plot in all 
directions.  
Baseline transformation 
Baseline transformation includes baseline offset and linear baseline correction. The formula for the 
baseline offset can be written as in Eq. 1.13, where xi is a variable and X denotes all selected 
variables for a spectrum. For each sample, the value of the lowest point in the spectrum is 
subtracted from all the variables. The result of this is that the minimum value is set as zero and the 
rest are positive values. 
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)min(, Xxx ioffseti −=                                                               Eq. 1.13 
Linear baseline correction transforms a sloped baseline into a horizontal baseline. The technique is 
performed by pointing out two variables which are set as zero and as a new baseline. The rest of the 
variables are transformed according to this with linear interpolation or extrapolation.   
3.2 Principal component analysis (PCA) 
The further details of PCA are available elsewhere [50, 60-62]. A brief introduction is given here 
based on spectral data. PCA is the basis of multivariate data analysis. The most important use of 
PCA is to represent a multivariate data set as a low dimensional space to find interesting 
phenomena, often without prior knowledge. As a result, outliers, clustering of objects and gradients 
between clusters may be detected [50].  
PCA is a mathematical procedure that resolves the data into orthogonal components whose linear 
combination approximates the original data. The original data matrix X, consisting of i spectra and 
each spectrum having j variables (data-points), is described by two smaller matrices called score T 
(i, R) and loading P (j, R) as shown in Eq. 1.14. R is the principal components (PCs) of the PCA 
model, which expresses the complexity of the observed variations in the data. The matrices T and P 
can be calculated by nonlinear iterative partial least square (NIPALS). The matrix E (i, j) consists of 
the difference between the values in the data matrix and the values obtained from the multiplication 
of T and LT. It is called residual matrix or error matrix [63].   
ETPX T +=                                                                            Eq. 1.14 
The obtained scores and loadings can be used in scores plots that allow an efficient interpretation of 
the whole data space [50].To discriminate several different materials, score vectors are plotted 
against each other. If the vectors form different clusters which are clearly separated from each 
other, identification is possible.  
3.3 Multivariate calibration for quantitative analysis 
The PCs from the PCA are found by successively reducing the residual sums of squares of X (e.g. 
NIR spectra) with no consideration to interest Y (e.g. concentration); there is no predictive 
optimality that will subsequently be used for regression onto Y. Thus, PCA cannot be used for 
quantitative analysis. The multivariate calibration methods most frequently used in quantitative 
analysis are principal component regression (PCR) and partial least squares regression (PLSR) [64]. 
They are the most successful applications of the combinations of Chemometrics with spectral data 
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[50]. PCR uses the PCs provide by PCA to perform regression on sample property. PLS finds the 
direction of greatest variability by comparing both spectral (X) and target property (Y) information 
with the new axes, called PLS components or PLS factors. The main difference between these two 
methods is that the first PC or factor. In PCR, the first factor represents the largest variations in the 
spectrum, whereas in PLS it presents the most relevant variations showing the best correlation with 
the target property. Therefore, to reach an ideal regression model, PCR needs more PCs than PLS.  
PLS relates two data matrices, X and Y, to each other by a linear multivariate model. It models both 
X and Y matrices simultaneously to find latent variables in X that will predict the latent variables in 
Y. No direct closed mathematical description can be made for PLSR [65], but it may be simply 
given in Eq. 1.15. B is the regression coefficients, which is helpful in spectroscopic analyses and 
band assignment [66]. The detailed algorithm of PLS can found elsewhere [67].  
FXBY +=                                                                        Eq. 1.15 
3.4 Soft independent modelling of class analogy (SIMCA) 
The detailed theory of SIMCA has already been extensively discussed by others [67-69]. The idea 
behind this method is that objects in one class or group show similar behaviour and this approach 
allows the objects to display intrinsic individualities as well as their common patterns, but only 
common properties of the class are modelled. SIMCA is based on making a PCA model for each 
class in the training set. Each class is modelled separately with a certain number of significant PCs. 
The number of PCs is normally selected by cross-validation automatically. This can be described in 
Eq. 1.16 for one class or group (c) [69].  
)()()( ijc
T
jRciRccc EPTXX ++=                                                         Eq. 1.16 
Where cX  is the mean centred data matrix, )(iRcT  is the score matrix obtained for i objects and R 
selected PCs. T jRcP )( is the loading matrix obtained for R selected PCs and j variables and )(ijcE  is the 
residual matrix.  
After the PCA models have been contrasted, the distances between classes e.g. RMSE(X)c can be 
calculated as in Eq. 1.17, and also the distance from an object to the specified class e.g. RMSE(X)i,c 
can be calculated as in Eq. 1.18.   
∑= }/)({)( 2, NXRMSEXRMSE cic                                         Eq. 1.17 
)}/({)( ' ,,,,, RjeeXRMSE RciRcici −=                                           Eq. 1.18 
Where, RMSE is the root-mean-square average. N is the sample size of class c. R is the selected 
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PCs, and j is the number of variables of X, The X-residual vector is ei,cR.  
The class modes are cross-classified and evaluated. Then a new unknown sample can be classified 
by checking if it falls inside the boundaries of any class models and assigned to classes according to 
its analogy to the training samples. The detailed methodology of SIMCA is described in [68]. 
  17
      References  
  
1. http://www.vaclib.org/news/vaccinelicense.htm Feb. 2006. 
2. Guideline on adjuvants in vaccines for human use. The European Medicines Agency. 
http://www.emea.eu.int. Feb. 2006.  
3. Grzela K, Lazarczyk M, Dziunycz P, Milewski L, Niderla J, Grzela T. Molecular therapy 
versus standard treatment in allergy. International Journal of Molecular Medicine, 2004; 
14:3-22. 
4. Bousquet J, Lockey RF, Malling HJ. WHO position paper. Allergen immunotherapy: 
therapeutic vaccines for allergic diseases. Allergy 1998; 53: 1-43. 
5. Noon L. Prophylactic inoculation against hay fever. Lancet, 1911; 1:1572-1573. 
6. Rogan D, Babiuk LA. Animal health: biologics/biopharmaceutics- novel vaccines from 
biotechnology. Revue Scientifique et Technique – Office International des Epizooties, 2005; 
24: 159-174. 
7. Matheis W, Zott A, Schwanig M. The role of the adsorption process for production and 
control combined adsorbed vaccines, Vaccine, 2000; 20: 67-73. 
8. Gupta RK, Siber GR.  Adjuvants for human vaccines—current status, problems and future 
prospects, Vaccine, 1995; 14: 1263-1276. 
9. Goldsby RA, Kindt TJ, Osborne BA, Kuby J. Immunology, 5th edition, W.H. Freeman 
Company. New York, 2003, p66 
10. Glenny AT, Pope CG, Waddington H, Wallace UJ. The antigen value of toxoid precipitated 
by potassium alum, Journal of Pathology and Bacteriology, 1926; 29:31-40. 
11. Gupta RK, Rost BE, Relyveld E, Siber GR. Adjuvant properties of aluminium and calcium 
compounds. In: Powell MF, Newman MJ, editors. Vaccine design: the subunit and adjuvant 
approach. New York: Plenum Press, 1995, p229-148. 
12. Lindblad EB, Aluminium adjuvants—in the retrospect and prospect, Vaccine, 2004; 22: 
3658-3668. 
13. Shirodkar S, Hutchinson RL, Perry DL, White JL, Hem SL. Aluminium compounds used as 
adjuvants in vaccines, Pharmaceutical Research, 1990; 7: 1282-1288. 
14. Morten JM, Rasmus LK. Adsorption of proteolytic enzymes to the adjuvant aluminium 
hydroxide, Master’s thesis, BioCentrum-DTU, 2005. 
  18
15. Jones LS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR. Effect of adsorption to 
aluminium salt adjuvants on the structure and stability of model protein antigens. The 
Journal of Biological Chemistry, 2005: 280: 13406-13414. 
16. HogenEsch H. Mechanisms of stimulation of the immune response by aluminium adjuvants, 
Vaccine, 2002; 20: 34-39. 
17. Cox JC, Coulter AR. Adjuvants—a classification and review of their modes of action, 
Vaccine, 1997; 15: 248-256. 
18. Alexander J, Brewer JM, Adjuvants and their modes of action, Livestock Production 
Science, 1995; 42: 153-162.  
19. Weet MVD, Hennink W, Jiskoot W. Protein instability in poly (lactic-co-glycolic acid) 
microparticles. Pharmaceutical Research, 2000; 17: 1159-1167.  
20. Cleland JL, Powell MF, Shire SJ. The development of stable protein formulations: a close 
look at protein aggregation, deamidation, and oxidation. Critical Reviews in Therapeutic 
Drug Carrier System, 1993; 10: 307-377. 
21. Pasquini C. Near infrared spectroscopy: fundamentals, practical aspects and analytical 
applications. Journal of the Brazilian chemical Society, 2003; 14: 198-219.  
22. Burns DA. Historical development. In: Burns DA. Ciurczak EW (Eds.), Handbook of near-
infrared analysis. Marcel Dekker Inc. New York, 1992, p 1-6. 
23. Doyle WM. Near-IR and mid-IR process analysis – a critical comparison. Axiom Analytical 
Inc. www.gozxiom.com/an_911.html.  
24. Williams PC, Norris KH, Zarowski WS. Influence of temperature on estimation of protein 
and moisture in wheat by near-infrared reflectance. Cereal Chemistry, 1982; 59: 473-480. 
25. Siesler HW, Ozaki Y. Kawata S, Heise HM (Eds.). Near-infrared spectroscopy: principles, 
instruments, Applications.WILEY-VCH Verlag GmbH, Germany, 2002 p179-328.  
26. Reich G. Near-infrared spectroscopy and imaging: basic principles and pharmaceutical 
applications. Advanced Drug Delivery Reviews 2005; 57: 1109-1143.  
27. Bokobza L. Origin of near-infrared absorption bands. In: Siesler HW, Ozaki Y. Kawata S, 
Heise HM (Eds.), Near-infrared spectroscopy: principles, instruments, applications. 
WILEY-VCH Verlag GmbH, Germany, 2002, p11-41. 
28. Olinger JM, Griffiths PR, Burger T. Theory of diffuses reflection in the NIR region, in: 
Burns DA, Ciurczak EW. (Eds.), Handbook of near-infrared analysis, 2nd edition, Marcel 
Dekker Inc., New York, 2001, pp 75-84. 
  19
29. Osborne BG, Fearn T, Hindle PH. Practical NIR spectroscopy with applications in food and 
beverage analysis. Longman Scientific & Technical. Harlow, England, 1993, p13-35. 
30. Kawano S. Sampling and sample presentation. in: Siesler HW, Ozaki Y. Kawata S, Heise 
HM (Eds.). Near-infrared spectroscopy: principles, instruments, Applications.WILEY-VCH 
Verlag GmbH, Germany, 2002, p115-124. 
31. Sukowski L. NIR based process analytical technology: In-line residual moisture 
determination for a complete batch inspection of lyophilized end-products. PhD thesis, 
University of Basel, Deutschland, 2003. 
32. Pasquini C. Near infrared spectroscopy: fundamentals, practical aspects and analytical 
applications. Journal of the Brazilian Chemical Society, 2003; 14: 198-219. 
33. Weet MVD, Haris PI, Hennink WE, Crommelin DJA. Fourier Transform infrared 
spectrometric analysis of protein conformation: effect of sampling method and stress factors. 
Analytical Biochemistry, 2001; 297: 160-169. 
34. Prehoda KE, Mooberry ES, Markley JL. Pressure denaturation of proteins: evaluation of 
compressibility effects. Biochemistry, 1998; 37: 5785-5790. 
35. Tanaka N, Nishizawa H, Kunugi S. Structure of pressure-induced denatured state of human 
serum albumin: a comparison with the intermediate in urea-induced denaturation. 
Biochimica et Biophysica Acta, 1997; 1338: 13-20. 
36. Carpenter JF, Prestrelski SJ, Arakawa T. Separation of freezing- and drying-induced 
denaturation of lyophilized proteins using stress-specific stabilization. I:  enzyme activity 
and calorimetric studies. Archives of Biochemistry and Biophysics, 1993; 303: 456-464. 
37. Costantino HR, Nguyen TH, Hsu CC. Fourier-transform infrared spectroscopy demonstrates 
that lyophilization alters the secondary structure of recombinant human growth hormone. 
Journal of Pharmaceutical Sciences, 1996; 2: 229-232. 
38. Costantino HR, Carrasquillo KG, Cordero RA, Mummenthaler M, Hsu CC, Griebenow K. 
The effect of excipients on the structure and stability of lyophilized recombinant human 
growth hormone. Journal of Pharmaceutical Sciences, 1998; 87: 1412-1420. 
39. Goormaghtigh E, Raussens V, Ruysschaer JM. Attenuated total reflection infrared 
spectroscopy of proteins and lipids in biological membranes. Biochimica et Biophysica 
Acta, 1999; 1422: 105-185. 
40. Chittur KK. FTIR/ATR for protein adsorption to biomaterial surfaces. Biomaterials, 1998; 
19: 375-369. 
  20
41. de Jongh HHJ, Goormaghtigh E, Ruysschaert JM. The different molar absorptivities of the 
secondary structure types in the amide I region: an attenuated total reflection infrared study 
on globular proteins. Analytical Biochemistry, 1996; 242: 95-103.  
42. Muller G, Abraham K, Schaldach M. Quantitative ATR spectroscopy: some basic 
considerations, Applied Optics, 1981; 20: 1182-1190. 
43. Oberg KA, Fink AL. A new attenuated total reflectance Fourier transform infrared 
spectroscopy method for the study of proteins in solution. Analytical Biochemistry, 1988; 
256: 92-106. 
44. Hancer M, Sperline RP, Miller JD. Anomalous dispersion effects in the IR-ATR 
spectroscopy of water. Applied Spectroscopy, 2000; 54: 138-143. 
45. Max JJ, Chapados C. Influence of anomalous dispersion on the ATR spectra of aqueous 
solutions. Applied Spectroscopy, 1999; 53: 1045-1053. 
46. Reich G. Near-infrared spectroscopy and imagine: Basic principles and pharmaceutical 
applications. Advanced Drug Delivery Reviews, 2005; 57: 1109-1143. 
47. Murry I. Scattering information: philosophy and practice of near infrared spectroscopy. In: 
Davies AMC, Garrido-Varo A (Eds.) Near infrared spectroscopy: proceedings of the 11th 
international conference. NIR publications, Chichester, England, 2004. pp 1-12. 
48. Barton FE, Kays SE. Analytical application to fibrous foods and commodities. In: Williams 
P, Norris K (Eds.), Near-infrared technology in the agricultural and food industries. 
American Association of Cereal Chemists, Inc. St. Paul, Minnesota, USA. 2001, p215-231. 
49. Martens H, Martens M. Multivariate analysis of quality; an introduction. John Wiley & 
Sons, LTD. 2001, p3-23.  
50. Geladi P. Chemometrics in spectroscopy. Part 1: Classical chemometrics. Spectrochimica 
Acta Part B, 2003; 58: 767-782. 
51. Wold S. Sjostrom M. Eriksson L. PLS-regression: a basic tool of chemometrics. 
Chemometrics and Intelligent Laboratory System, 2001; 58: 109-130. 
52. Hesise HM, Winzen R. Chemometrics in Near-infrared spectroscopy, in: Siesler HW, Ozaki 
Y. Kawata S, Heise HM (Eds.). Near-infrared spectroscopy: principles, instruments, 
Applications.WILEY-VCH Verlag GmbH, Germany, 2002, p125-162. 
53. Pravdova V, Walczak B, Massart DL, Kawano S, Toyoda K, Tsenkova R. Calibration of 
somatic cell count in milk based on NIR spectroscopy. Analytica Chimica Acta, 2001; 450: 
131-141. 
  21
54. Martens H, Nielsen JP, Engelsen SB. Light scattering and light absorbance separated by 
extended multiplicative signal correction. Application to near-infrared transmission analysis 
of powder mixture. Analytical Chemistry, 2003; 75: 394-404. 
55. Mark H., Workman JJ. Derivatives in spectroscopy Part I- The behavior of Derivative. 
Spectroscopy 2003; 4: 32-37. 
56. Mark H., Workman JJ. Derivatives in spectroscopy Part II- the true derivative. Spectroscopy 
2003; 9: 25-28. 
57. Mark H., Workman JJ. Derivatives in spectroscopy Part III- Computing the derivative. 
Spectroscopy 2003; 12: 106-111. 
58. Mark H., Workman JJ. Derivatives in spectroscopy Part IV-Calibrating with derivatives. 
Spectroscopy 2004, 1: 44-51. 
59. Beebe K, Pell RJ, Seasholts MB. Chemometrics: A practical guide. John Wiley & Sons, 
INC. New York, 1998; p 33. 
60. Martens H, Martens M. Multivariate analysis of quality. An introduction. John Wiley & 
Sons, LTD. 2001, p93-109. 
61. Howard M. Data analysis: multilinear regression and principal component analysis, in: 
Burns DA, Ciurczak EW (Eds.), Handbook of near-infrared analysis, 2nd edition, Marcel 
Dekker Inc., New York/Basel, 2001, p 129-184. 
62. Esbensen KH, Multivariate data analysis --in practice. 4th edition, CAMO ASA, 2000, p19-
97. 
63. Kramer K, Ebel S. Application of NIR reflectance spectroscopy for the identification of 
pharmaceutical excipients, Analytical chimica Acta, 2000; 420: 155-161. 
64. Naes T, Isaksson T, Fearn T, Davies T. A user friendly guide to multivariate calibration and 
classification. NIR publication, Chichester, 2002, 27-54. 
65. Andersson CA. Exploratory multivariate data analysis with applications in food technology. 
PhD thesis, the Royal Veterinary and Agricultural University, Denmark. 2000, 15-16. 
66. Šašić S, Ozaki Y. Band assignment of near-infrared spectra of milk by use of partial least-
squares regression. Applied Spectroscopy, 2000; 54: 1327-1338. 
67. Esbensen KH. Multivariate data analysis – in practice: an introduction to multivariate data 
analysis and experimental design. 5th Edition. CAMO ASA/ CAMO Process AS. 2001; 
p145. 
  22
68. Martens H, Martens M. Multivariate analysis of quality: an introduction. John Wiley & 
Sons, Ltd. England, 2001; p163-169. 
69. Candolfi A, Maesschalck, Massart DL, Hailey PA, Harrington ACE. Identification of 
pharmaceutical excipients using NIR spectroscopy and SIMCA. Journal of Pharmaceutical 
and Biomedical Analysis, 1999; 19: 923-935. 
  23
Chapter II: Protein structure and protein structure analysis 
 
This chapter briefly introduces protein structures and the methods used for protein structure 
analysis. The main focus of the chapter is on protein structures when adsorbed onto surfaces and 
FTIR spectroscopy. 
1 Protein structures 
The primary structure of a segment of a polypeptide chain or of a protein is the amino-acid 
sequence of the polypeptide chain, without regard to spatial arrangement [1]. The secondary 
structure of a segment of polypeptide chain is the local spatial arrangement of its main-chain atoms 
without regard to the conformation of its side chains or to its relationship with other segments [1]. 
The secondary structures are formed through certain patterns of hydrogen bonding of the peptide 
backbone. There are three common secondary structures in proteins, namely α-helix, β-sheet, and 
turns. Those segments, which cannot be classified as one of the standard three classes is usually 
grouped into a category called ‘other’ or ‘random coil’ [1].  
 
 
 
 
 
 
 
 
Fig. 2.1 The secondary structures of protein: A, α-helix; B, β-sheet; and C, turns [2, 3].  
 
The α-helix is characterized by hydrogen bonds along the chain, almost co-axial (Fig. 2.1A) [2]. An 
α-helix is an element of secondary structure adopting a right handed helical conformation with 
approximately 3.6 residues per turn. In a perfect α-helix, there is a repeating pattern of hydrogen 
bonds from the carbonyl oxygen of residue i to the amide hydrogen of residue i+4. Favourable 
dipole interactions stabilize the α-helix. Side chains that are perpendicular to the helix axis may 
interact with each other, which also stabilize the helix structure. Another helix structure which is 
called 310 helix has entirely different hydrogen bonding pattern, i. e. from i to i+3. It accounts about 
12% of all protein helices. Beta-sheet is composed of two or more different regions of stretches of 
A B C 
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at least 5 to 10 amino acids, which are stabilized by hydrogen bonds crossing between chains (Fig. 
2.1B) [2]. Beta-sheets include parallel and anti-parallel forms and also the mixture of both β-sheets.  
In parallel sheets adjacent peptide chains proceed in the same direction; i.e. the direction of N-
terminal to C-terminal is the same. In anti-parallel sheets adjacent chains are aligned in opposite 
directions. The third type of secondary structures is turns. Turns involve 4 amino acid residues 
which form a loop. A hydrogen bond is formed between the carbonyl oxygen of residue i and the 
amide nitrogen of i+3 (Fig. 2.1C) [3].  
The tertiary structure of a protein molecule is the arrangement of all its atoms in space, without 
regards to its relationship with neighbouring molecules. The quaternary structure of a protein 
molecule is the arrangement of its subunits in space and the ensemble of its inter-subunit contacts 
and interactions, without regards to the internal geometry of the subunits.  
2 Protein structure analysis 
Protein structure analysis has gained increasing interests in recent years. The information of protein 
structures is important for the understanding of protein function and facilitates pharmaceutical drug 
development [4]. The function and activity of proteins depends on their three-dimensional (3D) 
structure. However, the 3D structures of proteins do not only depend on the protein molecules 
themselves, but result from van der Walls, electrostatic and hydrophobic interactions between the 
various amino acids residues and surrounding molecules, as well as the formation of hydrogen and 
disulfide bonds [5]. Protein molecules are amphoteric, i.e. they contain both acidic and basic 
moieties, and they are amphiphilic molecules, i.e. they contain both hydrophilic and hydrophobic 
moieties. This chemical character causes proteins to be easily adsorbed by a wide rage of different 
surfaces.  
The adsorption of proteins by material surfaces is not only a fundamental phenomenon but is also a 
key to several important and novel applications. For examples, the applications of protein 
purification and protein analysis by chromatography rely on the protein adsorption [6, 7]. Protein 
adsorption is the first step in the integration of an implanted material with tissue [8]. The adsorption 
of serum proteins can influence the adhesion of leukocytes, macrophages or platelets, and 
ultimately lead to fibrous encapsulation [9].  In pharmaceuticals, vaccines are formulated by protein 
antigens adsorbed onto adjuvants to enhance the immune response. Several reviews are available on 
physicochemical aspects of the adsorption of proteins onto biomaterials [10-12]. The structure of 
protein is often thought to be changed after they are adsorbed by biomaterial surface. The protein-
surfaces interaction involves a large number of dynamic steps, e.g., transport (diffusion) of proteins 
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toward to the surface, reversible attachment, structural rearrangement, irreversible adsorption, and 
desorption from the surfaces of adsorbents [13-15].  Direct observation of protein-surface 
interaction is presently impossible [5], but progress has been made toward determining protein 
structure on a surface and useful structural information can be obtained. Many available techniques 
have been introduced [16]. A number of common methods are briefly discussed in this thesis with 
regard to the advantages, limitations, sample requirements and especially the application of 
measurement of protein adsorption by adsorbents.  
X-ray crystallography 
This method yields information on the three-dimensional structure of protein molecules [17-19]. 
However, the main challenges of this method are to form a well ordered single crystals and pure 
protein is required, thus, it is not suitable to study the structure of the adsorbed protein, since a two-
dimensional crystal is difficult to obtain [20]. Furthermore, a question arises as to whether the 
relatively ‘static’ structure in single crystal adequately represents the protein conformation in a 
complex and dynamic environment. Moreover, data interpretation is also complex and time-
consuming.  
Multidimensional nuclear magnetic resonance (NMR) spectroscopy 
This is another method which can provide full three-dimensional structural determination [21, 22]. 
NMR is used for measuring sample in solution; the concentration of protein is normally from 2 to 
20 mg/ml. This technique is only suitable for the small proteins (~15-30 kDa), since interpretation 
of the NMR spectra of large proteins is very complex, and the assignment of inter-proton distances 
generated by the NMR experiment is not always feasible [23]. The method for the study of 
adsorbed proteins is also severely limited by experimental difficulties; only a few applications have 
been reported on protein structural changes and the adsorption of protein on a solid interface [24, 
25].  
Circular Dischroism (CD) spectroscopy 
This is a good method to monitor the secondary and tertiary structure of proteins in solution [26, 
27]. Far-UV CD (170-250 nm) spectroscopy is a good tool to obtain overall information on the 
secondary structure, i.e., the relative amount of α-helix, β-sheet, turns and random coil. The amount 
of α-helix or β-sheet can be estimated after fitting the Far-UV CD spectra to the corresponding 
spectra with known secondary structures [28]. The tertiary structure can be measured using near-
UV CD spectroscopy (250 -300 nm), where the spectral characteristics of the aromatic amino acids 
are dependent on solvent exposure. Since the aromatic residues tryptophan and tyrosine are also 
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fluorescent, near-UV CD spectroscopy is complementary to the intrinsic fluorescence spectroscopy.  
CD spectroscopy has been applied to study the conformation of adsorbed protein both on colloidal 
suspension adsorbent and solid macroscopic interfaces. Usually, concentrations of protein in the 
range of 0.05 to 1mg/ml are used [25]. The particles of adsorbents should not significantly absorb in 
the UV band and should have a refractive index that is close to that of water. 
Circular dichroism together with fluorescence spectrometry and Fourier transform infrared 
spectroscopy, which will be introduced later, provide global insight into the overall secondary 
structure of proteins without being able to establish a precise three-dimensional structure.  
Fluorescence spectrometry:  
Steady state fluorescence and quenching of fluorescence are useful tools for determination of 
secondary and tertiary structure [29-31], although one should be aware that these methods only 
reflect local changes in the environments of the fluorophore.  Most measurements focus on the 
fluorescent amino acid residue, tryptophan. Tyrosine and phenylalanine can also be measured; 
however, the intensity is often low.  Some proteins contain either no or many trytophan residues, 
thus limiting its use to provide detailed structural information. Fluorescence spectroscopy is not 
necessarily restricted to the fluorescence of intrinsic fluorophores. Specific residues on the protein 
can be labeled with a fluorescent group [32], but this modification of a protein may lead to 
structural change. For intrinsic fluorescence measurements, the concentration of protein is usually 
above 50 μg/ml. 
Fluorescence spectroscopy can be used to measure the system in which suspended adsorbent 
particles provide an interface for protein adsorption [32, 33]. In contrast to CD, the wavelengths 
used are higher and the concentration of protein and adsorbent used are lower. This drastically 
reduces the effect of light scattering in fluorescence spectroscopy compared to CD spectroscopy. In 
addition, fluorescence spectroscopy is more sensitive than CD spectroscopy.  
3 Protein structure determination using Fourier transforms infrared spectroscopy 
(FTIR) 
The application of FTIR spectroscopy to protein analysis is based on the assessment of the amide 
bands. FTIR is a good method to determine the secondary structure of globular proteins [34-36]. 
Kumosinski et al. [37] demonstrated that the secondary structures of 14 proteins from FTIR 
spectroscopy was in excellent agreement with the values calculated from X-ray crystallographic 
data. Structural analysis using FTIR offers many advantages over other spectroscopy techniques. 
The major advantage is the lack of dependence on the physical state of the sample. Samples may be 
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gas, aqueous or organic solution, hydrated film, inhomogeneous suspension, or solid. The use of 
FTIR spectroscopy to analyze the structure of proteins has been extensively reviewed [36, 38-41]. 
FTIR is particularly suitable for the analysis of adsorbed proteins [42, 43]. It was applied to track 
the loss of secondary structure during insulin unfolding on a model lipid-water interface [44], 
proteins adsorb to silica surfaces [45-47], different clay surfaces [48], oil-water interface [49], air-
water interface [50], and brushite [51]. The conformation of adsorbed protein depends on properties 
of the surface.  
3.1 FTIR spectrum of protein 
FTIR absorption bands are particularly sensitive to bond angles and hydrogen bands, theoretically, 
any specific alteration, peak shifts or intensity change, is caused by the changes in secondary 
structure of protein. Each type of secondary structure is thought to absorb at a specific frequency in 
FTIR spectrum [38]. The amide groups of polypeptides or proteins exhibit nine vibrational modes 
in the infrared region, giving rise to the amide bands A, B, and I-VII [40, 52]. However, due to the 
very low intensities, the amide IV-VII bands are not important in mid-infrared region. Only the 
amide I, amide II and amide III can be applied to determine secondary structure of proteins [53]. 
Amide I 
The amide I vibration present as an infrared band from 1600 to 1700 cm-1, around 1650 cm-1, arises 
mainly from the C=O stretching vibration with minor contributions from the out-of-phase CN 
stretching vibration, the CNN deformation and the NH in-plane bend [34, 52]. About 70-85 % of 
the band intensity is from C=O stretching and 10-20 % is from CN stretching [34]. The amide I 
band is hardly affected by the nature of the amino acid side-chain. It only depends on the secondary 
structure of the backbone. Thus, it is best suited to determine the secondary structure of proteins.   
Amide II 
Amide II vibration is from 1500 to 1600 cm-1, around 1550 cm-1. Amide II is the out-of-phase 
combination of the NH in-plane bending (40-60 %) and the CN stretching vibration (18-40 % with 
smaller contributions from the CO in-plane bend and the CC and CN stretching vibrations [34]. As 
amide I, amide II is hardly affected by side-chain vibrations. However, the correlation between 
secondary structure and frequency is less straightforward as compared to the amide I region.  
Amide III 
Amide III vibration can be seen in the infrared region from 1200 to 1400 cm-1. It is the in-phase 
combination of the NH bending and the CN stretching vibration with small contribution from the 
CN in-plane bending and CC stretching vibration [34]. Therefore, the amide III band is affected by 
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side-chain, and the backbone vibrations vary considerably, which makes the amide III vibration less 
suitable for secondary structure analysis. However, amide III vibration also has an advantage for 
secondary structure analysis of protein because of the reduced water effect. Previous studies also 
showed that the amide III region can be used to calculate the secondary structures for various 
proteins [54-57], although the amide III is much weaker than the amide I band. However, better 
band separation allows for curve-fitting without the need of employing resolution-enhancement 
methods. Griebenow and Klibanov found that the amide III results and X-ray data were in good 
agreement for most proteins [58].  
3.2 The correspondence between protein secondary structure and amide bonds 
A critical step in the interpretation of infrared spectra of proteins is to assign the component bands 
to different types of secondary structures. Theoretical and experimental attempts have been made to 
correlate FTIR absorption bands of protein to the secondary structure of protein either in aqueous 
state or in solid state. Briefly, bands in the range 1650-1658 cm-1 is generally associated with the 
presence of α-helix conformers in aqueous environments. Nevertheless, intensity increase in this 
region of the spectrum is hardly assigned to increase in α-helical structure alone, since α-helical 
structures overlap significantly with those from random or unordered structure (1645-1652 cm-1) 
[59] and loops (1658-1665 cm-1) [60]. When helical proteins are associated with membranes, the 
band appears in the range 1656 to 1658 cm-1, whereas in soluble proteins this band occurs at the 
lower wave numbers, approximately 1650 to 1655 cm-1 [61]. 
The β-sheet vibration has been shown in region 1620 to 1640 cm-1. The exact position is affected by 
varying strengths of the hydrogen bonding and transition dipole coupling in different β-strands [59]. 
The possibility of distinguishing between parallel and anti-parallel β-sheets was investigated in a 
previous study [62]. Bands around 1662-1690 cm-1 has been assigned as β-turn or turn. Beta-turns 
appear at a broad region in the amide I region due to the diversity of its geometries. Moreover, β-
turn with internal hydrogen bonds gives rise to absorption band around 1638-1646 cm-1 [63]. Like 
the amide I, the amide II region is also used for investigation of the secondary structure of protein, 
but the correspondence between FTIR absorption bands and secondary structure is more complex 
than in the amide I region. Bands in the amide II region have not been well studied. Generally, 
bands in the range 1540-1550 cm-1 are regarded as α-helix. The β-sheet vibration is at the range 
1520-1530 cm-1 [64, 65]. Beta-turns are assigned around 1568 cm-1 [66, 67].  
In the amide III region, the protein absorption bands have not been fully understood due to the low 
intensity and high contribution from side chain vibrations. Cai and Singh [56] have reported that α-
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helix bands usually appear in range 1295-1340 cm-1; β-turns gives rise to bands around 1270-1295 
cm-1; random structure is at 1250-1270 cm-1; and β-sheet is assigned from 1220 to 1250 cm-1. The 
assignments of FTIR bands are given in Tab. 2.1.  
 
         Tab. 2.1 Band assignments in the amide I region of FTIR spectrum.  
FTIR region Wavenumbers (cm-1) Secondary structure References 
1620-1640 β-sheet [59] 
1645-1652 Random or unordered [59] 
1650-1658 α-helix [59] 
Amide I 
1662-1690 β-turn [59, 63] 
1520-1530 β-sheet [64, 65] 
1540-1550 α-helix [64, 65] 
Amide II 
1568 β-turn [66, 67] 
1220-1250 β-sheet [56] 
1250-1270 Random  [56] 
1270-1295 β-turn [56] 
Amide III 
1295-1340 α-helix [56] 
3.3 Water absorption in FTIR spectrum 
The absorption bands of a specific component can also be influenced by the contribution of other 
compounds. These contributions need to be removed before further analysis of the spectrum. The 
most common interfering substance is liquid water, which has three prominent bands centred at 
3360 cm-1 (H-O stretching band), 2130 cm-1 (water association band) and at 1640 cm-1 (the H-O-H 
bending vibration) [43]. The amide I band for proteins absorption bands overlap directly with a 
water bending vibational band at 1640 cm-1. The intensity of the water band at 1640 cm-1 is about 
an order of magnitude larger than the amide I bands of proteins and yet precise subtraction of the 
water band is possible because of the frequency precision in FTIR spectra.   
Techniques have been developed to automatically subtract the water band to obtain information 
from the protein. The objective of these techniques is to eliminate the possible individual bias and 
uncertainty in the selection of the scale factor due to baseline variations. Powell and co-workers 
[68] approached the water subtraction problem through analysis of the change in the region from 
1900 to 1790 cm-1 in the protein spectrum as the scale factor for the water spectrum is changed. 
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Dousseau et al. [69] assume that 2125 cm-1 water association band is not affected by the presence of 
protein. This assumption works for most proteins except when they are highly charged. The 
accuracy of subtraction of the very large water band at 1640 cm-1 is always a concern, but studies 
have shown that the positions and intensities of the bands are maintained even with deliberate over 
or under subtraction of the water peak [70]. A simple and practical method is to subtract the water 
band until the region from 1900 to 1740 cm-1 is flat. This method works well with most proteins and 
surface combinations if applied consistently.  
3.4 Resolution-enhancement 
Compared to NIR spectra, the peaks of MIR spectra are not that broad and overlapped, but it is still 
difficult to perform a straightforward analysis of the spectra, especially for complicated samples, 
e.g. proteins. Resolution-enhancement methods are applied to solve this problem. However, this 
terminology is misleading. Resolution is an instrumental parameter that cannot be changed after the 
spectra are collected. These mathematical techniques are more correctly referred to as band-
narrowing procedures.  
Fourier self-deconvolution (FSD) and derivation have been used for many years to allow 
visualization of overlapping bands [71-74].  
FSD requires knowledge of the number of bands, their shapes and parameters, such as position, 
band width and intensity. For example, if the chosen band width is greater than the width of the 
peak being studied, the result will be side-lobes at the edges of the deconvoluted bands, which can 
lead to problems with visualization of weaker neighbouring bands. On the other hand, if the chosen 
band width is too small, the deconvoluted spectra will appear unaltered and no additional 
information will be gained.  Moreover, if the bands are highly overlapped, the results obtained may 
be ambiguous and largely dependent on the initial parameters [75]. FSD also reduces the width of 
water vapour absorption and enhance noise, producing very sharp peaks with even minimal 
deconvolution. Noise and water vapour can very quickly become a problem in deconvoluted 
spectra. Thus, FSD should only be performed on spectra with a high signal-to-noise ratio (SNR) and 
a low contribution from water vapour [38]. A spectrum may be judged to be water vapour-free if no 
sharp absorption is seen from 1700 to 1800 cm-1.  
Derivative spectroscopy was introduced by Dong et al. [76], who analyzed the secondary structure 
of proteins in aqueous solution. It is mainly employed to identify the number of bands and their 
position. The derivative spectra are applied rarely for quantitative studies. The pitfalls that apply to 
FSD are also applicable to derivation. Furthermore, derivation suffers from the fact that relative 
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integrated intensities are not maintained. In addition, significant edge effects are possible in 
derivative spectra [38, 77]. If the spectrum has a significant slope at the edges of the peak to which 
derivation is to be performed, distortions will be introduced at the edges of the derivative spectrum. 
This is easily avoided by choosing a wider spectral region for derivative calculation, and the 
features at the edges of the extended region should be ignored. 
3.5 Disadvantages of FTIR for protein structure analysis 
As mentioned above, FTIR cannot provide full three-dimensional structural information of proteins. 
The spectrum of a protein may be influenced by water and other components.  It also should be 
noted that high protein concentration (10-20% w/w) is normally needed for FTIR measurements for 
obtaining the SNR necessary for conformational analyses. This is due to the use of small path 
length in FTIR measurements [78, 79].  
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Chapter III: Characterization of the structural changes of model antigen when it is absorbed 
onto and released from aluminium hydroxide using FTIR-ATR 
 
 
 
Abstract 
Aluminium hydroxide is often used as adjuvant in specific immunotherapy, i.e. allergy vaccination. 
Structural integrity of antigens upon adsorption and release is not only important for investigating 
vaccine immunogenicity, but also for the epitope specificity of the resulting immune response and 
hence therapeutic efficacy. However, it is also important for understanding the mechanism of how 
adjuvants can enhance the immune response. However, little is known about an antigen’s structure 
when it is adsorbed and subsequently released from aluminium adjuvants. In this study, the 
structural changes of two model antigens, bovine serum albumin (BSA) and β-lactoglobulin (BLG), 
were investigated using Fourier transform infrared – attenuated total reflection (FTIR-ATR) 
spectroscopy. The secondary structures of both model antigens change when absorbed to aluminium 
hydroxide. The structural perturbation depends on the amount of the adsorbed protein. Maximal 
adsorption gives a more native-like structure than lower protein adsorption. This may indicate that 
protein is adsorbed by aluminium hydroxide by different mechanisms depending on the 
concentration. The adsorbed model antigens are released using phosphate buffer (PBS) pH 7.4 with 
final concentrations between 5 mM and 200 mM. The maximum antigen recovery is 80% after 40 
min in the presence of phosphate buffer (PBS). The recovery curves of both proteins also indicated 
two different adsorption modes. FTIR-ATR and circular dischroism (CD) spectroscopy yield 
similar results suggesting that the antigens refold to their native state after release. Released BSA 
regains its native structure more complete than BLG.  
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1 Introduction 
Antigens are proteins capable of inducing specific immune responses when injected to humans. The 
molecular properties of antigens and the way in which these properties contribute to immune 
activation are central to determine the outcome of vaccination treatments. All four levels of protein 
organization—primary, secondary, tertiary, and quaternary—affect its immunogenicity [1]. The 
structural information of the antigen is not only important for investigating its immunogenicity; it is 
also important to understanding of the interaction between antigen and adjuvant and the mechanism 
of how adjuvant can enhance the immune response. In general, proteins have a very fragile three-
dimensional structure [2, 3], and this structure may easily change in different environments, such as 
binding to membranes, at air-water interfaces,  under pressure, or even during drying and storage. 
Protein adsorption processes are believed to cause structural changes in the protein. Previous studies 
have shown that the adsorption of a protein onto interfaces or solid surfaces induces structural 
changes in the protein [4-8]. These structural changes during absorption may lead to irreversible 
aggregate formation, inactivate the ability to induce an immune response, or even cause serious 
side-reactions. Protein aggregation is difficult to control and hampers precise prediction of the 
release profile of the protein. Furthermore, protein aggregates can be immunogenic and may 
potentially constitute risk patients.  
Aluminium adsorbed vaccines have been safely used for many years. However, the structure of the 
antigen when adsorbed to aluminium-containing adjuvants, have not been well characterized. Two 
studies have addressed the structure of aluminium adsorbed proteins [9, 10], but a major obstacle is 
the lack of experimental techniques allowing structural information to be obtained directly on this 
complex system. Hem and white demonstrated that a slight deformation of the structure of pepsin 
occurred when adsorbed by aluminium hydroxide using infrared spectroscopy. They regarded this 
an example of ligand exchange [9]. Jones et al. [10] studied the structures of model antigens as a 
function of temperature by FTIR-ATR spectroscopy in order to investigate vaccine stability. To our 
knowledge, there is no available structural information of released antigens from aluminium-
containing adjuvants.  
FTIR spectroscopy is a good method to determine the secondary structure of globular proteins. It 
offers many advantages over other spectroscopic techniques [11, 12]. A major advantage is the lack 
of dependence on the physical state of the sample. Sample can be gas, aqueous or organic solution, 
hydrated film, inhomogeneous suspension, or solid. FTIR is particularly suitable for the analysis of 
proteins adsorbed by other materials, especially when an ATR crystal is used. FTIR was applied to 
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study the loss of secondary structure during insulin unfolding in a lipid-water interface model [13] 
and protein adsorption by silica, polysulfone, and other biomaterials [14-17].  
CD spectroscopy is a suited method to monitor the secondary and tertiary structure of proteins in 
solution [18]. Far-UV CD (170-250 nm) spectroscopy is a good tool to obtain the overall 
information of the secondary structure. However, the analyses involve complex calculations using a 
standard set of reference proteins as a basis for estimation and thus yield only indirect measures 
[19]. Moreover, CD spectroscopy is not a suitable technique for measuring the adsorbed protein in 
suspension because light cannot pass through such high density samples.  
   
 Tab. 3.1 Secondary structures content in two model 
proteins [21]. 
 
 
In this study, FTIR-ATR and CD spectroscopy were applied to investigate the structural changes of 
model antigens. The model antigens were adsorbed by aluminium hydroxide and subsequently 
released using phosphate buffer (PBS) at pH 7.4. PBS was chosen because phosphate anions easily 
adsorb onto the surface of aluminium hydroxide through ligand exchange displacing the antigens 
from the aluminium adjuvant [20]. Bovine serum albumin (BSA) and β-lactoglobulin (BLG) were 
used as model antigens because their structures have been well studied. They are α-helix-rich and β-
sheet-rich proteins, respectively. BSA consists of 66% α-helix and BLG contains 46% β-sheet as 
shown in Tab. 3.1[21]. BSA is made up of 100 acidic side chains with 41 Asp and 59 Glu residues 
and 99 basic side chains with 23 Arg, 59 Lys, and 17 His. The isoelectric point of BSA is 4.8 [22]. 
BSA is a small globular protein with a molecular weight of approximate 66.4 kDa. BLG has a well-
known structure containing one very short helix segment and eight strands of anti-parallel β-sheet, 
which wrap to form an anti-parallel β-barrel. BLG exists at neutral pH as a dimmer in its native 
state. Each monomer constituted by identical 162 amino acids, with one free thiol group and two 
disulphide bridges. The isolectric point of BLG is 6.5 and the molecular weight is approximately 
18.3 kDa [23, 24].  
2 Materials and methods 
2.1 Materials 
Clinical reagent grade BSA (reference L84960) and approximate 90% pure BLG (reference L3908) 
Protein  α-helix β-sheet Random
BSA 66 03 31 
BLG 06 46 48 
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were purchased from ICN biomedical Inc and Sigma respectively. Both proteins were used directly 
without further purification. Aluminium hydroxide adjuvant was purchased from Superfos 
Biosector A/S (Denmark) and used without further treatment. Other chemicals were all of analytical 
grade and obtained from commercial sources. 
2.2 Adsorption experiments 
Sample preparation 
A protein stock solution (10 mg/ml) was prepared by dissolving protein in Milli-Q water. Working 
samples were prepared by mixing the appropriate amount of protein stock solution and aluminium 
hydroxide and subsequently diluted to 1 ml using Milli-Q water. The final calculated aluminium 
concentration was 3.4 mg/ml for all samples; the final protein concentrations were from 1mg/ml to 
5mg/ml, with final pH 6.5. Samples were mixed gently by end-over-end rotation for 30 min to 
obtain the maximum protein adsorption before FTIR measurement.  
FTIR-ATR measurement 
Spectra were collected using a FTIR spectrometer (PerkinElmer Spectrum One), which was 
mounted with a three bounces ZnSe ATR crystal (PerkinElmer). An 8 μl sample was deposited onto 
ATR crystal and by evaporating the solvent to obtain a film. The calculated amount of aluminium 
hydroxide for a film was 27.2 μg; and the calculated value of protein was from 8 μg to 40 μg, 
respectively. Spectra were directly recorded on the film by co-adding 128 scans with a resolution of 
4 cm-1 at a scan speed 0.2 cm/s. Control spectra were collected from the samples which contained 
the same components except protein at same experimental conditions. All samples were analyzed at 
least in duplicate. 
2.3 Release experiments 
Sample preparation 
Samples were prepared as described for the adsorption experiments. The final concentration of 
aluminium hydroxide was 3.4 mg/ml for each sample; final protein concentration was 4 mg/ml for 
BSA and 3 mg/ml for BLG. The samples were gently rotating by end-over-end at room temperature 
for one hour, and stored at 4 ºC overnight.  Adsorbed proteins were released by adding PBS pH 7.4 
to a final concentration between 5 and 200 mM at room temperature. Samples were incubated for 
40 min before measurement.  
FTIR-ATR measurements 
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FTIR measurements were performed on the same instrument as mentioned for the adsorption 
experiments. Measuring films were made in either of two ways: by evaporating the complex of 
protein and aluminium hydroxide; or by measuring released protein alone after centrifugation at 
6800 × g for 10 min. Blank samples contained the same components except protein at same 
condition. All samples were measured at least in duplicate.  
CD measurements 
Adsorbed protein was released using PBS pH 7.4 at a final concentration of 150 mM for 40 min. 
Control samples were in prepared using the same components except protein. Free protein solutions 
were prepared by dissolving appropriate amounts of protein in the supernatant which was obtained 
from the control experiment. 
CD measurements were carried out using an Olis spectropolarimeter (On-line instrument systems, 
Inc. USA), equipped with a temperature control system. Protein solutions were scanned in a 0.1 cm 
quartz cuvette five times at 15 ºC. In order to compare the CD spectra of the free protein and the 
released protein, protein concentrations were identical. Free protein solutions were also measured 
from 15 ºC to 90 ºC, with 5 ºC interval. At each temperature, the sample was incubated for 2 min 
before scanning.  
Ultraviolet spectrophotometry (UV) measurements 
After 40 minutes release, the samples were centrifuged at 6800 × g for 10 min, and the supernatants 
were measured using an UV/VIS spectrophotometer (Lamda 800, PerkenElmer instruments) at 280 
and 320 nm. The protein recovery from aluminium hydroxide was calculated from the following 
equation (Eq. 3.1):  
%100
320280
'
320
'
280
×
−
−
−
=
AC
AAAA
R εε                                        Eq. 3.1 
Where R is protein recovery, ε is extinction coefficient, AC is adsorption capacity, 280A  is the 
absorbance of protein at 280 nm in MilliQ water. '280A  is absorbance at 280 nm in the presence of 
PBS. So are the 320A  and
'
320A .  
2.4 Data analysis 
FTIR data 
All FTIR spectra were analyzed using Unscrambler Ver. 9.2 software (Camo process AS). The 
replicated spectra of the same sample were averaged first. The spectrum of a corresponding blank 
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sample was subtracted from the spectrum of adsorbed proteins. A flat baseline from 1900 to 1740 
cm-1 was obtained for each spectrum after background subtraction.  A window size of 23-point 
Savitsky-Golay smoothing function was applied to each spectrum. The second derivative spectra 
were calculated using a window size of 11-point Savitsky-Golay function from 1750 to 1220 cm-1. 
The inverted second derivative spectra were obtained by multiplying with -1 for convenient 
interpretation.  Finally, the spectra were baseline corrected, mean normalized, transferred into Excel 
file and plotted.  
CD data 
Before analysis, a CD spectrum of control sample, which contained all components except protein, 
was subtracted from each CD spectrum.  
3 Results and discussion 
3.1 Protein adsorption by aluminium hydroxide 
Typical FTIR spectra of BSA and BLG adsorbed by aluminium hydroxide and recorded on films 
are shown in Fig. 3.1. For comparison, the spectrum of pure aluminium hydroxide is also presented 
in same figure. It is seen that amide I (1700-1600 cm-1) and amide II (1600-1500 cm-1) bands are 
not affected by the absorption of aluminium hydroxide enabling to the aluminium hydroxide 
background subtraction. The subtracted spectra in the region from 1800 cm-1 to 1200 cm-1 are given 
in Fig. 3.2. Subtraction of background is dangerous. Over or under subtraction of the spectra may 
damage the final spectra. A simple and practical method is to subtract background until the region 
from 1900 to 1740 cm-1 is flat. This method works well with most proteins when adsorbed by other 
materials, if it is applied consistently. However, studies also have shown that the positions and 
intensities of the bands are maintained even with deliberate over or under subtraction of the 
background spectrum [25]. In this study, potential alterations of the secondary structure of model 
antigens are monitored in the amide I and amide II region of the final inverted 2nd derivative FTIR 
spectra.  
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Fig. 3.1 Typical FTIR spectra of protein adsorbed by aluminium hydroxide measured on 
films:  absorbed BSA (dotted line), adsorbed BLG (solid line), and aluminium hydroxide alone 
(dashed line) 
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Fig. 3.2 The subtracted spectra of protein: BSA (dotted line) and BLG (solid line).  
 
The inverted 2nd derivative FTIR spectra of free BSA, adsorbed BSA and aggregated BSA are given 
in Fig. 3.3.  Except when specifically mentioned, in this paper free protein means pure protein; 
adsorbed protein means that protein adsorbed to aluminium hydroxide; and the aggregated protein 
is the protein that has been preheated at 90 ºC for 30 min. The spectra present that there are band-
broadening and induction of new peak for adsorbed BSA in amide I and amide II regions. A novel 
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peak at 1646 cm-1 is induced and can be assigned to random structure. Another band at 1653 cm-1 
decreases in intensity, which ascribes to α-helix. In other words, adsorbed BSA loses its α-helix but 
gains random structure in amide I range. In amide II region, two new bands are induced at 1549 cm-
1 and 1533 cm-1. Bands around 1570 cm-1 and 1513 cm-1 increase in intensity during adsorption. 
The significant difference in the spectra of adsorbed BSA and free BSA indicates that the secondary 
structure of BSA changes when adsorbed to aluminium hydroxide. Noinville et al. [26] had studied 
BSA adsorbed by montmorillonite and concluded that all unfolding processes involve about 20% of 
the backbone.  
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   Fig. 3.3 Inverted 2nd derivative spectra of BSA in amide I and amide II region: free BSA 
(solid line), adsorbed BSA (dashed line) and aggregated BSA (dotted line).  
 
In order to compare the structural difference of adsorbed protein and the aggregated protein, BSA 
was preheated at 90 ºC for 30 min and the spectrum was recorded under identical experimental 
condition at room temperature. The final inverted 2nd derivative spectrum of aggregated BSA is also 
shown in Fig. 3.3 for comparison. For aggregated BSA, there are two novel bands around 1622 cm-1 
and 1694 cm-1 in the amide I region. The band at 1622 cm-1 is extremely strong. These two bands 
relate to intermolecular anti-parallel β-sheet formation. The result agrees with other heat-denatured 
protein aggregates [27-29]. In the amide II range, aggregated BSA loses intensities at 1549 cm-1 and 
1541 cm-1 compared to adsorbed and free BSA. These significant differences indicate that the 
adsorption-induced secondary structural change is not the same as observed for protein aggregation.   
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   Fig. 3.4 Inverted 2nd derivative spectra of different amount of BSA adsorbed by same 
amount of aluminium hydroxide in amide I and amide II region. 
 
Protein adsorption capacity by aluminium adjuvants has well been studied. Aluminium hydroxide 
can adsorb different amounts of protein depending on the protein.  Adsorption of different amounts 
of protein may not result in same structural changes. To elucidate the absorption level effect, we 
investigated the structures at different ratios for protein adsorption by aluminium hydroxide.  
Five amounts of BSA, from 8 μg to 40 μg with 8 μg interval, were adsorbed by same amount of 
aluminium hydroxide (27.2μg), and measured under identical experimental condition. The inverted 
2nd derivative spectra are given in Fig. 3.4. The spectra were significantly different in the amide I 
and amide II regions due to the intensity changes and peak shifts. For low ratio of adsorbed BSA, 
e.g. 8 μg, bands in amide I region increase in intensity around 1685, 1675, 1662, and 1606 cm-1. On 
the other hand, in the spectra of high ratio of adsorbed BSA, e.g. 40 μg,  bands increase around 
1654 and 1646 cm-1, which are the α-helix and random structure. In the amide II region, high ratio 
of adsorbed protein loses intensities at 1549 and 1532 cm-1, but the band at 1941 cm-1 increase. The 
band at 1532 cm-1 shifts to 1533 cm-1 for a low ratio of adsorbed BSA. Therefore, the structure of 
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adsorbed protein depends on how much protein is adsorbed by the aluminium adjuvant. A high ratio 
of adsorbed BSA gives a native-like structure.   
In the case of BLG, the experiments were performed using the same experimental condition as for 
BSA. Fig. 3.5 presents the inverted 2nd derivative spectra of free BLG, adsorbed BLG and 
aggregated BLG. The spectral difference between adsorbed BLG and free BLG are due to peak 
shifts and band broadening in the amide I region, and intensity changes in the amide II region. The 
broadest band widens and shifts from 1630 to 1636 cm-1 for adsorbed BLG, which can be ascribed 
to β-sheet. A shoulder peak is induced at 1644 cm-1, which can be assigned to random structure. 
Another difference in the amide I range is the intensity of the band at 1665 cm-1; adsorbed BLG has 
a stronger absorption. In the amide II region, the intensities of three peaks increase considerably 
around 1551, 1533, and 1514 cm-1 for adsorbed BLG. These significant spectral alterations 
indicated that the secondary structure of BLG is dramatically modified when adsorbed by 
aluminium hydroxide, revealing a strong effect of the aluminium adjuvant on BLG. The results is 
excellent an agreement with other study, in which BLG rearranged when adsorbed to 
dimyristoyphosphatidylglycerol (DMPG) [30].  
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   Fig. 3.5 Inverted 2nd derivative spectra of BLG in amide I and amide II region: free BLG 
(solid line), adsorbed BLG (dashed line) and aggregated BLG (dotted line). 
In order to compare the adsorption-modified structure and the heat-induced structure, Heat induced 
aggregation of BLG was also investigated in this work. Fig. 3.6 presents the spectrum of aggregated 
BLG. It has been preheated at 90 ºC for 30 min and measured under identical experimental 
conditions. The spectrum of aggregated BLG differs from free BLG by band-broadening and band 
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shift from 1630 to 1628 cm-1 in amide I region. In contrast, this band of adsorbed BLG shifts to 
high wavenumber, 1636 cm-1. In the amide II range, the intensities of three bands around 1551, 
1533 and 1514 cm-1 increase for both aggregated BLG and adsorbed BLG. Surprisingly, adsorbed 
BLG has stronger absorption for these three bands than aggregated BLG. This is an indication that 
BLG is not extensively unfolded at this heat process or that the unfolded structure refold when 
retuning to room temperature. However, the structure is dramatically modified by adsorption onto 
aluminium hydroxide.  
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Fig. 3.6 Inverted 2nd derivative spectra of different amount of BLG adsorbed by same 
amount of aluminum hydroxide in amide I and amide II region.  
 
Five concentrations of BLG, from 8 to 40 μg with an 8 μg interval, were adsorbed by 27.2 μg 
aluminium hydroxide, respectively. FTIR spectra were collected at identical conditions.  The 
inverted 2nd derivative spectra are shown in Fig. 3.6. Spectral differences are mainly due to band 
shifts and intensity changes. The β-sheet band shifted from 1636 cm-1 to 1631 cm-1 according to 
protein adsorption increasing, e.g. from 8 μg to 40 μg. The band at 1644 cm-1, which is random 
structure, loses intensity for a high ratio of adsorbed BLG, e.g. 40 μg. This phenomenon is different 
from was observed with adsorbed BSA.  
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Two bands at 1675 and 1665 cm-1 have stronger absorption at a low ratio adsorbed of BLG. In the 
amide II range, a low ratio of adsorbed BSA has a stronger absorption at 1551 cm-1. Therefore, the 
structures differ as a function of amount of adsorbed BLG. The more BLG adsorbed, the more 
native-like the structure is. Interference from free BLG in the adsorbed sample can not be excluded 
in this case, as BLG can not be totally adsorbed by aluminium hydroxide even at very low 
concentrations. Free protein may affect the final spectra, especially for high amount of protein 
adsorption such as 40 μg.  
Antigen adsorption is believed resulting from the electrostatic attraction between protein and 
aluminium adjuvant. When antigen is adsorbed onto aluminium surface, the resulting 
intermolecular electrostatic interaction may weaken the intramolecular forces that stabilize the 
protein native structure. It may be the reason of adsorption-induced structural changes in the 
antigens.  
The manner by which the structural changes depends on the adsorbed amount of protein, which is in 
agreement with other studies [31, 32]. Urano et al. [31] demonstrated that BSA was adsorbed on the 
Al2O3 surface by formation of a monomolecular layer. A model of BSA adsorption was proposed 
according to which protein was adsorbed in two different configurations depending on the amount 
of adsorbed protein. Nevertheless, Urano et al. [31] did not conclude that protein structure changes 
due to adsorption using potentiometric titration. It is probably because the conformation of adsorbed 
protein depends on the prosperities of the aluminium hydroxide surface [33, 34]. In this study, two 
model proteins are adsorbed by aluminium hydroxide resulting in different conformations. Small 
amounts of protein are strongly adsorbed by aluminium hydroxide. The protein molecules form a 
monomolecular layer on aluminium hydroxide and secondary structure becomes more denatured. 
On the other hand, the structural perturbation of the protein becomes smaller when the degree of 
banding decreases. A high ratio of adsorbed protein is weakly adsorbed via few linking points. The 
protein molecules are oriented perpendicular onto the aluminium hydroxide, which results in a 
native-like structure. This model is illustrated in Fig. 3.7. However, structural changes of the 
proteins when adsorbed on the ATR crystal cannot be excluded. Previous study showed that the 
changes in protein structure may occur upon adsorption onto ATR surface [35].  
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   Fig. 3.7 The model of protein adsorbed by aluminium hydroxide: large cure presents the 
molecule of aluminium hydroxide; and small cures present the molecules of protein. The direction 
of arrow shows the protein concentration increasing.  
 
The mechanism of how aluminium adjuvants can enhance the immune response is still poorly 
understood. Jones et al. [10] proposed that protein structure became destabilized upon adsorption by 
aluminium adjuvants. These physical changes of adsorbed antigens made them more susceptible to 
proteolytic processing by the immune system, resulting in an enhanced antigen presentation. 
According to this hypothesis, vaccines with low ratio of protein adsorption should induce stronger 
or similar immune response as compared to high ratio adsorption, since it has a more destabilized 
structure. This hypothesis is confirmed by Lund et al. (unpublished data). Lund and co-workers 
studied the immune response after immunisation of mice using different ratios of antigen and 
aluminium hydroxide. They concluded that low protein adsorption give rise to similar immune 
response as did maximal protein adsorption. In this study, the different structures resulting from 
different amount protein adsorption may give the explanation of this phenomenon. Moreover, 
denatural proteins may be pharmaceutically inactive for its treating purposes, but it may be the 
reason why it causes immunogenicity, which was regarded as side effect in other fields [36, 37]. 
3.2 Release of protein from aluminium hydroxide 
PBS is capable of replacing pre-adsorbed BSA and BLG from aluminium hydroxide. The protein 
recovery (amount of released proteins / adsorbed protein) at different PBS concentration is shown 
Fig. 3.8. Protein release from aluminium hydroxide is quite fast; recovery is around 80% within 40 
minutes both for BSA and BLG. These high values indicate that pH 7.4 PBS is a good candidate for 
replacement of protein from aluminium hydroxide. Some surfactants have also been used for 
protein release from aluminium adjuvant [38, 39]. The recovery of protein is proportional to the 
concentration of buffer, especially for BLG. The amount of released BSA decreases after at PBS 
exceeding 130 mM. Both for BSA and BLG, adsorbed protein can not be totally released from 
aluminium hydroxide. Incomplete release may associate with aggregation. The aggregated protein 
can not be released from aluminium hydroxide.  Protein recoveries do not increase significantly 
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even when increasing the final PBS concentration from 50 mM to 100 mM. The curves have two 
platens lat stages. It may indicate that proteins have different adsorption conformations on the 
aluminium hydroxide.  
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   Fig. 3.8 Recovery of proteins that are first adsorbed by aluminium hydroxide and 
subsequently released using pH 7.4 PBS at different concentrations. The incubation time in 
the presence of PBS is 40 min. The recovery was calculated by the released amount / adsorbed 
protein. 
 
The structure of released protein was measured by FTIR spectroscopy in two ways, either using the 
complex of protein and aluminium hydroxide or using only the released protein without adjuvant 
after centrifugation. Fig. 3.9 shows the inverted 2nd derivative spectra of released BSA in the amide 
I and the amide II regions. For comparison, the adsorbed BSA and free BSA are also shown in same 
figure. In the amide I range, released BSA loses random structure at 1646 cm-1 and regains α-helix 
structure at 1654 cm-1. In the amide II range, band at 1546 cm-1 shifts from 1549 cm-1 comparing to 
adsorbed BSA, and a band is lost at 1533 cm-1. All makes the spectrum of released BSA look like 
the spectrum of free one.  This may be an indication that released BSA again regains the native 
structure. This meets to the study of Engel et al. [39]. They showed that released bovine α-
lactalbumin (BLA) from polystyrene nanospheres had native spectroscopic properties. The structure 
of adsorbed BLA refolded to its native state upon release from the surface. There is a small spectral 
difference between released BSA when measured in complex of the released protein and aluminium 
and when measured on the released protein alone. This can be explained by the former sample 
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having 20 % adsorbed BSA, which cannot be released.  
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   Fig. 3.9 Inverted 2nd derivative spectra of BSA in amide I and amide II region: free BSA 
(solid line), adsorbed BSA (dashed line), released BSA which measured on the complex of 
protein and aluminium hydroxide (dotted line), and released BSA which measured on protein 
alone after centrifugation (dash-dotted line). 
 
The refolding procedure was studied by investigating the release using different final PBS 
concentrations, from 5 mM to 200 mM. The spectra were recorded on the complex sample of 
protein and aluminium hydroxide. For low PBS concentration the sample has more adsorbed 
protein, whereas, there is more released protein in sample containing high PBS concentration. Fig. 
3.10 presents the inverted 2nd derivative spectra of released BSA. It is seen that in amide I range, 
Band at 1646 cm-1loses, and the band at 1653 cm-1 becomes stronger with increasing PBS 
concentration. Random structure is lost and the amount of α-helix increases. In amide II region, 
bands at 1569, 1549, 1533 and 1514 cm-1 lose intensity, and the band at 1543 cm-1 increases. These 
structural alterations make the spectrum more native-like if increasing PBS concentration.  
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   Fig. 3.10 Inverted 2nd derivative spectra of released BSA in amide I and amide II region: 
adsorbed protein has been released using pH 7.4 PBS at different concentrations (from 5 mM to 
200 mM) for 40 min respectively. The spectra are recorded on the complex of protein and 
aluminium hydroxide. 
 
The inverted 2nd derivative FTIR spectra of free BLG, adsorbed BLG, and released BLG are given 
in Fig. 3.11. In the amide I region, β-sheet band shifts from 1636 cm-1 to 1631 cm-1 for released 
BLG as compared to adsorbed BLG, and thus the spectrum of released BLG more closely resembles 
that of free BLG. In the amide II range, bands at 1569, 1551, 1533, and 1514 cm-1 for released BLG 
are similar to free one. These indicate released BLG regain its native structure. However, it is not as 
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complete as BSA. Fig. 3.12 shows the inverted 2nd derivative spectra of BLG which are released 
using different PBS concentrations, from 5 mM to 200 mM. The spectra were also measured on the 
complex of protein and aluminium hydroxide. It is seen that β-sheet band at 1636 cm-1 shifts to 
1631 cm-1, and band at 1541 cm-1 becomes stronger. A few bands 1665, 1644, 1569, 1551, 1533 
and 1514 cm-1 decrease intensity as a function of PBS concentration. These changes make the 
spectrum become more native-like since there is more released protein in the sample.  
0
2
4
1700 1680 1660 1640 1620 1600 1580 1560 1540 1520 1500
Wavenumber
In
ve
rt
ed
 2
nd
 d
er
iv
at
iv
e
1636
1630
1631
1644 1551 1533 1514
1569
1665
 
   Fig. 3.11 Inverted 2nd derivative spectra of BLG in amide I and amide II region: free BLG 
(solid line), adsorbed BLG (dashed line), released BLG which measured on the complex of 
protein and aluminium hydroxide (dotted line), and released BLG which measured on protein 
alone after centrifugation (dash-dotted line). 
 
The structural information from CD spectra are in agreement with the FTIR results. The CD spectra 
of released BSA and free BSA as well as released BLG and free BLG are given in Fig. 3.13 A and 
B, respectively. The almost identical spectra illustrate that released BSA refold to its native state. 
The spectra of released BLG and free BLG are similar except lower ellipticity between 194-206 nm 
for released BLG. This is an indication that released BLG may not totally refold to its native state. 
In addition, this confirms the results obtained by FTIR. To confirm that the free proteins remain the 
native state before CD measurement, free BSA and BLG were at different temperatures. The spectra 
are presented in Fig. 3.13 C and D, respectively. 
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   Fig. 3.12 Inverted 2nd derivative spectra of released BLG in amide I and amide II region: 
adsorbed protein has been released using pH 7.4 PBS at different concentrations (from 5 mM to 
200 mM) for 40 min respectively. The spectra are recorded on the complex of protein and 
aluminium hydroxide.  
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   Fig. 3.13 CD spectra BSA (A, C) and BLG (C, D): free protein (solid line) and released protein 
(dotted line); C and D represent CD spectra of BSA and BLG at different temperatures 
respectively. The arrows indicate the direction of increasing temperature.  
4 Conclusion 
FTIR-ATR spectroscopy provides direct information on the secondary structural changes of the 
model antigens when adsorbed to aluminium hydroxide, and following release. It is shown that the 
secondary structure of BSA and BLG change when adsorbed by aluminium hydroxide. The 
adsorption-induced structural changes depend on how much protein is adsorbed by the aluminium 
hydroxide. Maximal adsorption gives a more native-like structure than low protein adsorption.  
PBS replace pre-adsorbed antigen from aluminium hydroxide. The recovery of released protein is 
approximate 80% after 40 min in the presence of PBS. The released antigens generally refold to 
their native state. However, released BSA regains its native structure more completely than does 
BLG.  
(C) 
(A) (B) 
(D) 
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Chapter IV: The structural stability of model antigens adsorbed by aluminium hydroxide in 
heating and aging processes in comparison to the antigens in solutions 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
The structural stability of two model antigens adsorbed to aluminium-containing adjuvant was 
studied. The two model antigens were bovine serum albumin (BSA) and β-lactoglobulin (BLG), 
and the method used was Fourier transform infrared – attenuated total reflection (FTIR-ATR) 
spectroscopy. The stability was studied during heating and storage. The results showed that the 
structure of proteins when adsorbed onto the surface of aluminium hydroxide was more stable than 
proteins in solution at high temperature and/or after a period of storage. This indicated that 
adsorption by aluminium-containing adjuvants protected antigens against degrading. This 
phenomenon was more pronounced for BSA than BLG. The reason might be that there are more 
free BLG in the sample system compared to BSA. Reduced adsorption of proteins to the adjuvant in 
a vaccine may facilitate the degradation of the antigen in the vaccine. 
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1 Introduction  
Aluminium-containing adjuvants are used in vaccines to adsorb the antigens and enhance the 
immune response upon injection. Although the mechanism by which aluminium-containing 
adjuvants potentiate the immune response is not fully understood, it is generally accepted that the 
antigens should be adsorbed by the adjuvants [1]. The World Health Organization recommends that 
at least 80% of tetanus and diphtheria toxoids should be adsorbed onto aluminium-containing 
adjuvants [2]. Therefore, vaccines are produced by selecting adjuvants, pH, buffer, and/or ionic 
strength to achieve maximal adsorption of the antigens [1]. 
The study of Jones et al. [3] and our previous work [4] have shown changes in secondary structure 
when protein antigens are adsorbed by an aluminium hydroxide adjuvant. The stability of this 
modified structure is of major importance, since it may affect degradation of the antigens during the 
storage and/or due to high temperature, and this could potentially pose a risk to patients. The term 
stability, when it relates to proteins, is often used in a variety of ways [5]. It includes chemical 
and/or physical degradation. Chemical degradation refers to modifications involving covalent 
bonds, such as deamidation, oxidation, and disulphide bond shuffling. Physical degradation 
includes protein unfolding, undesirable adsorption to surfaces, and aggregation [6, 7]. However, the 
definition in this paper is the stability of the secondary structure of protein.  
In this study the secondary structures of two model antigens were investigated during heating and 
storage in comparison to the antigens in solutions using Fourier transform infrared-attenuated total 
reflection (FTIR-ATR) spectroscopy. For the storage experiments, apart from normal storage 
temperature (4ºC), an accelerated degradation test (ADT) was also employed, which subjected the 
samples to elevated temperature (37ºC) at which denaturation should occur more rapidly than at the 
normal storage temperature. It is well known that some vaccines are temperature sensitive [8]. Both 
high and low (freezing) temperatures can cause inactivation of vaccines. The structural stabilities of 
the model antigens were investigated at different heating temperatures in this work, since the 
temperature alterations are an important problem during the transportation and storage of vaccines, 
especially in developing countries where the quality of the cold chain is not always optimal [9].  
 
2 Materials and methods 
2.1 Materials 
Clinical reagent grade bovine serum albumin (BSA, reference L84960) and approximate 90% β-
lactoglobulin (BLG, reference L3908) were purchased from ICN biomedical Inc and Sigma 
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respectively. Both proteins were used directly without further purification. Aluminium hydroxide 
adjuvant was purchased from Superfos Biosector A/S (Denmark). A stock aluminium hydroxide 
adjuvant was prepared by adjusting pH to 8 by the addition of 1 M NaOH. All other chemicals were 
analytical grade and obtained from commercial sources without further treatment. 
2.2 Sample preparation 
A stock protein solution (20 mg/ml) was prepared by dissolving a certain amount protein in Milli-Q 
water. Model vaccines were prepared by mixing the appropriate amount of protein stock solution 
and aluminium hydroxide. The final calculated aluminium concentration was 3.4 mg/ml and the 
final protein concentrations 4 mg/ml. The final pH value for BSA and BLG model vaccines were 
7.41 and 7.60, respectively. Samples were mixed gently by end-over-end rotation for 30 min to 
obtain the maximal protein adsorption. Protein water solutions were prepared by diluting the stock 
solution to 4 mg/ml using Milli-Q water. Blank samples containing 3.4 mg/ml aluminium hydroxide 
without proteins, were prepared by diluting the stock aluminium adjuvants using Milli-Q water. 
2.3 FTIR-ATR measurement  
Spectra were collected using a FTIR spectrometer (PerkinElmer Spectrum One), which was 
mounted with a three bounces ZnSe ATR crystal (PerkinElmer). For the storage process, samples 
were stored at 4 ºC and 37 ºC between experiments, respectively. All samples were measured at 
room temperature. For the heating process, the samples were divided into different vials and were 
heated at different temperature (25, 37, 50, 60, 70, 80, 90 ºC) for 30 min, respectively; and cooled 
to room temperature before FTIR spectra were recorded.  
A sample film was obtained by depositing an 8 μl sample onto the ATR crystal and evaporating the 
solvent. The calculated amount of aluminium hydroxide for each film was 27.2 μg; and the 
calculated amount of protein was 32 μg. Spectra were directly recorded on the film by co-adding 
128 scans with a resolution of 4 cm-1 at a scan speed 0.2 cm/s. Control spectra were recorded by 
measuring the blank samples which contained the same components except protein under the same 
experiment conditions. All samples were analyzed at least in duplicate. 
2.4 Data analysis 
All FTIR spectra were analyzed using the Unscrambler ver. 9.2 software (Camo process AS). 
Replicated spectra of the same sample were averaged first. For the adsorbed proteins, the spectra of 
a corresponding blank sample were subtracted from the spectra of the adsorbed proteins. A flat 
baseline from 1900 to 1740 cm-1 was obtained for each spectrum after subtraction.  A 23-point 
  65
Savitsky-Golay smoothing function was applied to each spectrum from 1800 cm-1 to 1200 cm-1. The 
second derivative spectra were calculated using an 11-point Savitsky-Golay function from 1750 to 
1220 cm-1. The inverted second derivative spectra were obtained by multiplying by -1 for 
convenient interpretation.  Finally, the spectra were baseline corrected and mean normalized. 
3 Results and discussion 
3.1 Structural stability during the heating process 
FTIR-ATR spectroscopy was applied to monitor the secondary structure of the model antigens in 
solution and adsorbed onto aluminium hydroxide as a function of temperature. The potential 
changes of the secondary structure were detected in the amide I (1700-1600 cm-1) and amide II 
(1600-1500 cm-1) regions of the inverted secondary derivative spectra.  
For BSA adsorbed by aluminium hydroxide, the distinguishable spectral changes occur at or above 
70 ºC (Fig.4.1). Results showed that the α-helix band around 1653 cm-1decreases, but increases in 
β-sheet structure at 1636 cm-1. Another spectral difference in the amide I region observed is the 
intensity of the band at high wavenumbers 1693 cm-1. This band increases as a function of 
temperature, especially above 70 ºC. In the amide II region, the intensity of bands around 1549 cm-1 
and 1533 cm-1 decreases when the temperature increases. However, compared to the spectra of BSA 
in solution (Fig.4.2), the above mentioned heating-induced spectral changes are less pronounced. 
BSA in solution has significantly low thermal stability. A band resulting from intermolecular 
aggregation is induced around 1626 to 1622 cm-1, even at very low temperature, i.e. 25 ºC. This 
band increases as a result of increasing temperature. Two other bands increase around 1695 cm-1 
and 1680 cm-1 as function of temperature. These three bands relate to intermolecular anti-parallel β-
sheet formation [10-12]. A molecule of BSA contains 17 disulphide bonds and one free thiol of a 
cysteine residue [13]. Thus it is reasonable to assume that a new S-S bond results from 
intermolecular reaction of thiol-groups. Liu et al. [14] showed that no aggregation was observed if 
the free sulfhydryl group was alkylated. These aggregation-induced bands were also observed in 
other heat-denatured protein aggregates [15-17]. In the amide I region, the main α-helix absorption 
at 1653 cm-1 shifts to 1652 cm-1 and the intensity decreases dramatically with increasing 
temperature. Therefore, BSA in solution loses α-helix but gains intermolecular β-sheet structure. In 
the Amide II region, spectra at high temperature lose the band at 1548 cm-1, but a few bands 
increases around 1533 cm-1 and 1532 cm-1.  
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Fig.4.1 Inverted 2nd derivative spectra of adsorbed BSA in amide I and amide II regions. 
BSA was adsorbed by aluminium hydroxide and incubated for 30 min before heated at different 
temperatures for 30 min. The arrows represent increasing temperatures. 
 
The spectral stability of adsorbed BSA (Fig.4.1) differs dramatically from that of BSA in solution 
(Fig.4.2), revealing that a modified structure of BSA is induced by adsorption onto aluminium 
hydroxide. It confirms the conclusion in our previous study [4].  It also indicates that the modified 
adsorbed structure increases the thermal stability of BSA, which prevents intermolecular 
aggregating of protein during the heating process.  
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Fig.4.2 Inverted 2nd derivative spectra of BSA solution was in amide I and amide II 
regions. BSA solution was heated at different temperatures for 30 min. The arrows represent 
increasing temperatures 
 
In the case of BLG, the spectra of adsorbed protein (Fig.4.3) are also significantly different from 
that of the protein in solution (Fig.4. 4). The bands of adsorbed protein are located at wavenumbers 
that are similar to the corresponding components of the free BLG, which indicates that the 
secondary structure of adsorbed BLG dramatically changes as compared to the protein in solution. 
As the temperature is increasing, the band of the adsorbed BLG around 1630 cm-1 loses intensity, 
but there is a gain in the random structure as seen at 1644 cm-1. The main broad β-sheet band shifts 
from1636 cm-1 to 1638 cm-1.  
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Fig.4.3 Inverted 2nd derivative spectra of adsorbed BLG in amide I and amide II regions. 
BLG was adsorbed by aluminium hydroxide and incubated for 30 min before heated at different 
temperatures for 30 min. The arrows represent increasing temperatures. 
 
For BLG in solution, the spectra at different temperatures are presented in Fig.4.4. The main β-sheet 
band appears at 1628 cm-1 and the band broadens with increasing temperature. It can be seen that 
the band at 1694 cm-1 increases at high temperatures (80, 90 ºC), but no peak is induced around 
1623 cm-1. The aggregation of BLG should be similar to BSA due to intermolecular thiol-disulphide 
interchanges, since BLG also contains one free thiol group and two disulphide bridges [18, 19]. 
However, the association state of BLG results from equilibrium between its monomeric and dimeric 
forms. Dimeric BLG is characterized by having two components around 1632 cm-1 and 1623 cm-1, 
while monomeric BLG reveals only one component near 1630 cm-1 [20]. Therefore, in the current 
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experimental conditions, BLG seems to be primarily in the monomeric form. This probably results 
from low protein concentration [21, 22]. Infrared spectra of BLG vary significantly in the low 
concentration range (0.25-10% w/v) [19]. The spectra are characterized by one band between 1640 
and 1623 cm-1 at low concentrations, whereas two bands around 1634 and 1623 cm-1 are present at 
high concentrations. High temperatures [19] and low ionic strength [23] may also result in the BLG 
spectrum having one FTIR band between 1640 and 1623 cm-1 instead of two bands around 1634 
and 1623 cm-1. 
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Fig.4.4 Inverted 2nd derivative spectra of BLG solution in amide I and amide II regions. 
BLG solution was heated at different temperatures for 30 min. The arrow represents increasing 
temperatures. 
 
A small band around 1680 cm-1 is induced for free BLG at high temperature (80, 90 ºC). It can also 
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be attributed to the formation of intermolecular β-sheets that result from the self-aggregation of the 
proteins [24]. The intensity of this band is weak probably because the spectra are recorded at room 
temperature. The decreased temperature may facilitate refolding of the BLG structure. In the amide 
II region, the intensities of bands around 1551, 1534, and 1514 cm-1 increase significantly. 
In this study, no intermolecular aggregation occurred for adsorbed protein at high temperature 
(above 70 ºC), while free protein aggregates under same conditions. The results suggest that the 
adsorption onto aluminium hydroxide can prevent intermolecular aggregating of the antigen when it 
is exposed to high temperature. However, the structure of adsorbed protein also changes at very low 
temperature (37 ºC). Jones and co-workers [3] demonstrated that the transition of aluminium 
hydroxide adsorbed BSA started at approximately 35 ºC using differential scanning calorimetry. 
This temperature was lower than the temperature which caused transition of BSA in solution. Thus, 
it was concluded that proteins adsorbed to aluminium-containing adjuvant show significantly 
reduced thermal stability compared to the protein in solution. However, they only observed the 
temperatures at which the protein started to destabilize, but made no conclusion concerning the high 
temperature effects. The difference of the FTIR measurements in these two studies is that Jones et 
al. [3] measured the slurry after centrifugation compared to evaporated films which were analyzed 
in this work. When measuring slurry, the sample has to be smeared onto the ATR surface, which 
may increase the variability because the sample may not be uniform. Furthermore, the water content 
in the slurry sample may also affect the measurement of the protein spectra, although most of the 
water absorbance can be subtracted. Jones et al. [3] measured the sample at the denaturing 
temperature in comparison to room temperature in this work. Another source of variability is the 
different buffers, which were used for model vaccine preparation. A previous study illustrated that 
the influence of the buffer plays an important role in the structural stability of BSA [25].  
The thermal effect on the stability of absorbed BSA and BLG is not the same. This result agrees 
with the study of Jones at al. [3] showing that the stability of ovalbumin was less affected by 
adsorption than BSA.  
3.2 Structural stability during the storage process 
The structural stability of adsorbed antigen is important especially when the vaccine is stored for 
long periods prior to use. It is well known that vaccines lose their potency during storage, especially 
at high temperature [26]. The mechanism by which vaccine loses potency is not clear. The 
structural stability may influence the immunogenicity of the vaccine. FTIR-ATR spectroscopy was 
applied here to monitor the structural changes of protein antigens during the storage in the amide I 
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and the amide II region of the inverted secondary derivative spectra.  
 
 
 
 
 
Fig.4.5 Inverted 2nd derivative spectra of adsorbed BSA during 120 days storage in amide 
I and amide II regions. BSA was adsorbed by aluminium hydroxide and stored at 37 ºC (A) 
and 4 ºC (B) respectively.  
 
The alteration of the secondary structure of two model antigens during 4 months storage is studied 
in this work. Fig.4.5 shows the second derivative FTIR spectra of adsorbed BSA which was stored 
at 37 ºC and 4 ºC, respectively. Similar spectra indicate that the structure of adsorbed BSA by 
aluminium hydroxide is stable. Slight spectral differences occur, but the changes are irregular. The 
spectral variability may be caused by experiment-to-experiment variation and inconsistent 
measurement of the temperature. FT-NIR spectroscopy shows the same irregular alteration of 
spectra (Chapter V).  
The stability of BSA in solution stored at 37 ºC and 4 ºC were also investigated. The secondary 
structure of BSA in solution changes dramatically in 44 days (Fig.4.6), and white sedimentation is 
observed within 65 days when stored at 37 ºC. A new peak is induced at 1625 cm-1 after 16 days 
storage. The intensity of the peak increases as a function of time. The band is due to the 
intermolecular anti-parallel β-sheet formation. On other hand, α-helix band around 1653 cm-1 
decrease with increasing storage time (Fig.4.6). Thus, for BSA in solution, α-helix is reduced 
accompanied by an increase in anti-parallel β-sheet explained by intermolecular aggregation. BSA 
in solution is quite stable when it is stored at 4 ºC. The spectrum changes after 65 days of storage by 
shifting to low wavenumber (Fig.4.7). 
 
(A) (B) 
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Fig.4.6 Inverted 2nd derivative spectra of BSA solution during 44 days storage in amide I 
and amide II regions. BSA solution was stored at 37 ºC.  
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Fig.4.7 Inverted 2nd derivative spectra of BSA solution during 65 days storage in amide I and 
amide II regions. BSA solution was stored at 4 ºC.  
 
In the case of BLG, the secondary derivative FTIR spectra of adsorbed BLG stored at 37 ºC and 4 
ºC are given in Fig.4.8 and Fig.4.9, respectively. The β-sheet band around 1636 cm-1 shift to higher 
wavenumbers, and the intensity decreases as a function of time. The change is more pronounced in 
the early stage (first three weeks) of storage. On the other hand, the bands from 1606 to 1587 cm-1 
increase with storage. In the amide II region, bands around 1551 and 1534 cm-1 increase. The 
results agree with another study [27], in which it was demonstrated that adsorption of BLG to an 
oil-water interface lead to time-dependent changes in the protein structure. The dramatic changes of 
adsorbed BLG may result from free protein in the samples. BLG (4 mg/ml) cannot be totally 
adsorbed by 3.4 mg/ml aluminium hydroxide. Adsorbed BLG desorbs from aluminium hydroxide 
during storage, while the amount of adsorbed BSA remains constant (Chapter V). Moreover, if 8 
mg/ml BSA is added to 3.4 mg/ml aluminium hydroxide it will lead to more free BSA in the system 
and the sample aggregates rapidly. The data do not allow for an accurate estimation of structural 
analysis due to the aggregation after 4 weeks at 37 ºC. Therefore, free antigens in vaccine may 
facilitate the degradation of the system. FT-NIR analysis of BLG model vaccine also showed a 
time-dependent decrease of the spectral intensity (Chapter V). Furthermore, the alteration of pH 
during storage may also affect the structural stability of adsorbed BLG.  
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Fig.4.8 Inverted 2nd derivative spectra of adsorbed BLG during 120 days storage in amide 
I and amide II regions. BLG was adsorbed by aluminium hydroxide and stored at 37 ºC. 
 
For BLG in solution, the changes of FTIR spectra differ when comparing storage at 37 ºC and 4 ºC 
(Fig.4.10 and Fig.4.11). The β-sheet band at 1630 cm-1 increases and it shifts to lower wavenumbers 
1628 cm-1 for BLG solution with increasing storage time at 37 ºC. It indicates that the molecules of 
BLG aggregate due to intermolecular interaction.  No new band is induced around 1623 cm-1 
because of the low protein concentration [21, 22]. If BLG solution is stored at 4 ºC, the β-sheet 
band at 1630 cm-1 loses intensity as function of storage time. However, a band around 1545 cm-1 
increases, which can be described as random structure. In other words, BLG loses β-sheet but gains 
random structure when the solution is stored at low temperature. When BLG is stored at 37 ºC, the 
variability of the spectra around 1586 cm-1 is evident. The intensity of this band increases as 
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function of time. The band around 1608 cm-1, however, decreases with time. 
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Fig.4.9 Inverted 2nd derivative spectra of adsorbed BLG during 120 days storage in amide 
I and amide II regions. BLG was adsorbed by aluminium hydroxide and stored at 4 ºC. 
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Fig.4.10 Inverted 2nd derivative spectra of BLG solution during 65 days storage in amide I 
and amide II regions. BLG solution was stored at 37 ºC. 
.   
Based on these observations the adsorption by aluminium hydroxide prevents aggregating 
compared to the proteins in solution. Aggregation is obvious for BSA when it is stored at 37 ºC. In 
the case of BLG model vaccine, due to the low protein concentration, this phenomenon is not 
observed. As expected, at elevated temperature (37 ºC), both for adsorbed protein and free protein 
and both for BSA and BLG, the proteins denature or degrade more rapidly than at the normal 
storage temperature (4 ºC). The degradation of BLG solution differs when it is stored at 4 ºC and 37 
ºC. 
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Fig.4.11 Inverted 2nd derivative spectra of BLG solution during 65 days storage in amide I 
and amide II regions. BLG solution was stored at 4 ºC. 
 
4 Conclusion 
FTIR-ATR spectroscopy can be used to monitor the changes of the secondary structure of protein 
antigens during vaccine storage and temperature variation. This study has shown that the structure 
of an antigen can be stabilized by adsorption onto aluminium hydroxide during exposure to high 
temperature and/or during storage. It may be one of reasons why adjuvant can enhance the immune 
response and/or exert its activities [28]. This phenomenon of structural stabilization is more obvious 
for BSA than BLG, which may be ascribed to the low protein concentration of BLG. Another 
explanation is that it may be that there is more free protein which is not adsorbed onto aluminium 
hydroxide in the BLG model vaccines. In any case the structural stabilisation seems to be protein 
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specific. Free protein antigens present in vaccines may facilitate degradation of the vaccine, but 
further experiments are required to confirm this hypothesis.   
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Chapter V: Stability of model vaccines during storage analysed by NIR spectroscopy 
 
 
 
 
Abstract 
Two model vaccines were monitored during storage at normal and elevated temperatures. The 
results showed that the release of pre-adsorbed protein antigen decreases drastically. It may indicate 
why vaccine loses or decreases potency during storage. The protein adsorption by aluminium 
hydroxide and pH of vaccine also change during storage, and these two parameters are protein 
specific. NIR spectroscopy is for the first time used to monitor the aging of vaccine. The results 
suggest that it may be possible to detect the changes of adsorption/desorption of protein antigens, 
but difficult to determine the alteration of particle size during vaccine storage, even though 
analyzing the particle size of aluminium hydroxide may be practical. The rotation effects on both 
model vaccines and aluminium hydroxide are also investigated. Drastically rotation increases the 
particle size of aluminium hydroxide and may denature protein antigens. Thus, it should be 
minimised in vaccine productions.   
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1 Introduction 
It is well known that vaccines may lose potency prior to vaccination after long period storage, 
especially at high temperatures [1]. To ensure the optimal potency of vaccines, storage and handling 
need careful attention. However, the ‘cold chain’ system required during storage and shipment is 
not always optimal in developing countries [2]. The stability of vaccine especially the rate at which 
vaccine may lose its potency is of great importance to decide whether the vaccine should be 
destroyed, retesting or used [3]. It is also valuable to ensure reproducible efficacy of the 
vaccination. The loss of potency has been studied for some specific vaccines during storage at 
different conditions [4, 5], but the reason that vaccine loses potency is not clear. Previous 
investigators hypothesised that it might be due to the reversal of protein adsorption from aluminium 
adjuvant or because of the secondary, tertiary or quaternary structure or even fragmentation of the 
protein antigens [6, 7].   
To well understand the stability of vaccine and the potential reasons that vaccines lose the potency 
during storage, a few parameters such as pH, adsorption capacity onto aluminium adjuvant, in vitro 
release of the adsorbed antigen and near infrared (NIR) absorbance of two model vaccines were 
investigated in this study. To our knowledge, NIR spectroscopy (more details are available in 
Chapter I and Chapter VI) was for the first time reported here for monitoring the aging process 
during vaccine storage. Apart from stored at the normal storage temperature (4 ºC), an elevated 
temperature (37 ºC) was also applied in this study, at which the degradation of vaccine should occur 
more rapidly than at 4 ºC. 
2 Materials and methods 
2.1 Materials 
Clinical reagent grade BSA (reference L84960) and approximate 90% BLG (reference L3908) were 
purchased from ICN biomedical Inc and Sigma respectively. Both proteins were used directly 
without further purification. Aluminium hydroxide adjuvant was purchased from Superfos 
Biosector A/S (Denmark). A stock aluminium hydroxide adjuvant was prepared by adjusting pH to 
8 by the addition of 1 M NaOH. Other chemicals were all of analytical grade and obtained from 
commercial sources. 
2.2 Model vaccine preparation 
Model vaccines were prepared by mixing the appropriate amount of protein stock solution and 
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aluminium hydroxide. The final calculated aluminium concentration was 1.14 mg/ml and the final 
protein concentration was 2.5 mg/ml. Samples were mixed gently by end-over-end rotation. The 
protein adsorption capacity onto aluminium hydroxide was investigated as the function of time at 
room temperature. To study the influence of the rotation time on the aluminium hydroxide, two 
concentrations in two different tubes were studied. The samples were measured using FT-NIR 
spectroscopy and the slopes of the NIR absorption curves were probed.  
The model vaccines for storage experiments were produced at the identical conditions with 30 min 
rotation. Thereafter, all samples were stored at 4 ºC and 37 ºC, respectively.  
2.3 Experimental procedures 
Model vaccine preparation 
Protein adsorption capacity was determined by measuring the light absorbance at 280 and 320 nm 
using a UV/VIS spectrophotometer (Lamda 800, PerkenElmer instruments) with a 1 cm pathlength 
after centrifugation at 9000 × g for 10 min. Protein adsorption capacity was calculated by following 
equation (Eq. 5.1):  
Alum
pro
C
AAC
AC ε
320280 −
−
=                                                               Eq. 5.1 
where AC is adsorption capacity, ε  is extinction coefficient, Cpro is total added protein and CAlum is 
total added aluminium hydroxide, 280A  and 320A  are the UV absorbance of protein at 280 nm and 
320 nm, respectively.  
The data of rotation effects on protein adsorption capacity and aluminium hydroxide were analyzed 
using the Prism software, version 4.03 (GraphPad Software, USA). 
Stability of model vaccine during storage  
One randomly selected vial for each sample was withdrawn every week. After the sample had 
reached room temperature, pH was determined using a pH meter (Meterlab PHM220, Radiometer 
Analytical SAS).  
The same sample was gently mixed for 10 min before Fourier transform near infrared spectroscopy 
(FT-NIR) analysis using a FT-NIR spectrometer (PerkinElmer Spectrum One, PerkinElmer) with an 
InGaAs detector. Each spectrum was the average of 80 scans at 16 cm-1 resolution over the range of 
780-2500 nm. The raw NIR spectra were investigated and subsequently analysed by a partial least 
squared regression (PLS) modelling using the Unscrambler software, version 9.2 (Camo process 
AS, Oslo, Norway).  
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Protein release from aluminium hydroxide was estimated by addition of pH 7.4 phosphate buffer 
(PBS) to a final concentration of 150 mM. The samples were equilibrated at room temperature 
under continuous orbital rotation for 30 min. Then, the samples were centrifuged for 10 min at 9000 
× g. The protein in the supernatant was determined using the procedure mentioned above. The 
protein recovery from aluminium hydroxide was calculated using Eq. 3.1.   
3 Results and discussion 
3.1 The production of model vaccines  
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Fig. 5.1 Protein adsorption capacity as a function of rotation time: (■): BSA; and (▲): BLG.  
 
Vaccines are produced by mixing antigens and aluminium-containing adjuvants, and rotating the 
mixture to obtain maximal adsorption. The rotation time may affect the final protein adsorption 
capacity. In this work, we investigated the changes of adsorption capacity of two model vaccines. It 
is observed that the adsorption capacities significantly increase as a function of rotation time for 
both BSA (p <0.0001) and BLG (p = 0.04) model vaccines, see Fig. 5.1. This result may be 
explained by different mechanisms. For example the proteins aggregate and precipitate and 
therefore contribute to an overestimation of the protein adsorbed. Another reason could be an 
increase in particle size of the aluminium hydroxide. The larger particles might adsorb more 
protein. However, antigens may not easily be released from the adjuvant in this case. Therefore, 
prolonged rotation of vaccines is not recommended.   
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Fig. 5.2 Stability of aluminium hydroxide as a function of rotation time: (■): 1.14 mg/ml 
aluminium hydroxide 1.5 ml in a 2 ml tube (p = 0.04); (▲): 1.14 mg/ml aluminium hydroxide 18 
ml in a 50 ml tube (p < 0.0001); and (▼): 2.28 mg/ml aluminium hydroxide 1.5 ml in 2 ml tube (p 
=0.15). 
 
Previous studies indicated that the slope of the NIR absorption spectrum can reflect the particle size 
of suspension samples [8]. An increasing slope reflects an expanding particle size. The rotation 
effects on particle size of aluminium hydroxide are shown in Fig. 5.2. The sample with a low 
concentration aluminium hydroxide is more pronouncedly influenced by rotation time than high 
concentrations. The free space in the sample container also seems affect the results; a large free 
space leads to a more drastic change. Thus, vigorous rotation also should also be avoided for 
aluminium hydroxide.  
The model vaccines for the storage experiments are produced by gentle rotation for 30 min. The 
aluminium hydroxide is used without further treatment after pH adjustment.  
3.2 Changes in protein adsorption capacity during model vaccines storage 
Vaccines are produced by maximal adsorption of antigens onto aluminium-containing adjuvants in 
order to enhance the immune response following vaccination. Even though the mechanism by 
which aluminium-containing adjuvants potentiate the immune response is not fully understood, it is 
generally accepted that the antigens should be adsorbed to the adjuvants [9]. The World Health 
Organization recommends that at least 80% of tetanus and diphtheria toxoids should be adsorbed 
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onto aluminium-containing adjuvants [10]. 
Adsorption capacity is a measure of the maximal mass unit of protein adsorbed per mass unit of 
aluminium. It is an important parameter for physicochemical characterization of the adsorption of 
an antigen.  
The changes in adsorption capacity of two model vaccines were investigated in this work. The data 
are shown in Fig. 5.3. The mechanism of protein adsorption onto adjuvants is not clear, but 
electrostatic force and hydrophobic interactions play an important role in this process [11]. 
Aluminium hydroxide is a crystalline aluminium oxyhydroxide, which has an isoelectric point (pI) 
of approximately 11, thus, it is a good adsorbent for acidic proteins at neutral pH [12]. The 
adsorption capacities of BSA and BLG are 1.91 and 1.95 mg / mg aluminium respectively for the 
freshly prepared vaccines as measured in the present study. The adsorption capacity of BSA 
remains constant during 7 weeks of storage. It can be observed that aluminium hydroxide can 
adsorb more protein at 37 ºC than at 4 ºC. This may result from aggregation of protein at high 
temperature. In contrast, the adsorption capacity of BLG is reduced as a function of storage time 
both at room temperature and at elevated temperatures. The reduction is more pronounced within 
the first two weeks. The elevated temperature accelerates this decline. Therefore, the alteration of 
adsorption capacity during storage may be a protein specific parameter. López et al. [13] 
demonstrated that the adsorption of synthetic SPf(66)n malaria vaccine occurred with small 
variations during storage at three different  temperatures. Accelerated reduction was also observed 
when vaccine was stored at a higher temperature in their study. Adsorption of antigens onto 
aluminium hydroxide is an important parameter for inducing an adequate humoral immune response 
[14]. Reduced adsorption may result in loss of potency during vaccine storage.  
The change in antigen adsorption during vaccine storage may be caused by changes in the protein 
antigens and/or the aluminium adjuvant, as well as the changes in their interactions. In a previous 
study a continuous decline in the capacity of aluminium hydroxide to adsorb Congo red dye was 
observed during storage at temperature of 4 to 10 ºC for 5.5 years [1]. In the present study, 
however, the aging of aluminium hydroxide may not be the dominating reason, since both BSA and 
BLG model vaccines were prepared using same batch of aluminium hydroxide and stored and under 
the same experimental conditions, and yet produced different results. Degradation of protein or 
changes in the interaction between protein and adsorbent may have greater influences.  
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Fig. 5.3 Changes in protein adsorption capacity during model vaccines storage at two 
different temperatures.  
 
3.3 Protein antigen recovery from model vaccines during storage 
One hypothesis for the enhancement of immune responses by aluminium containing adjuvants is 
formation of a depot at the site of injection allowing the antigen to be gradually released [15, 16]. In 
addition to the term ‘release’, terms such as ‘displacement’ [17] and ‘elution’ [18-20] are also used 
to indicate the detachment of molecules from an interface. Release can be defined as a process in 
which other molecules displace pre-adsorbed protein molecules by competing for adsorption onto 
the surface.  
Surfactants have been well studied in the release of pre-adsorbed protein from surfaces [17-20]. 
Rinella and co-workers [20] have shown that nonionic and zwitterionic surfactants caused no or 
small degree of release of ovalbumin from aluminium hydroxide, while ionic surfactants were much 
more effective. They proposed that the effectiveness of surfactants in displacing pre-adsorbed 
proteins was directly related to their ability to denature the protein.  
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Fig. 5.4 Protein recovery from aluminium hydroxide in model vaccines during storage at two 
different temperatures. 
 
In the previous study (Chapter III), It was shown that 150 mM PBS at pH7.4 is a good candidate to 
release model antigens from aluminium hydroxide, because the phosphate anion can easily be 
adsorbed onto aluminium hydroxide by ligand exchange [21]. Protein recoveries from freshly 
prepared BSA and BLG model vaccines were 63.74% and 69.91% respectively at the present 
experimental conditions. Protein recoveries as a function of storage for the two model vaccines at 
two storage temperatures are illustrated in Fig. 5.4. The amount of released protein decreases 
dramatically in the first week, especially when the vaccines are stored at 37 ºC. The BSA recovery 
declines from 63.74% to 8.34% after one week, and the BLG recovery changes from 69.91% to 
11.23% in the same period. After 7 weeks of storage, the recoveries are 6.73% and 0.98% for BSA 
and BLG respectively. For vaccines stored at 4 ºC, the protein recoveries decrease to 28.75% and 
40.76% for BSA and BLG, respectively, after 7 weeks. The loss of protein recovery has also been 
observed for other proteins, releasing agents, and a variety of surfaces [19, 22]. An aging effect was 
noted as less fibrinogen was released from polyurethane surfaces using 3% sodium dodecyl sulfate 
(SDS) with increasing storage [23]. In another study [24], there was no protein recovery from the 
Montanide® ISA 720 adjuvant after 8 weeks storage at 37 ºC. The potency was tested and showed 
that the vaccine had lost all immunogenicity. In contrast, no aging effect was observed in the 
previous studies [25]. Aging at 4 ºC did not affect the release of lysozyme in interstitial fluid, but 
decreased the release of ovalbumin within 11 weeks storage. Furthermore, by adding SDS within 10 
days after the vaccine was prepared, Rinella et al. [20] demonstrated that there was no change of 
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protein release of the model vaccine composed of ovalbumin-aluminium hydroxide by adding SDS 
within 10 days after the vaccine was prepared. Therefore, the release of adsorbed protein is not only 
dependent on the specific protein, but also depends on the releasing agents and the absorbents.   
The loss of protein recovery may result from conformational changes of adsorbed protein molecules 
due to intra- and intermolecular aggregation which leads to a more tightly bound complex. 
However, FTIR analysis (chapter IV) showed that the secondary structure of adsorbed BSA did not 
change during four months of storage; while the structure of adsorbed BLG changed dramatically. 
The release of both BSA and BLG are reduced during storage in the present work. Therefore, the 
conformational change of the adsorbed protein is not the only reason leading to loss of protein 
release. Degradation of the aluminium adjuvant, changes in the interaction between the protein and 
the adjuvant, and changes in protein-water bonding may also play an important role.  
Another hypothesis described that the loss of protein release was due to a change in the adsorption 
mechanism from principally electrostatic attraction to the much stronger ligand exchange [25].  
3.4 Changes in pH of model vaccines during storage 
The pH was measured weekly in the two model vaccines stored at two temperatures for 7 weeks, 
see Fig. 5.5. It can be observed that changes in pH are accelerated at elevated temperature. For the 
BSA model vaccine, pH decreased during the 7 weeks of storage at 37 ºC, while it remained 
constant at 4 ºC. In the case of the BLG model vaccine, pH decreased at 4 ºC; but when stored at 37 
ºC, the pH decreased during the first two weeks and then increased. In a previous study, pH changes 
were also observed in the storage of outer membrane vesicles vaccines at 56 ºC [26]. Furthermore, 
the pH of milk samples first decreased and then increased during 100 days of storage [27].  
The pH changes may be explained by chemical degradation of the proteins, such as oxidation, 
deamidation, and fragmentation. In this connection it was noticed that the BLG model vaccine 
smelled like sulphide during the later stage of storage when opening the vial. However, this was not 
further investigated in this study. The degradation of aluminium hydroxide may also play a role in 
the pH change, since the pH of a diluted aluminium hydroxide (1.14 mg/ml) declines as a function 
of time at room temperature (Fig. 5.6). Other investigators also demonstrated that the pH changed in 
diluted aluminium-containing adjuvants [28]. The alteration of pH may affect the structural stability 
of the proteins. In chapter IV, it is shown that the structure of adsorbed BSA remained constant, 
while adsorbed BLG changed dramatically. Moreover, the structural changes of adsorbed BLG 
were different when stored at 4 ºC as compared to 37 ºC. Further experiments are required to 
ascertain whether the slight change in pH can lead structural changes. 
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Fig. 5.5 Changes in pH the model vaccines during storage at two different temperatures. 
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Fig. 5.6 Changes in pH of aluminium hydroxide (1.14 mg/ml) during storage at room 
temperature.  
3.5 Changes in NIR spectra of model vaccines during storage 
NIR can be used to monitor the amount of protein adsorbed by aluminium-containing adjuvant [29] 
as well as the particle size [29-33].  To our knowledge, this study represents the first study to use 
NIR spectroscopy to monitor the aging process during vaccine storage. The NIR spectra of BSA 
and BLG model vaccines at both 4 ºC and 37 ºC during the storage are presented in Fig. 5.7. 
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Fig. 5.7 NIR spectra of BLG (A, B) and BSA (C, D) model vaccines: stored at 37 ºC (A, C) and 4 
ºC (B, D) for 7 weeks. The arrows indicate the direction of change with time. 
 
The intensity of the NIR spectra for BLG model vaccine dramatically decreased at both 4 ºC and 37 
ºC during the storage. The decrease was more pronounced during the first two weeks. In the case of 
BSA model vaccine, the NIR spectra also changed during the storage, but not nearly as dramatic 
and furthermore, the spectral changes were not a regular function of time. In both cases, however, 
the NIR spectra underwent rapid modification with time of storage at 37 ºC. Similar changes were 
seen with samples stored at 4 ºC, although at a slower rate compared to storage at 37 ºC. The 
regular spectral change of the BLG model vaccine and the irregular spectral change of the BSA 
model vaccine during the storage agree well with FTIR-ATR studies [34].  
To investigate the mechanism behind the changes in the NIR spectra during the storage of model 
vaccines, PLS regression was performed in order to construct a calibration model correlating NIR 
(A) (B) 
(D) (C) 
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absorption (780-1300 nm) to protein adsorption (reference data of protein adsorption, see section 
3.2). The model was assessed by full cross validation and showed a correlation of 0.98 and RMSEP 
of 0.06 mg protein / mg Al, see Fig. 5.8. The model indicates that the decrease of NIR absorbance is 
due to a reduction in the amount of protein adsorbed onto aluminium hydroxide during the storage. 
The results suggest that NIR spectroscopy can be used as a fast method to monitor adsorbed protein 
in vaccine samples. 
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Fig. 5.8 PLS model: the correlation between NIR absorbance and protein adsorption, R2 = 0.98 and 
RMSEP = 0.06 mg protein/ mg Al.  
 
By inspecting the scores plots, the first principle component (PC1) describes the amount of 
adsorbed protein onto aluminium hydroxide: BSA vaccine stored at 37ºC > BSA stored at 4 º C > 
BLG vaccine stored at 4 º C > BLG stored at 37 ºC. BSA model vaccine stored at 37 ºC and 4 ºC 
are separated by PC2. This may be due to a change in particle size resulting from aggregation of 
protein antigen, aluminium hydroxide or the interaction between them. To confirm the influence of 
aluminium hydroxide, the aging of aluminium hydroxide alone is also studied by NIR spectroscopy 
in this work. The same concentration aluminium hydroxide (1.14 mg/ ml) without protein is stored 
at room temperature and measured as a function of time. The spectra are given in Fig. 5.9. The NIR 
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absorbance of aluminium hydroxide increases as a function of storage time. The change was caused 
by increasing light scattering resulting from morphological and structural changes. It indicates that 
the particle size of aluminium hydroxide change during storage. However, for the model vaccines 
the change in particle size is concealed by the changes of protein adsorption/desorption. Therefore, 
it may be difficult to determine the alteration of particle size of a vaccine during the storage using 
NIR spectroscopy.  
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Fig. 5.9 NIR spectra of aluminium hydroxide: stored at room temperature over 16 weeks. The 
arrow presents the  
 
4 Conclusion  
This study systematically monitored changes of model vaccines during storage at normal vaccine 
storage temperature and at an elevated temperature. The data presented here show that the release of 
pre-adsorbed protein antigen decreases during storage. This may indicate why vaccine may change 
potency during storage. The protein adsorption by aluminium hydroxide and the pH of the vaccine 
also change during storage, and these two parameters are protein specific. Model vaccines generally 
undergo rapid modification with the time when stored at 37 ºC. Similar changes are observed upon 
storage at 4 ºC, although at a slower rate. NIR spectroscopy is for the first time used to monitor the 
aging of vaccine. The results suggest that it may be possible to detect changes in 
adsorption/desorption of protein antigens, but impossible to determine the alteration of particle size 
during vaccine storage, even though analyzing the particle size of aluminium hydroxide alone may 
be practical. Both BSA and BLG model vaccines as well as aluminium hydroxide are profoundly 
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affected by rotation. Vigorous rotation increases the particle size of aluminium hydroxide and may 
denature protein antigens. Thus, it should be minimised in vaccine production.   
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Chapter VI: Determination of residual moisture content of lyophilized allergen vaccines by 
NIR spectroscopy 
 
 
 
 
 
 
 
 
 
Abstract 
Residual moisture content is an important parameter for lyophilized vaccines. Currently, Karl 
Fischer (KF) titration is widely used for moisture determination in routine analysis. However, this 
method is time-consuming, sample destructive and requires environment polluting reagents, as well 
as the results rely on the random samplings. Near infrared spectroscopy (NIR) was used as a fast, 
non-invasive and non-destructive method to determinate the residual moisture content in 
lyophilized allergy vaccines in this study. Five different vaccine products were investigated, which 
contained water from 0.168 to 1.51 % (w/w) analyzed by KF titration as reference measure. 
Different data pre-treatments, wavelength selection and partial least squares regression were applied 
to construct calibration models. Acceptable multi-products model (with RMSEP 10.20 μg H2O/vial, 
2 PLS factors) and product-specific models were obtained. The results summarized in this work 
suggest that NIR is an optimal alternative for determination moisture content in lyophilized 
vaccines. 
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1 Introduction 
Lyophilization (freeze-drying) is widely applied for the preservation and storage of many vaccines. 
Lyophilized vaccines always contain some water, known as residual moisture, which is usually 
constitutes between 1% and 5% of the final product after the bulk of the aqueous solvent has been 
removed during the freeze-drying process. Residual moisture content (RMC) is a critical quality 
parameter influencing not only the vaccine appearance and quality but also its shelf life [1-3]. 
Therefore, RMC should be sufficiently low so that immunological potency and integrity of the 
product are not compromised over time. However, RMC of the vaccine should not be so low that 
the properties of the product are deteriorated due to over-drying.  Over-drying results in broken 
product cake. It may also cause the structure of the antigen to change, which may induce 
aggregation of the protein complex, and lead to increased difficulty predicting the release profile of 
the antigens. Furthermore, RMC is also an important parameter for manufacturers to control their 
lyophilizing cycle.  
Pharmaceutical companies have to verify that the RMC in their products is consistently within 
specifications. Currently, KF titration is widely used for RMC determination in lyophilized 
products [4]. This method is time-consuming, sample destructive and requires environment 
polluting reagents. Thermogravimetry and gas chromatography are also applied for RMC analysis 
[5, 6]. However, the methods are also expensive, time-consuming and destructive. Ambient 
moisture may affect the results for low moisture level samples since the vials have to be opened 
before analysis. IN addition, many random samples have to be analysed for each batch in the 
production line, which is a resource consuming procedure, and random sampling has inherent 
disadvantages. Clusters of products deviating in water content caused by momentary production 
problems may not always be monitored and entire batches of the product may have to be rejected 
due to the results from the outliers that have been sampled. It would therefore be advantageous to 
replace these procedures with an automated online method.  
Near infrared spectroscopy (NIR) offers many advantages over traditional methods for moisture 
determination. It is a physical, non-invasive, non-destructive method. Thus, the analysis can be 
performed through sealed glass vials, directly on the final product without opening the vials. It is 
suitable for online analysis because NIR radiation can penetrate the glass vial making sample 
preparation redundant. NIR analyses are typically rapid and the spectra provide information on both 
physical and chemical properties of the product analysed, such as sample identity and 
concentration, particle size, hardness, and even taste. NIR is easy and safe to use, since there is no 
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sample preparation, no reagents are used, and no wastes are produced. Lastly, the use of NIR 
spectroscopy avoids random sampling in the control of RMC.  
Water is the strongest absorbing compound in the NIR region, exhibiting four absorption maxima 
around 970, 1190, 1450, and 1940 nm. The NIR absorption of water has been well investigated 
because of its importance in all applications of the technique. Strong absorption bands of water 
appear around 1400-1450 nm and 1900-1950 nm, which are due to the first overtone of OH 
stretching and combination of the OH stretching band and OH bending [7]. Variations in the water 
band around the 1400 nm region are dependent on the state of water in the sample. In samples with 
a water content reaching 70-90% the adsorption band appears at similar wavelengths to those of 
pure water, around 1400-1410 nm. In dry samples the band associated with free water seems to 
disappear except for a trace of absorption near 1430 nm [8]. These two bands have often been used 
to quantify water content in various samples. Other water bands in the NIR region are located at 970 
nm and 1190 nm. The intensities of these bands are not strong, since they arise from the second 
overtone of the OH stretching band, as well as the combination of the first overtone of the OH 
stretching and the OH bending [7].  
The determination of moisture content by NIR spectroscopy in both transmittance and reflectance 
modes have been described extensively in the literature, covering applications in agriculture, 
forestry, textiles, chemicals, and pharmaceutical areas. NIR has been used for lyophilized products 
and for tablet analyses. NIR is also applied to measure the amount of moisture during granulation, 
drying, and purification stages of solids and liquids, and the monitoring of moisture during process 
optimization [9-16]. Most of the early studies using NIR for water determination have been 
summarized and discussed by Blanco et al. [13], and recent applications have been reviewed by 
Reich [9]. 
NIR applications for protein pharmaceuticals, however, have not been widely adopted [9, 11]. 
Lyophilized pharmaceutical products typically contain 1% to 2% residual water, which is a narrow 
range for the construction of a calibration model. In order to compensate for the narrow range 
previous studies have extended the range by adding artificial samples, which were obtained by 
adsorbing and/or further secondary drying [11, 17]. The artificial calibration samples, however, 
were damaged before NIR measurements, and the model did not improve the prediction results 
significantly.  
To our knowledge, NIR has never been used to determine RMC in vaccine products. The objective 
of this study was to develop a non-invasive, non-destructive and rapid method for RMC 
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determination for lyophilized allergen vaccines. All samples were directly measured using a Fourier 
transform NIR (FT-NIR) spectrometer without sample preparation, i.e. through the bottom of the 
intact glass vials by diffuse reflectance. A general calibration model was constructed for five 
vaccine products using KF titration as reference method. Calibration models for each vaccine 
product were also built for comparison. The models were validated by cross validation.  
2 Materials and methods 
2.1 Samples 
Five different lyophilized allergy vaccine products, a total of 95 vials were collected by random 
sampling. Detailed information is given in Tab. 6.1.  
2.2 NIR measurement 
All NIR measurements were carried out using a FT-NIR spectrometer (PerkinElmer Spectrum One, 
PerkinElmer) with an InGaAs detector. NIR spectra were collected in the reflectance mode at 
ambient temperature, although products were stored refrigerated. Each spectrum was the average of 
80 scans at 16 cm-1 resolution over the range 700-2500 nm. For each sample, four spectra were 
collected by rotating the vial in different angles. Therefore, a total of 380 spectra were obtained. 
2.3 KF titration analysis 
After NIR measurement, the same vials were analyzed for RMC using a 737 KF Coulometer 
(Metrohm, Switzerland). A well-defined amount of dry methanol (1 ml) was added to each test vial. 
The vial was mixed thoroughly using a Vortex mixer until the sample was uniform. The vial was 
incubated at room temperature for two hours, and centrifuged at 2000 rpm. The RMC was detected 
immediately after centrifugation. A plastic syringe was rinsed first using dry methanol.  
Approximately 400 μl sample was drawn into the syringe.  Pointing the needle upwards, air bobbles 
and excess materials was removed until 350 μl samples remained in the syringe. Sample was added 
under the surface of the fluid. The needle was pulled away from the surface of the fluid, and 
simultaneously the plunger was drawn back to avoid leaving sample drops inside the membrane. 
Then the equipment was started. 
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   Tab. 6.1 The detailed information of calibration samples 
Vaccine 
products 
Concentration 
of allergy 
(SQ-U) 
Vials of each 
concentration 
Batches of 
each 
concentration 
Total bottles RM 
(μg/vial, 
KF) 
45 3 3 
450 3 3 
4500 3 3 
45000 2 3 
Api mel 
450000 5 3 
16 22.9-70.7 
45 6 2 
450 7 2 
4500 6 2 
45000 6 2 
Cat 
450000 8 2 
33 16.8-122.7 
45 1 1 
450 1 1 
4500 1 1 
45000 1 1 
Der 
450000 3 1 
7 24.9-74.4 
45 2 2 
450 2 2 
4500 2 2 
45000 4 2 
Grass 
450000 6 2 
16 22.4-66.1 
45 3 3 
450 3 3 
4500 3 3 
45000 3 3 
Ves 
450000 11 3 
23 24.6-151.0 
 
The final RMC for each sample was calculated from the following formula (Eq. 6.1): 
D
CBARMC ∗−= )(
                                                                   Eq. 6.1  
A= measured water content 
B= blank (average of 3 measurements of 350 ml dry methanol) 
C= volume of methanol added (ml) 
D= volume of methanol injected (ml) 
The RMC was given in μg for each vial (μg H2O/vial).  
2.4 Calibration model construction 
The KF data were assigned to their corresponding NIR spectra. Partial least squares (PLS) 
regression was performed to build calibration models using the Unscrambler software, version 9.2 
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(Camo process AS). Different data pre-treatments were applied to remove baseline offset and other 
physical information before PLS regression. The number of PLS components or factors (PLS 
factors), correlation (R2) and root mean square error of prediction were used to describe the 
calibration models.  
 
 
Fig. 6.1 380 NIR spectra of 95 calibration samples: raw spectra (A), EMSC spectra (B), EMSC + 
2nd derivative (C), SNV (D). X axis represents wavelength (nm) and Y axis represents NIR 
absorbance (log (1/R)). 
 
3 Results and discussion  
3.1 Relationship between RMC and NIR data 
The major challenges in this work are the small amount of sample, low RMC, and variances of 
sample cakes and bottles. The sample amount is approximately 10 mg/vial. The overall range of 
RMC in these lyophilized samples (as analyzed by KF titration and given in Tab. 6.1) is in the range 
from 16.8 to 151.0 μg/vial, which correspond to 0.17 – 1.51% (w/w). The detailed information of 
RMC in each vial is presented in Appendix I. Raw NIR spectra of the 95 calibration samples are 
(A) (B) 
(C) (D) 
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shown in Fig. 6.1.A. Because of the small amount of sample a part of the NIR radiation passes 
through the sample cake and cannot be reflected back to the detector, which results in low NIR 
absorbance and baseline offsets. Light scattering due to the physical conditions of the sample such 
as particle size, density and bottle variation affect the raw spectra as well. Due to these reasons and 
the very low water content, the two water bands at 1400-1450 nm and 1900-1950 nm are almost 
missing, especially for the latter peak.  
 
 
   Fig. 6.2 The correlation between RMC and protein content 
 
Different methods of data pre-treatments were tested to remove the effect of light scattering, see 
Fig. 6.1. In Fig. 6.1.B the spectra are shown after pre-treatment using extended multiplicative 
scatter correction (EMSC). EMSC is a method suited for removal of physical effects from the 
chemical information [18]. By visual inspection of the EMSC spectra, there is no clear quantitative 
relationship between the NIR adsorption and the RMC levels, although most light scattering 
interferences in the raw spectra are drastically reduced. However, these lyophilized samples contain 
not only residual moisture, but also other components, such as antigens, adjuvants, inorganic salts, 
and other chemicals to facilitate the lyophilizing process and cake formation. All these compounds 
may interact with water, which results in spectral variation in other regions. Water information can 
also be derived from these spectral alterations indirectly. For example, there is 60% correlation 
between RMC and the protein contents in the data set, see Fig. 6.2. 
3.2 Multi-products calibration model for RMC 
Since no clear correlation between differences in the NIR spectra and RMC at 1400-1450 nm and 
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1900-1950 nm were detected, all significant X variables (wavelength) after Jack-knifing were taken 
into account in the calibration model. For comparison, one NIR water band (1900-1960 nm) was 
also investigated to construct models.  First, we attempted to make build one model w involving all 
five vaccine products using PLS regression. The sample size in this study was not large enough, 
even though it covered 5 products, 3 batches and 5 different antigen concentrations. To solve this 
problem all NIR spectra were used as calibration data set instead of dividing them into calibration 
and prediction data sets. Calibration models were built after different data pre-treatment procedures 
and assessed by segment cross validation (numbers of each segment is four, since there are four 
spectra for each sample). The models that considered the whole wavelength were rebuilt using 
significant X variables from Jack-knifing. Each pre-treatment performed differently and the 
corresponding results for the prediction are listed in Tab. 6.2. 
Acceptable correlations (from 0.88 to 0.93, Tab.2) were obtained for each PLS model. This is an 
indication that PLS is a good tool that can extract spectral variations related to varying moisture 
levels. Spectral pre-treatments are preformed to remove the spectral noise and improve the 
performance of the calibration models. In this study, most pre-treatment methods applied (Tab. 6.2) 
improved the performance of the calibration models. NIR region 1900-1960 nm is still a good 
wavelength window for quantitative water analysis; even though there were no clear water band 
alterations in the spectra by visual inspection. The model based on this region was better than the 
model with the significant X variables from Jack-knifing, since less PLS factors were used. This is 
due to less noise in region 1900-1960 nm. Spectra should contain more information when spanning 
the entire NIR window, but also contain more noise. Thus, it requires more PLS factors to explain 
the data set.  
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   Tab. 6.2 Calibration models built by PLS regression with different data pre-treatment 
methods based on the entire data set: MSC- multiplicative scatter correction; SNV- standard 
normal variate; EMSC- Extended multiplicative scatter correction; PLS factors- PLS components 
or factors; RMSEP- root mean square error of prediction 
Wavelength 
window  
Data  
Pre-treatment 
Jack-knifing Optimum 
PLS factors  
Correlation  RMSEP  
(μg H2O/vial) 
None Yes 8 0.88 12.02 
Baseline 
correction 
Yes 8 0.88 10.91 
MSC Yes 10 0.89 11.73 
2nd derivative  Yes 7 0.89 11.38 
SNV Yes 8 0.88 12.00 
EMSC Yes 6 0.93 8.83 
Whole region 
EMSC +  
2nd derivative  
Yes 5 0.92 8.85 
None  No  4 0.90 10.37 
EMSC No 3 0.91 9.09 
2nd derivative  No  2 0.90 10.20 
SNV No  3 0.89 10.82 
Baseline  No 2  0.90 10.37 
Baseline +  
2nd derivative  
No  5 0.88 11.31 
1900-1960 
EMSC +  
2nd derivative  
No 2 0.90 10.23 
 
The best calibration model was obtained with second derivative data over region 1900-1960nm 
after removal of 4 outliers. The model has a RMSEP of 10.20 μg H2O/vial with 2 PLS factors. The 
RMC correlation plot of the data set for the best EMSC model is given in Fig. 6.3. For this plot, a 
slope of 1 and an offset of 0 should be ideal. In this case, a slope of 1 and an offset of -3.83 × 10-7 
were achieved. Correlation was 0.90 and the root mean square error of deviation (RMSED) was 
9.94.  
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   Fig. 6.3 The RMC correlation plot between NIR prediction and KF measurement: slope is 1; 
offset is -3.85 × 10-7; correlation is 0.90; and RMSED is 9.94 μg/vial. 
 
 
   Tab. 6.3 Calibration models built by PLS regression with different data pre-treatment 
methods based on the reduced data set 
Wavelength Data 
pre-treatment  
Jack-knifing Optimum 
PLS 
factors 
Correlation RMSEP 
(μg H2O/vial) 
None Yes 8 0.89 10.90 
EMSC Yes 3 0.90 9.96 
2nd derivative Yes 7 0.92 8.90 
whole region 
EMSC +  
2nd derivative  
Yes 5 0.93 8.75 
None  No  4 0.89 10.59 
EMSC No  2 0.92 8.99 
2nd derivative  No 2 0.90 9.23 
1990-1960 
EMSC +  
2nd derivative  
No 2 0.90 9.75 
 
Four NIR spectra were recorded for each sample at different angles. These four spectra should yield 
same information, e. g. RMC, if the angle effect can be completely excluded. In this case the four 
spectra can be regarded as four replicates. Therefore, the four NIR spectra can be averaged to one 
spectrum for each sample. A total of 95 spectra for 95 samples were obtained in this case. 
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Calibration models were built on this reduced data set using different pre-treatments and assessed 
by full cross validation. The results are shown in Tab. 6.3. The best calibration model was obtained 
with EMSC data over 1900-1960 nm after removing 5 outliers. The model had a RMSEP of 8.99 μg 
H2O/vial with 2 PLS factors. The RMC correlation plot of the reduced data set for this calibration 
model is presented in Fig. 6.4. This plot is slightly better than the one based on the entire data set 
because of the higher correlation (0.93) and lower RMESD (8.65).  
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Fig. 6.4 The RMC correlation plot between NIR prediction and KF measurement base on 
reduced data set: slope is 1; offset is -4.25 × 10-6; correlation is 0.92; and RMSED is 8.64 μg/vial. 
 
The best model, which was based on the reduced data, did not differ significantly compared to the 
model with the original data set. This shows that the angle effect cannot be excluded, and these four 
spectra resulting from 4 different angles may therefore not represent the real information of the 
sample. This interference may, however, be removed with a sample spinner. A spinner rotates the 
sample during detection resulting in a truly average spectrum.   
3.3 Product-specific calibration model for RMC 
The multi-calibration model set included five different products; however, different protein antigens 
may interact with water in different ways affecting the final calibration model. To investigate the 
product-specific effect, calibration models were built for each product except Der, because the 
samples size (n=7) was too small. Calibration models were constructed on the reduced data set (the 
average spectrum of the four spectra resulting from four different angles for each sample) and 
assessed by full cross validation using different data pre-treatment methods in two wavelength 
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windows: whole wavelength and 1900-1960 nm. The results are shown in Appendix II. 
 
   Tab. 6.4 Comparison of multi-product models and product-specific models 
Models  Optimum 
PLS factors 
Correlation  RMSEP  
(μg H2O/vial) 
RMSEP 
 (% w/w) 
Multi-products model  
(all data set) 
2 0.90 10.20 0.10 
Multi- products model 
(reduced data set) 
2 0.92 8.99 0.09 
model for Cat 
(reduced data set) 
2 0.95 8.66 0.09 
model for Grass 
(reduced data set) 
1 0.92 5.54 0.06 
model for Ves (reduced 
data set) 
2 0.97 6.66 0.07 
 
Both EMSC and second derivative pre-treatment improved the performance of the calibration 
models for each product. Wavelength selection e.g. 1900-1960 nm, also benefits the models for Cat 
and Ves. The best calibration model for Cat is obtained with 2nd derivative data over the significant 
X variables in region of 1900-1960 nm. The model has a RMSEP of 8.86 μg H2O/vial with 2 PLS 
factors. For Grass, the best calibration model is achieved with EMSC data over the significant X 
variables in the whole NIR region. The model possesses a RMSEP of 5.54 μg H2O/vial with one 
PLS factor. The best model for Ves is gained with 2nd derivative data using the significant X 
variables in region of 1900-1960 nm. The model has a RMSEP of 6.66 μg H2O/vial with 2 PLS 
factors. The RMC correlation plots of the calibration data sets for the best models are shown in Fig. 
6.5.  
For the Api mel product it was not possible to build an acceptable calibration model for the 
determination of RMC. This may be caused by the small sample size (n=16) and large batch effect 
(3 batches). Further investigations are acquired for this product.    
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For comparison, in Tab. 6.4, both the product-specific calibrations models and the multi-product 
models are outlined. The product-specific models are slightly better than the multi-product models; 
(A) 
(B) 
(C) 
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however, the sample sizes in the current product-specific models are not large enough, because 100 
samples is ideal in a training data set [19]. Thus, further investigations are required for the product-
specific models. Nevertheless, a multi-product calibration model is more useful for routine analysis 
because of easy use. 
4 Conclusion 
This study for the first time demonstrates that NIR spectroscopy is reliable method for RMC 
prediction in lyophilized allergy vaccines. RMC results obtained from NIR spectroscopy show good 
agreement with results obtained by KF titration. The acceptable product-specific models and multi-
product models indicate that NIR spectroscopy can be used as a quantitative method to determine 
RMC in lyophilized allergy vaccines. The models based on product-specific data are slightly better 
than models based on multi-product data; however, a general multi-product model is more useful, 
since one model can predict all samples in a pharmaceutical production of allergy vaccines.  
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Chapter VII: Classification and identification of lyophilized allergen vaccines by NIR 
spectroscopy 
 
 
 
 
 
 
 
Abstract  
In pharmaceutical production scenario quality control is essential to guarantee safety, efficacy and 
reproducibility of the products. However, there is no method which can meet all requirements in 
routine analysis. Near infrared spectroscopy combined with SIMCA as a rapid non-destructive tool 
to classify and identify allergy vaccines at different concentrations, different species and different 
batches has been demonstrated in this work. The results indicate that the highest concentration 
vaccines are successfully classified from low concentrations (100% at the level of 95% confidence) 
without the bee venom (api). Five different vaccine products at highest concentration are 
discriminated from each other by a SIMCA model. The classification of different batches may be 
possible for the highest concentrations vaccines. However, more experiments are required for low 
concentration samples and if many batches involved data. The results indicate that NIR 
spectroscopy can be applied as a rapid and non-destructive tool to classify and identify allergen 
vaccines.  
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1 Introduction  
In a pharmaceutical production scenario, quality control is essential to guarantee safety, efficacy 
and reproducibility of products, as well as to document identity, potency, and quality. Quality 
control involves analysis of raw materials, intermediate productions, and final products [1], and 
thus, quality control is performed in different ways, and at different steps in the production as well 
as in careful analysis of final products [2]. In every case, a lot of random samples have to be 
withdrawn and analysed in order to control the production process in an optimal way [3]. 
Conventional quality control methods involve time-consuming, laborious, and costly procedures, 
and often also require reagents [4], which also needs to be controlled. It would be desirable to 
overcome these disadvantages by the introduction of new methods. The new technique should be 
sufficiently accurate and precise and without sample preparation, preferentially with simultaneous 
determination of several parameters in a single experiment; and it should be fast, efficient, and 
suitable for online or inline analysis [1]. Near infrared spectroscopy (NIR) is such a method. 
NIR spectroscopy has many advantages over other analytical techniques. It offers many interesting 
applications in pharmaceutical research, production, and quality control, such as identification and 
qualification of raw materials, product quality control and process monitoring. Reich [5] recently 
reviewed the application of NIR in the pharmaceutical industry.  NIR spectroscopy has played a 
significant role in quality control analysis to identify and classify the material [6-8]. NIR users have 
called this application ‘qualitative analysis’, ‘discriminant analysis’, ‘product identification’,  
‘pattern recognition’, or other terms [6]. 
In our previous study, NIR was demonstrated to be an as a fast, non-invasive, and non-destructive 
method to determine the residual moisture content in lyophilized vaccines in Chapter VI. The 
advantages of NIR spectroscopy has been discussed as well. One great advantage of NIR is that a 
variety of information can be extracted from a same spectrum. Besides moisture content, the same 
spectrum contains information capable of classifying and identifying different vaccine products. 
Moreover, it is an easy way to provide information of the reproducibility from batch to batch. In the 
present work, we describe a simultaneous and rapid identification and classification assay for the 
determination of different species of allergy vaccines at different concentrations and different 
batches. 
2 Materials and methods 
2.1 Samples 
Commercially available allergen vaccines (ALK-Abelló A/S, Denmark) used in this study 
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comprised the following species:  bee venom (api), cat hair and dander (cat), house dust mite (der), 
grass pollen (grass), and wasp venom (vespula). A total of 665 random samples representing 
different concentrations and different batches were sued.  Detailed information is given in Appendix 
C.  
2.2 NIR measurement 
All NIR measurements were carried out using a FT-NIR spectrometer (PerkinElmer Spectrum One, 
PerkinElmer) with an InGaAs detector. NIR spectra were recorded in the reflectance mode through 
the bottom of the intact glass vials at ambient temperature. Each spectrum was the average of 80 
successive scans at 16 cm-1 resolution. The spectral region used for the data analyses was from 700 
to 2500 nm, the data were measured in 1.67 nm intervals, which resulted in 1078 data points per 
spectrum. For each sample, four spectra were collected by rotating the vial at different angles. 
Therefore, a total of 2660 spectra were obtained. 
2.3 Data analysis 
Spectra were exported in ASCII format into The Unscrambler software, version 9.2 (CAMO, Oslo, 
Norway) for further analysis.  
3 Results and discussion 
3.1 Data pre-treatment  
Since multivariate NIR spectral data contain huge numbers of X variables and because of the large 
sample set (665 samples), there is a need to reduce the number of X variables for relatively rapid 
analyses. An increase of the data interval to 8.35 nm result in each spectrum having 216 data points 
after reduction. The entire data set is randomly divided into a calibration set (training set) and a test 
set, with the calibration set being sufficiently large (532 samples) to detect unknown variation. The 
test data set (665 samples) is composed of the calibration set (532 samples) and other new samples 
(123 samples).   
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Fig 7.1 NIR spectra of five allergen vaccines: raw spectra (A); EMSC spectra (B); the mean 
EMSC spectra for each vaccine product at region 2000-2400 nm (C); EMSC 2nd derivative 
spectra at region 2000-2400 nm (D). X indicates wavelength (nm) and Y represents 
absorbance: )/1log( RA = . 
 
Raw NIR spectra often exhibit a baseline shift due to variation in the sample presentation and 
properties of the samples. Due to the small amount of sample (10 mg/vial), part of the NIR radiation 
passes through the sample cake and cannot be reflected back to the detector, which results in low 
NIR absorbance and baseline offsets (Fig. 7.1A). Other parameters can affect the spectra as well, 
such as particle size, density, vial variances, temperature, humidity, and the stability of the 
instrument. Different data pre-treatment methods are applied to remove the influence of light 
scattering. Among these methods, EMSC is effective to remove physical effects from the chemical 
information [9].  
(C) (D) 
(A) (B) 
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The spectra after EMSC pre-treatment are shown in Fig. 7.1B. Most light scattering interferences in 
the raw data are removed by the EMSC function. In Fig. 7.1C, the mean EMSC spectra of five 
different vaccines at the highest concentration are shown in the region from 2000 nm to 2400 nm. 
By inspection of these spectra, the shapes of the spectra are slight different from each other. It 
indicates that the classification of different vaccine products may be possible. The second derivative 
spectra are calculated using a segment of 3 points Savitsky-Golay function from 2000 nm to 2400 
nm on the EMSC data, and are shown in Fig. 7.1D. After EMSC and second derivative correction, 
the spectral differences are more distinguishable.  
3.2 Classification of different concentrations for vaccine products 
Each vaccine product is represented in five different concentrations in this work, from 45 to 
450,000 SQ with a 10 fold interval. A single principal component analysis (PCA) model for five 
products is constructed using the EMSC + 2nd derivative data at wavelength region from 2007 to 
2408 nm. This wavelength window contains much protein information. The PC1 and PC2 score 
plots are shown in Fig. 7.2. Samples are grouped by different concentrations in Fig. 7.2A, and the 
same plot is also showing grouping by different products in Fig. 7.2B. It is easily observed that the 
highest concentration (i.e. 450,000 SQ) is separated from the other four low concentrations, except 
for the api samples, where only two PCs are used. The first and second PC can explain 84% and 9% 
data variance, respectively. From the analysis of the score plots, it is evident that the PC1 promotes 
the separation of different concentrations. However, the api samples at 450,000 SQ are overlapping 
with low concentrations even though more PCs are used. Thus, the discrimination of api at 450,000 
SQ from other products concentrations may be impossible when using one single PCA model. After 
excluding the api samples, a new PCA model was built for other four products. The score plot is 
given in Fig. 7.2C. All samples containing the highest concentrations are discriminated from the 
low concentrations by the PC1. The SIMCA model is constructed on two PCA models of highest 
concentration and low concentrations.  
To verify the prediction ability of the SIMCA model, a test data set consisting of the calibration 
data and 73 new samples were predicted. The results showed almost 100% correct predication at a 
confidence level of 95% except a few outliers which were removed during the building of the PCA 
models. The predicting results in details are available in Appendix D. 
Due to the complicated nature and heterogeneity of the data set (different species, concentrations 
and batches), the other low concentrations (e.g. < 450,000 SQ) cannot be distinguished with the use 
of one single PCA model. The classification of low concentrations may be possible if a PCA model 
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is built for each specified product. However, the classification using too many PCA models is 
troublesome in routine quality control.   
3.3 Classification of different vaccines at the highest concentration 
A single PCA model was constructed for five different kinds of vaccines at the highest 
concentration (i.e. 450,000 SQ) based on EMSC data at wavelength from 2007 to 2408 nm. The 
three dimensional score plot is shown in Fig. 7.3. The different vaccines were distinguished from 
each other. The PC1, PC2 and PC3 explain 79%, 12% and 5% data variance, respectively.   It is 
observed that the api and vespula vaccines are not related in the score plot, even though both belong 
to the venom group of vaccines. This may indicate that the protein antigens in these two vaccines 
are not similar. The influence of excipients may also play a role. The batch to batch difference for 
vespula vaccine is quite clear: one batch is totally separated from the other two batches.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.3 The score plot of five different kinds of vaccines at concentration of 450,000 SQ. 
A—api; C—cat; D—der; G—grass; and V—vespula.  
 
The SIMCA model was built on PCA models from each product. The predictions of the SIMCA 
model was verified by using a test data set containing the calibration data and the other new 18 
samples. A hundred percent correct prediction results at a confidence level of 95% was obtained. 
Detailed information about the prediction is available in Appendix E. 
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3.4 Classification of different batches of the same vaccine product at different 
concentrations  
One single model, which can predict different batch samples for all products, is not possible 
because the variables of concentration and species are more distinguishable in the data set. 
Therefore, the model for classifying different batches has to be built on specific products and 
specific concentrations. In the following section, PCA and SIMCA models are constructed for each 
product at each concentration except der vaccine since it only contains one batch samples.  
 
 
Fig. 7.4 The score plots of three batches of vespula vaccines. (A) 450,000 SQ; (B) 45,000 
SQ: 3—0000031223-7; 4—0000040986-16; 5—0000052716-20 (C) 4,500 SQ; (D) 450 SQ: 
1—0000031223-7; 2—0000040986-16; 3—0000052716-20 
 
 
Classification of different batches for vespula vaccines 
A PCA model was constructed for the vespula vaccine at concentration of 450,000 SQ using EMSC 
data after one outlier had been removed. The whole wavelength region was applied in this case, 
(A) (B) 
(C) (D) 
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since batch to batch difference not only results from the differences in the antigens, but the 
excipients play a more important role. Thus, wavelength selection (e.g. 2000-2400 nm) may not 
give a good calibration model. Fig. 7.4A shows the PC1 and PC2 score plot. It is observed that 
three different batch samples are separated from each other using two PCs. Since there are no 
influences from different species and concentrations, the batch variable has the largest data 
variance, and PC1 explains 70% data variance. PCA models for low concentrations (e.g. 45000, 
4500 and 450 SQ) vespula vaccine were also built using EMSC data at the entire wavelength 
window. The PC1 and PC2 score plots are shown in Fig. 7.4. The three different batch samples are 
almost discriminated from each other. 
The predictive ability of the SIMCA model of 450,000 and 45,000 SQ vespula was tested by data 
set consisting of the calibration set and 6 new samples, respectively. Almost 100% correct 
prediction results at a confidence level of 95% was obtained in both cases. The detailed information 
can be seen in Appendix F and Appendix G. However, the correct prediction for low concentrations 
of vespula (e.g. 45, 450 and 4500 SQ) decreases, since the samples are smiliar, even though 
different batches can be grouped in the score plots (Fig. 7.4C and Fig. 7.4D).  
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Fig. 7.5 The score plots of three batches of api vaccines at 450,000 SQ. 1—0000030417-21; 
2—0000041728-849; 3—0000050932-7 
 
Classification of different batches for api vaccines 
A PCA model for api vaccine at 450,000 SQ was constructed using EMSC data at the whole 
wavelength window. The PC1 and PC2 score plot is shown in Fig. 7.5. Three batch samples are not 
overlapping after removal of outliers. PC1, PC2 and PC3 explain 62%, 26% and 4% of the variance 
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respectively. The classification of the SIMCA model is verified by the calibration data and 14 new 
samples. About 78.5% correct predication result is obtained at a confidence level of 95%. This is an 
indication that the variable from batch to batch is not so clearly distinguishable in t this case. The 
detailed information is available in Appendix H. For the low concentration (< 450,000 SQ) api 
vaccine, the classification for each batch is not possible because of the similarity of the samples.   
 
Classification of different batches for cat vaccines  
PCA models were built for cat vaccines for each concentration using EMSC data at the whole 
wavelength region after removal of a few outliers. The PC1 and PC2 score plots are shown in Fig. 
7.6. Two batches were discriminated by PC1 for all five concentrations. Correct predictions results 
at 95% confidence level were gained for all SIMCA models which were tested using new test set. 
The detailed results are given in Appendix I to Appendix M. 
 
Classification of different batches for grass vaccines 
PCA models of the grass vaccine were constructed for each concentration using EMSC data at 
whole wavelength window after removal of outliers. The two batches at each concentration were 
well separated in PC1 and PC2 score plots (Fig. 7.7.), except for the concentration of 4,500 SQ 
(Fig. 7.7C) which is given in the PC1 versus PC3 plots. PC1 explains most data variance resulting 
from batch to batch difference. The prediction ability of the SIMCA models is tested using a test 
date set including calibration data and new samples. The results show correct predictions at a 
confidence of 95%. The predicted results are shown in Appendix N to Appendix R.  
For batch classification, when many batches are involved, the heterogeneity and complexity of the 
data set will increase, and this may reduce the reliability of the classification. More experiments are 
required to address this question. On the other hands, batch differences do not constitute a big 
problem for the allergen vaccines.  
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Fig. 7.6 The score plots of two 
batches of cat vaccines. (A) 450,000 
SQ; (B) 45,000 SQ;  (C) 4,500 SQ; (D) 
450 SQ; (E) 45 SQ; 3—0000032114-9; 
4—0000045531-5 
 
 
 
 
 
 
 
 
 
 
(A) (B) 
(C) (D) 
(E) 
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Fig. 7.7 The score plots of two batches of 
cat vaccines. (A) 450,000 SQ; (B) 45,000 
SQ;  (C) 4,500 SQ; (D) 450 SQ; (E) 45 SQ; 
3—0000032135-40; 5—0000050955-9 
 
 
 
 
 
4 Conclusion 
The potential of NIR spectroscopy and SIMCA as a rapid non-destructive tool to classify and 
identify allergy vaccines at different concentrations, different species and different batches has been 
demonstrated in this work. The results indicate that for the highest concentration of vaccines, a 
successful classification can be preformed from low concentrations (100% at the level of 95% 
confidence), with the exception of the api samples. Five different vaccine products at the highest 
(C) (D) 
(E) 
(B) (A) 
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concentration were discriminated from each other by a SIMCA model. The classification of 
different batches is possible when products at high concentrations are analyzed. However, more 
experiments are required for the low concentration samples and for analysis including many 
batches. The results indicate that NIR spectroscopy can be applied as a rapid and non-destructive 
tool to classify and identify allergy vaccines. If implemented this technique will increases the 
efficiency and decreases the costs of the quality control procedures in the allergy vaccine 
manufacturing industry.  
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Chapter VIII: Conclusions and perspectives 
 
Vaccine has had greatest impact on the world’s health. It prevents disease and death for millions of 
individual every year. For allergic diseases, SIT is the only treatment that may affect the course and 
it also may prevent the development of asthma in patients with allergic rhinitis. A successful SIT is 
dependent on the use of high quality allergen vaccines that are properly standardized and can be 
manufactured consistently. Allergen vaccines are produced by adsorption antigens onto ACA to 
accelerate and prolong the specific immune response towards the desired response. To well 
understand antigens and vaccines and to produce high quality vaccines and manufacture 
consistently, this study focuses on the structures of model antigens when they are adsorbed by 
aluminium hydroxide and when they are subsequently released. In relation this, the mechanism of 
ACA is also discussed. The stability of vaccines is investigated during storage and under different 
temperatures. A fast, non-destructive method is introduced for determining the residual moisture 
content and classification of lyophilized allergy vaccines as well.  
In chapter I, the background and purposes of the thesis are presented. The brief introductions to 
NIR, MIR and MVA which are the core technologies in this work are presented. Chapter II 
reviews the protein structures and the current methods for protein structural analysis. The 
advantages and disadvantages of the methods are presented in addition to whether they are suitable 
for adsorbed protein analysis, e.g., protein adsorbed by aluminium hydroxide. The technology is 
especially focused on FTIR-ATR spectroscopy.  
The results summarized in chapter III suggest that FTIR-ATR spectroscopy provides direct 
information on the secondary structural changes of the model antigens when adsorbed to aluminium 
hydroxide and subsequently release. It is shown that the secondary structures of protein antigens 
change when adsorbed by aluminium hydroxide. The adsorption-induced protein structural changes 
depend on how much protein is adsorbed by aluminium hydroxide. Maximal adsorption (e.g. 
achieving adsorption capacity) gives a more native-like structure than low protein adsorption. 
However, Less protein adsorbed may result in a stronger immune response, since the protein 
structure becomes more denatural and this modified structure is more easily presented to the 
immune system. According to Jones et al., protein structure became destabilized upon adsorption by 
aluminium adjuvant. The physical changes of adsorbed antigens made them more susceptible to 
proteolytic processing by the immune system, resulting in an enhanced antigen presentation. This 
may be the reason why different amounts of antigens adsorbed onto same amount aluminium 
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hydroxide show similar immune response. PBS is a good buffer to release adsorbed protein antigens 
from aluminium adjuvant. The current experiments showed that recovery is approximate 80% after 
40 min in PBS. The released antigens generally refold to their native state. However, released BSA 
regains its native structure more completely than does BLG.  
In chapter IV, the structural stability of aluminium-adsorbed model antigens is compared to the 
antigens in solutions. This study has shown that the structure of an antigen can be stabilized by 
adsorption onto aluminium hydroxide during exposure to high temperature and/or during storage. It 
may be one of the reasons why adjuvant can enhance the immune response and/or exert its 
activities. This phenomenon of structural stabilization is more obvious for BSA than BLG, which 
may be ascribed to the low protein concentration of BLG. Another explanation is that it may be that 
there is more free protein which is not adsorbed onto aluminium hydroxide in the BLG model 
vaccines. The free protein antigens may facilitate the degradation of vaccine, but further 
experiments are required to confirm this hypothesis.   
The changes of model vaccines during the storage at normal vaccine storage temperature and an 
elevated temperature are systematically monitored see chapter V. The data show that the pre-
adsorbed antigens are difficult to release from the adjuvant during the storage.  It may indicate why 
vaccine loses or decreases potency during storage. The protein adsorption and pH of vaccine also 
change during storage, and these two parameters are protein specific. Model vaccines generally 
undergo rapid modifications with the time upon storage at 37 ºC. Similar changes are seen upon 
storage at 4 ºC, although at a slower rate. NIR spectroscopy is for the first time used to monitor the 
aging of vaccine. The results suggest that it is possible to detect the changes of 
adsorption/desorption of protein antigens, but it is difficult to determine the change of particle size 
during vaccine storage, even though analyzing the particle size of aluminium adjuvants may be 
practical. Both BSA and BLG model vaccines as well as aluminium hydroxide are profoundly 
affected by rotation. Vigorous rotation increases the particle size of aluminium hydroxide and may 
denature protein antigens. Thus, it should be minimised in vaccine productions.  
A general ability of NIR spectroscopy combined with multivariate data analysis to predict RMC for 
lyophilized vaccines is conducted in chapter VI. RMC results obtained from NIR spectroscopy 
show good agreement with results from KF titration. The acceptable product-specific models and 
multi-product models indicate that NIR spectroscopy can be used as a quantitative method to 
determine RMC in lyophilized allergy vaccines. The models based on product-specific data are 
slightly better than models based on multi-product data; however, a general multi-product model is 
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more useful, since one model can predict all samples in a pharmaceutical production of allergy 
vaccines. However, the current models have to be revalidated by new unknown data in the future 
study.  
 
In chapter VII, NIR spectroscopy is applied to classify and identify allergen vaccines at different 
concentrations, different species and different batches. The vaccines with highest concentration 
antigens are successfully classified from low concentrations (100% at the level of 95% confidence) 
without the api samples. Five different vaccine products at the highest concentration are 
successfully discriminated from each other by a SIMCA model. The classification of different batch 
is possible for products which are at high concentrations antigens. However, more experiments are 
required in the future study for low concentration samples and for many batches involved. The 
results indicate that NIR spectroscopy can be applied as a rapid and non-destructive tool to classify 
and identify allergy vaccines. If implemented this technique will increases the efficiency and 
decreases the costs of the quality control procedures in the allergy vaccine manufacturing industry.  
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Appendices  
 
Appendix A in Chapter VI 
The RMC of the calibration samples by KF: The data were used as reference data for calibration 
models 
 vaccines 
Concentration 
of allergy (SQ-U) Batch No. KF (μg/vial) 
01API06B api 45 30417 50.9
02API10B api 45 41849 36.3
03API04B api 45 50938 39.7
11API04B api 450 30418 31.1
12API04B api 450 41848 36
13API05B api 450 50937 40.6
21API01B api 4,500 30419 22.9
22API01B api 4,500 41730 36
23API06B api 4,500 50934 40.9
31API05B api 45,000 30420 29.7
33API01B api 45,000 50933 39.7
41API08B api 450,000 30421 57.5
41API17B api 450,000 30421 25.7
42API01B api 450,000 41728 45.4
42API07B api 450,000 41728 70.7
43API05B api 450,000 50932 44.3
01CAT11B cat 45 32119 28
01CAT19B cat 45 32119 29.2
01CAT20B cat 45 32119 35.2
02CAT02B cat 45 45535 53
02CAT04B cat 45 45535 32.3
02CAT08B cat 45 45535 43.8
11CAT05B cat 450 32118 30.4
11CAT08B cat 450 32118 10.8
11CAT16B cat 450 32118 30.1
11CAT21B cat 450 32118 32.4
12CAT04B cat 450 45534 47.8
12CAT08B cat 450 45534 45.1
12CAT10B cat 450 45534 43.5
21CAT01B cat 4,500 32117 23.8
21CAT02B cat 4,500 32117 29
21CAT07B cat 4,500 32117 16.8
22CAT02B cat 4,500 45533 56.3
22CAT05B cat 4,500 45533 66.4
22CAT06B cat 4,500 45533 73
31CAT01B cat 45,000 32116 34.7
31CAT03B cat 45,000 32116 36.3
31CAT09B cat 45,000 32116 32.7
32CAT03B cat 45,000 45532 47
32CAT05B cat 45,000 45532 52.9
32CAT07B cat 45,000 45532 48.7
41CAT01B cat 450,000 32115 55.7
41CAT02B cat 450,000 32115 92.1
41CAT04B cat 450,000 32115 85.8
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41CAT07B cat 450,000 32115 77
42CAT01B cat 450,000 45531 122.7
42CAT02B cat 450,000 45531 98.4
42CAT03B cat 450,000 45531 112
42CAT06B cat 450,000 45531 103.5
01DER16B der 45 30016 24.9
11DER23B der 450 30019 31.1
21DER08B der 4,500 30021 48
31DER02B der 45,000 30023 44.3
41DER01B der 450,000 30025 74.4
41DER02B der 450,000 30025 61.5
41DER03B der 450,000 30025 51.4
01GRA08B grass 45 32140 43.9
02GRA03B grass 45 50959 34.2
11GRA06B grass 450 32138 55
12GRA03B grass 450 50958 43.3
21GRA12B grass 4,500 32137 46.8
22GRA04B grass 4,500 50957 33
31GRA01B grass 45,000 32136 34.5
31GRA09B grass 45,000 32136 28.7
31GRA11B grass 45,000 32136 22.4
32GRA06B grass 45,000 50956 31
41GRA04B grass 450,000 32135 58.2
41GRA07B grass 450,000 32135 61.2
41GRA09B grass 450,000 32135 63.5
42GRA03B grass 450,000 50955 55.8
42GRA06B grass 450,000 50955 66.1
42GRA07B grass 450,000 50955 65.6
01VES09B ves 45 31227 38.2
02VES05B ves 45 41633 27.6
03VES02B ves 45 52720 33.6
11VES01B ves 450 31226 37
12VES10B ves 450 41632 29
13VES09B ves 450 52719 30.2
21VES07B ves 4,500 31225 41.6
22VES02B ves 4,500 41631 32.5
23VES09B ves 4,500 52718 25.6
31VES04B ves 45,000 31224 46.5
32VES03B ves 45,000 41628 50.2
33VES10B ves 45,000 52717 33.6
41VES03B ves 450,000 31223 71.5
41VES05B ves 450,000 31223 87.2
41VES08B ves 450,000 31223 89.9
41VES11B ves 450,000 31223 94.4
42VES01B ves 450,000 40986 97.9
42VES03B ves 450,000 40986 98.4
42VES06B ves 450,000 40986 98.7
42VES07B ves 450,000 40986 151
43VES03B ves 450,000 52716 47
43VES06B ves 450,000 52716 59
43VES09B ves 450,000 52716 61.3
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Appendix B in chapter VI 
The results of calibration models for each vaccine product: PLS regression with different data 
pre-treatments and different wavelength windows. 
Product  Samples  Wavelength  Data 
pretreatment 
Jack-
knifing 
Optimum 
PCs 
Correlation  RMSEP
Whole region  None  No 4 0.91 11.85
Whole region None  Yes 3 0.91 11.63
1900-1960  None No 4 0.93 10.45
1900-1960 None Yes  4 0.95 9.20
Whole region  2nd 
derivative  
No 2 0.91 11.63
Whole region 2nd 
derivative  
Yes  2 0.91 11.57
1900-1960 2nd 
derivative  
No  2 0.94 9.78
1900-1960 2nd 
derivative  
Yes  2 0.95 8.86
Whole region  EMSC No  2 0.94 9.73
Whole region EMSC Yes  1 0.94 9.96
1900-1960 EMSC No  4 0.92 10.93
Cat  33 
1900-1960 EMSC Yes  4 0.93 10.31
Whole region  None No  5 0.93 5.50
Whole region  None  Yes  4 0.92 5.62
1900-1960 None  No  4 0.87 7.06
1900-1960 None  Yes  4 0.88 6.99
Whole region 2nd 
derivative  
No 1 0.92 5.71
Whole region  2nd 
derivative  
Yes 1 0.92 5.79
1900-1960 2nd 
derivative  
No 1 0.89 6.34
1900-1960 2nd 
derivative  
Yes  1 0.90 6.35
Whole region  EMSC No 1 0.92 5.77
Whole region  EMSC Yes 1 0.92 5.54
1900-1960 EMSC No 4 0.92 5.80
Grass  16 
1900-1960 EMSC Yes  3 0.90 6.63
Whole region  None  No 12 0.97 6.90
Whole region None  Yes  10 0.96 7.66
1900-1960 None  No  6 0.97 6.42
1900-1960 None  Yes  1 0.38 24.44
Whole region 2nd 
derivative  
No  6 0.95 7.84
Whole region 2nd 
derivative  
Yes  4 0.96 6.83
1900-1960 2nd 
derivative 
No  2 0.96 6.89
Ves  23 
1900-1960 2nd Yes  1 0.96 6.96
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derivative  
Whole region  EMSC No  5 0.94 8.82
Whole region  EMSC  Yes  3 0.94 9.23
1900-1960 EMSC No  3 0.97 6.67
  
1900-1960 EMSC Yes  2 0.97 6.66
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Appendix C in chapter VII 
Data set description of the sample collection 
Vaccine products Concentrations (SQ) Number of batches Number of vials or 
samples (total 665) 
45 3 42 
450 3 39 
4,500 3 41 
45,000 2 30 
api 
450,000 3 44 
45 2 21 
450 2 16 
4,500 2 24 
45,000 2 20 
cat 
450,000 2 17 
45 1 17 
450 1 16 
4,500 1 15 
45,000 1 16 
der 
450,000 1 4 
45 2 26 
450 2 26 
4,500 2 27 
45,000 2 23 
grass 
450,000 2 11 
45 3 42 
450 3 40 
4,500 3 41 
45,000 3 31 
vespula 
450,000 3 36 
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Appendix D in chapter VII 
Classification of highest concentration (450,000 SQ) vaccines from low concentrations  
H = 450,000 SQ and L < 450,000SQ (SIMCA results at 95% confidence level). 
Sample H L 
45 cat  * 
45 cat   * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
45000 cat   
45000 cat  * 
45000 cat  * 
45000 cat   
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat   
45000 cat  * 
45000 cat   
45000 cat   
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat   
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
45 cat  * 
45 cat   * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
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45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
45 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
450 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
4500 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat  * 
45000 cat   
45000 cat  * 
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
cat 450000 *  
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der   
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der   
45 der  * 
45 der  * 
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45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
45 der  * 
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45000 der  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
45 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
450 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
4500 grass  * 
45000 grass  * 
45000 grass  * 
45000 grass  * 
45000 grass  * 
45000 grass  * 
45000 grass  * 
45000 grass  * 
45000 grass  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
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450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
ves 450000 *  
45 ves   
45 ves   
45 ves   
45 ves   
45 ves  * 
45 ves  * 
45 ves  * 
45 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
450 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
4500 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
45000 ves  * 
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Appendix E in chapter VII 
Classification of different vaccines at concentration of 450,000 SQ 
A—api, C—cat, D—der, G—grass, and V—vespula, (SIMCA results at 95% confidence level).
Sample A C D G V 
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API      
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API      
API      
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API      
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API      
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT      
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
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CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
CAT  *    
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
DER   *   
GRA      
GRA    *  
GRA    *  
GRA      
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA      
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
GRA    *  
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
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API *     
API      
API      
API *     
API      
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
API *     
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
VES     * 
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Appendix F in chapter VII 
Classification of three batches of vespula vaccines at concentration 450,000 SQ 
The second number in the sample names indicates batch number: 1—0000031223-7; 2—
0000040986-1633; 3—0000052716-20. (SIMCA results at 95% confidence level).
Samples 
Batch 
numbers 
 1 2 3 
41VES1A *   
41VES1B *   
41VES1C *   
41VES1D *   
41VES2A *   
41VES2B *   
41VES2C *   
41VES2D *   
41VES3A *   
41VES3B *   
41VES3C *   
41VES3D *   
41VES4A *   
41VES4B *   
41VES4C *   
41VES4D *   
41VES5A *   
41VES5B *   
41VES5C *   
41VES5D *   
41VES6A *   
41VES6B *   
41VES6C *   
41VES6D *   
41VES7A *   
41VES7B *   
41VES7C *   
41VES7D *   
41VES8A *   
41VES8B *   
41VES8C *   
41VES8D *   
41VES9A *   
41VES9B *   
41VES9C *   
41VES9D *   
41VES10A *   
41VES10B    
41VES10C *   
41VES10D *   
42VES1A  *  
42VES1B  *  
42VES1C  *  
42VES1D  *  
42VES2A  *  
42VES2B  *  
42VES2C  *  
42VES2D  *  
42VES3A  *  
42VES3B  *  
42VES3C  *  
42VES3D  *  
42VES4A  *  
42VES4B  *  
42VES4C  *  
42VES4D  *  
42VES5A  *  
42VES5B  *  
42VES5C  *  
42VES5D  *  
42VES6A  *  
42VES6B  *  
42VES6C  *  
42VES6D  *  
42VES7A  *  
42VES7B  *  
42VES7C  *  
42VES7D  *  
42VES8A  *  
42VES8B  *  
42VES8C  *  
42VES8D  *  
42VES10A  *  
42VES10B  *  
42VES10C  *  
42VES10D  *  
43VES1A   * 
43VES1B   * 
43VES1C   * 
43VES1D   * 
43VES2A   * 
43VES2B   * 
43VES2C   * 
43VES2D   * 
43VES3A   * 
43VES3B   * 
43VES3C   * 
43VES3D   * 
43VES4A   * 
43VES4B   * 
43VES4C   * 
43VES4D   * 
43VES5A   * 
43VES5B   * 
43VES5C   * 
43VES5D   * 
43VES6A   * 
43VES6B   * 
43VES6C   * 
43VES6D   * 
43VES7A   * 
43VES7B   * 
43VES7C   * 
43VES7D   * 
43VES8A   * 
43VES8B   * 
43VES8C   * 
43VES8D   * 
43VES9A   * 
43VES9B   * 
43VES9C   * 
43VES9D   * 
43VES10A   * 
43VES10B   * 
43VES10C   * 
43VES10D   * 
41VES11A *   
41VES11B *   
41VES11C *   
41VES11D *   
41VES12A *   
41VES12B *   
41VES12C *   
41VES12D *   
41VES13A *   
41VES13B *   
41VES13C *   
41VES13D *   
41VES14A    
41VES14B *   
41VES14C *   
41VES14D *   
42VES11A  *  
42VES11B  *  
42VES11C  *  
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42VES11D  *  
42VES12A  *  
42VES12B  *  
42VES12C  *  
42VES12D  *  
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Appendix G in chapter VII 
Classification of three batches of vespula vaccines at concentration of 45,000 SQ 
The second number in the sample names indicates batch number: 1—0000031223-7; 2—
0000040986-1633; 3—0000052716-20. (SIMCA results at 95% confidence level). 
Samples 
Batch 
numbers 
 1 2 3 
31VES1A *   
31VES1B *   
31VES1C *   
31VES1D *   
31VES2A *   
31VES2B *   
31VES2C *   
31VES2D *   
31VES3A *   
31VES3B *   
31VES3C *   
31VES3D *   
31VES4A *   
31VES4B *   
31VES4C *   
31VES4D *   
31VES5A *   
31VES5B *   
31VES5C *   
31VES5D *   
31VES6A *   
31VES6B *   
31VES6C *   
31VES6D *   
31VES7A *   
31VES7B *   
31VES7C *   
31VES7D *   
31VES8A *   
31VES8B *   
31VES8C *   
31VES8D *   
31VES9A *   
31VES9B *   
31VES9C *   
31VES9D *   
31VES10A *   
31VES10B *   
31VES10C *   
31VES10D *   
32VES1A    
32VES1B  *  
32VES1C  *  
32VES1D  *  
32VES2A  *  
32VES2B  *  
32VES2C  *  
32VES2D  *  
32VES3A  *  
32VES3B  *  
32VES3C  *  
32VES3D  *  
32VES4A  *  
32VES4B  *  
32VES4C  *  
32VES4D  *  
32VES5A  *  
32VES5B  *  
32VES5C    
32VES5D  *  
33VES1A   * 
33VES1B   * 
33VES1C   * 
33VES1D   * 
33VES2A   * 
33VES2B   * 
33VES2C   * 
33VES2D   * 
33VES3A   * 
33VES3B   * 
33VES3C   * 
33VES3D   * 
33VES4A   * 
33VES4B   * 
33VES4C   * 
33VES4D   * 
33VES5A   * 
33VES5B   * 
33VES5C   * 
33VES5D   * 
33VES6A   * 
33VES6B   * 
33VES6C   * 
33VES6D   * 
33VES7A   * 
33VES7B   * 
33VES7C   * 
33VES7D   * 
33VES8A   * 
33VES8B   * 
33VES8C   * 
33VES8D   * 
33VES9A   * 
33VES9B   * 
33VES9C   * 
33VES9D   * 
33VES10A   * 
33VES10B   * 
33VES10C   * 
33VES10D   * 
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Appendix H in chapter VII 
Classification of three batches of api vaccines at 450, 000 SQ 
The second number in the sample names indicates batch number: 1—0000030417-21; 2—
0000041728-849; 3—0000050932-7. (SIMCA results at 95% confidence level).
Samples 
Batch 
 
 1 2 3 
41API1A *   
41API1B *   
41API1C *   
41API1D *   
41API2A    
41API2B    
41API2C    
41API2D    
41API3A   * 
41API3B   * 
41API3C   * 
41API3D   * 
41API4A *   
41API4B *   
41API4C *   
41API4D *   
41API5A *   
41API5B *   
41API5C *   
41API5D *   
41API6A * *  
41API6B *   
41API6C *   
41API6D * *  
41API7A * *  
41API7B * *  
41API7C * *  
41API7D * *  
41API8A *   
41API8B *   
41API8C *   
41API8D *   
41API9A    
41API9B    
41API9C    
41API9D    
41API10A *   
41API10B *   
41API10C *   
41API10D *   
41API11A * *  
41API11B * *  
41API11C * *  
41API11D * *  
41API12A * *  
41API12B *   
41API12C * *  
41API12D * *  
42API1A  *  
42API1B  *  
42API1C  *  
42API1D  *  
42API2A  *  
42API2B  *  
42API2C  *  
42API2D  *  
42API3A  *  
42API3B  *  
42API3C  *  
42API3D  *  
42API4A  *  
42API4B  *  
42API4C  *  
42API4D  *  
42API5A  *  
42API5B  *  
42API5C  *  
42API5D  *  
42API6A  *  
42API6B  *  
42API6C    
42API6D    
42API7A  *  
42API7B  *  
42API7C * *  
42API7D  *  
42API8A  *  
42API8B  *  
42API8C  *  
42API8D  *  
42API9A  *  
42API9B  *  
42API9C  *  
42API9D  *  
42API10A  *  
42API10B  *  
42API10C  *  
42API10D  *  
43API1A   * 
43API1B   * 
43API1C   * 
43API1D   * 
43API2A   * 
43API2B   * 
43API2C   * 
43API2D   * 
43API3A   * 
43API3B   * 
43API3C   * 
43API3D   * 
43API4A   * 
43API4B   * 
43API4C   * 
43API4D   * 
43API5A   * 
43API5B   * 
43API5C   * 
43API5D   * 
43API6A   * 
43API6B   * 
43API6C   * 
43API6D   * 
43API7A   * 
43API7B   * 
43API7C   * 
43API7D   * 
43API8A   * 
43API8B   * 
43API8C   * 
43API8D   * 
43API9A   * 
43API9B   * 
43API9C   * 
43API9D   * 
43API10A   * 
43API10B   * 
43API10C   * 
43API10D   * 
41API13A * *  
41API13B * *  
41API13C * *  
41API13D * *  
41API14A    
41API14B * *  
41API14C *   
41API14D *   
41API15A    
41API15B    
41API15C *   
41API15D *   
41API16A  *  
41API16B  *  
41API16C  *  
41API16D  *  
41API17A *   
41API17B *   
41API17C *   
41API17D *   
41API18A *   
41API18B *   
41API18C *   
41API18D *   
41API19A *   
41API19B *   
41API19C *   
41API19D *   
41API20A *   
41API20B *   
41API20C *   
41API20D * *  
41API21A    
41API21B *   
41API21C *   
41API21D    
41API22A    
41API22B    
41API22C *   
41API22D *   
42API11A  *  
42API11B  *  
42API11C  *  
42API11D  *  
42API12A  *  
42API12B  *  
42API12C    
42API12D  *  
43API11A   * 
43API11B   * 
43API11C   * 
43API11D   * 
43API12A    
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43API12B    
43API12C    
43API12D    
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Appendix I in chapter VII 
Classification of two batches of cat vaccines at concentration of 450,000 SQ 
The second number in the sample names indicates batch number: 1—0000032114-9; 2—
0000045531-5. (SIMCA results at 95% confidence level). 
Samples Batch number 
 
00000 
32114-9 
00000 
45531-5 
41CAT1-0 *  
41CAT1-1 *  
41CAT1-2 *  
41CAT1-9 *  
41CAT2-0 *  
41CAT2-1 *  
41CAT2-2 *  
41CAT2-9 *  
41CAT3-0   
41CAT3-1   
41CAT3-2   
41CAT3-9   
41CAT4-0 *  
41CAT4-1 *  
41CAT4-2 *  
41CAT4-9 *  
41CAT5-0 *  
41CAT5-1 *  
41CAT5-2 *  
41CAT5-9 *  
41CAT6-0 *  
41CAT6-1 *  
41CAT6-2 *  
41CAT6-9 *  
41CAT7-0 *  
41CAT7-1 *  
41CAT7-2 *  
41CAT7-9 *  
41CAT8-0 *  
41CAT8-1 *  
41CAT8-2 *  
41CAT8-9 *  
41CAT9-0 *  
41CAT9-1 *  
41CAT9-2 *  
41CAT9-9 *  
41CAT100 *  
41CAT101 *  
41CAT102 *  
41CAT109 *  
42CAT1-0  * 
42CAT1-1  * 
42CAT1-2  * 
42CAT1-9  * 
42CAT2-0  * 
42CAT2-1  * 
42CAT2-2  * 
42CAT2-9  * 
42CAT3-0  * 
42CAT3-1  * 
42CAT3-2  * 
42CAT3-9  * 
42CAT4-0  * 
42CAT4-1  * 
42CAT4-2  * 
42CAT4-9  * 
42CAT5-0  * 
42CAT5-1  * 
42CAT5-2  * 
42CAT5-9  * 
42CAT6-0  * 
42CAT6-1  * 
42CAT6-2  * 
42CAT6-9  * 
42CAT7-0  * 
42CAT7-1  * 
42CAT7-2  * 
42CAT7-9  * 
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Appendix J in chapter VII 
Classification of two batches of cat vaccines at concentration of 45,000 SQ 
The second number in the sample names indicates batch number: 1—0000032114-9; 2—
0000045531-5. (SIMCA results at 95% confidence level). 
Samples Batch numbers  
 
00000 
332115-9 
00000 
45531-5 
31CAT1-0 *  
31CAT1-1 *  
31CAT1-2 *  
31CAT1-9 *  
31CAT2-0 *  
31CAT2-1 *  
31CAT2-2 *  
31CAT2-9 *  
31CAT3-0 *  
31CAT3-1 *  
31CAT3-2 *  
31CAT3-9 *  
31CAT4-0 *  
31CAT4-1 *  
31CAT4-2 *  
31CAT4-9 *  
31CAT5-0 *  
31CAT5-1 *  
31CAT5-2 *  
31CAT5-9 *  
31CAT6-0 *  
31CAT6-1 *  
31CAT6-2 *  
31CAT6-9 *  
31CAT7-0 *  
31CAT7-1 *  
31CAT7-2 *  
31CAT7-9 *  
31CAT8-0 *  
31CAT8-1 *  
31CAT8-2 *  
31CAT8-9 *  
31CAT9-0 *  
31CAT9-1 *  
31CAT9-2 *  
31CAT9-9 *  
32CAT1-0  * 
32CAT1-1  * 
32CAT1-2  * 
32CAT1-9  * 
32CAT2-0  * 
32CAT2-1  * 
32CAT2-2  * 
32CAT2-9  * 
32CAT3-0  * 
32CAT3-1  * 
32CAT3-2  * 
32CAT3-9  * 
32CAT4-0  * 
32CAT4-1  * 
32CAT4-2  * 
32CAT4-9  * 
32CAT5-0  * 
32CAT5-1  * 
32CAT5-2  * 
32CAT5-9  * 
32CAT6-0  * 
32CAT6-1  * 
32CAT6-2  * 
32CAT6-9  * 
32CAT7-0  * 
32CAT7-1  * 
32CAT7-2  * 
32CAT7-9  * 
32CAT8-0  * 
32CAT8-1   
32CAT8-2   
32CAT8-9  * 
32CAT9-0  * 
32CAT9-1  * 
32CAT9-2  * 
32CAT9-9  * 
32CAT100  * 
32CAT101  * 
32CAT102   
32CAT109  * 
32CAT110  * 
32CAT111  * 
32CAT112  * 
32CAT119  * 
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Appendix K in chapter VII 
Classification of two batches of cat vaccines at concentration of 4,500 SQ 
The second number in the sample names indicates batch number: 1—0000032114-9; 2—
0000045531-5. (SIMCA results at 95% confidence level). 
Samples 
Batch  
numbers 
 
00000 
32114-9 
00000 
45531-5 
21CAT1-0 *  
21CAT1-1 *  
21CAT1-2 *  
21CAT1-9 *  
21CAT2-0 *  
21CAT2-1 *  
21CAT2-2 *  
21CAT2-9 *  
21CAT3-0 *  
21CAT3-1 *  
21CAT3-2 *  
21CAT3-9 * * 
21CAT4-0 *  
21CAT4-1 *  
21CAT4-2 *  
21CAT4-9 *  
21CAT5-0 *  
21CAT5-1 *  
21CAT5-2 *  
21CAT5-9 *  
21CAT6-0 *  
21CAT6-1 *  
21CAT6-2 *  
21CAT6-9 *  
21CAT7-0 *  
21CAT7-1 *  
21CAT7-2 *  
21CAT7-9 *  
21CAT8-0 *  
21CAT8-1 *  
21CAT8-2 *  
21CAT8-9 *  
21CAT9-0 *  
21CAT9-1 *  
21CAT9-2 *  
21CAT9-9 *  
21CAT100 *  
21CAT101 *  
21CAT102 *  
21CAT109 *  
22CAT1-0   
22CAT1-1  * 
22CAT1-2  * 
22CAT1-9  * 
22CAT2-0  * 
22CAT2-1  * 
22CAT2-2  * 
22CAT2-9   
22CAT3-0  * 
22CAT3-1  * 
22CAT3-2  * 
22CAT3-9  * 
22CAT4-0  * 
22CAT4-1  * 
22CAT4-2  * 
22CAT4-9  * 
22CAT5-0  * 
22CAT5-1  * 
22CAT5-2  * 
22CAT5-9  * 
22CAT6-0  * 
22CAT6-1  * 
22CAT6-2  * 
22CAT6-9  * 
22CAT7-0  * 
22CAT7-1  * 
22CAT7-2  * 
22CAT7-9  * 
22CAT8-0  * 
22CAT8-1  * 
22CAT8-2  * 
22CAT8-9  * 
22CAT9-0   
22CAT9-1   
22CAT9-2   
22CAT9-9   
22CAT100  * 
22CAT101  * 
22CAT102  * 
22CAT109  * 
21CAT110 *  
21CAT111 *  
21CAT112 *  
21CAT119 *  
21CAT120 *  
21CAT121 *  
21CAT122 *  
21CAT129 *  
22CAT110 * * 
22CAT111  * 
22CAT112  * 
22CAT119  * 
22CAT120   
22CAT121   
22CAT122   
22CAT129   
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Appendix L in chapter VII 
Classification of two batches of cat vaccines at concentration of 450 SQ 
The second number in the sample names indicates batch number: 1—0000032114-9; 2—
0000045531-5. (SIMCA results at 95% confidence level). 
Samples Batch number 
 
00000 
32115-9 
00000 
45531-5 
11CAT1-0 *  
11CAT1-1 *  
11CAT1-2 *  
11CAT1-9 *  
11CAT2-0 *  
11CAT2-1 *  
11CAT2-2 *  
11CAT2-9 *  
11CAT3-0 *  
11CAT3-1 *  
11CAT3-2 *  
11CAT3-9 *  
11CAT4-0 *  
11CAT4-1 *  
11CAT4-2 *  
11CAT4-9 *  
11CAT5-0 *  
11CAT5-1 *  
11CAT5-2 *  
11CAT5-9 *  
11CAT6-0 *  
11CAT6-1 *  
11CAT6-2 * * 
11CAT6-9 *  
12CAT1-0  * 
12CAT1-1  * 
12CAT1-2  * 
12CAT1-9  * 
12CAT2-0  * 
12CAT2-1  * 
12CAT2-2  * 
12CAT2-9  * 
12CAT4-0  * 
12CAT4-1  * 
12CAT4-2  * 
12CAT4-9  * 
12CAT5-0  * 
12CAT5-1  * 
12CAT5-2  * 
12CAT5-9  * 
12CAT6-0  * 
12CAT6-1  * 
12CAT6-2  * 
12CAT6-9  * 
12CAT7-0  * 
12CAT7-1  * 
12CAT7-2  * 
12CAT7-9  * 
12CAT8-0  * 
12CAT8-1  * 
12CAT8-2  * 
12CAT8-9  * 
12CAT9-0  * 
12CAT9-1  * 
12CAT9-2  * 
12CAT9-9  * 
12CAT100  * 
12CAT101  * 
12CAT102  * 
12CAT109  * 
12CAT120  * 
12CAT121  * 
12CAT122  * 
12CAT129  * 
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Appendix M in chapter VII 
Classification of two batches of cat vaccines at concentration of 45 SQ 
The second number in the sample names indicates batch number: 1—0000032114-9; 2—
0000045531-5. (SIMCA results at 95% confidence level).
Samples Batch number  
 
00000 
32115-9 
00000 
45531-5 
01CAT1-0 *  
01CAT1-1 *  
01CAT1-2 *  
01CAT1-9 *  
01CAT2-0 *  
01CAT2-1 *  
01CAT2-2 *  
01CAT2-9 *  
01CAT3-0 *  
01CAT3-1 *  
01CAT3-2 *  
01CAT3-9 *  
01CAT4-0 *  
01CAT4-1 *  
01CAT4-2 *  
01CAT4-9 *  
01CAT5-0 *  
01CAT5-1 *  
01CAT5-2 *  
01CAT5-9 *  
01CAT6-0 *  
01CAT6-1 *  
01CAT6-2 *  
01CAT6-9 *  
01CAT7-0 *  
01CAT7-1 *  
01CAT7-2 *  
01CAT7-9 *  
01CAT8-0 *  
01CAT8-1 *  
01CAT8-2 *  
01CAT8-9 *  
01CAT9-0 *  
01CAT9-1 *  
01CAT9-2 *  
01CAT9-9 *  
02CAT1-0 * * 
02CAT1-1 * * 
02CAT1-2 * * 
02CAT1-9 * * 
02CAT2-0  * 
02CAT2-1  * 
02CAT2-2  * 
02CAT2-9  * 
02CAT3-0 * * 
02CAT3-1  * 
02CAT3-2  * 
02CAT3-9 * * 
02CAT4-0 * * 
02CAT4-1 * * 
02CAT4-2 * * 
02CAT4-9 * * 
02CAT5-0  * 
02CAT5-1  * 
02CAT5-2  * 
02CAT5-9  * 
02CAT6-0 * * 
02CAT6-1 * * 
02CAT6-2 * * 
02CAT6-9 * * 
02CAT7-0 * * 
02CAT7-1  * 
02CAT7-2  * 
02CAT7-9  * 
02CAT8-0  * 
02CAT8-1  * 
02CAT8-2  * 
02CAT8-9  * 
02CAT9-0  * 
02CAT9-1  * 
02CAT9-2  * 
02CAT9-9  * 
02CAT100  * 
02CAT101  * 
02CAT102  * 
02CAT109  * 
02CAT110  * 
02CAT111  * 
02CAT112  * 
02CAT119  * 
02CAT120 * * 
02CAT121  * 
02CAT122  * 
02CAT129  * 
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Appendix N in chapter VII 
Classification of two batches of grass vaccines at concentration 450,000 SQ 
The second number in the sample names indicates batch number: 1—0000032135-40; 3—
0000050955-9. (SIMCA results at 95% confidence level). 
Sample  Batch number  
 
0000032135-
40 
00000-50955-
9 
41GRA1A   
41GRA1B   
41GRA1C   
41GRA1D   
41GRA2A *  
41GRA2B *  
41GRA2C *  
41GRA2D *  
41GRA3A *  
41GRA3B *  
41GRA3C *  
41GRA3D *  
41GRA4A *  
41GRA4B *  
41GRA4C *  
41GRA4D *  
42GRA1A  * 
42GRA1B  * 
42GRA1C  * 
42GRA1D  * 
42GRA2A  * 
42GRA2B  * 
42GRA2C  * 
42GRA2D  * 
42GRA3A  * 
42GRA3B  * 
42GRA3C  * 
42GRA3D  * 
42GRA4A  * 
42GRA4B  * 
42GRA4C  * 
42GRA4D  * 
42GRA5A  * 
42GRA5B  * 
42GRA5C   
42GRA5D  * 
42GRA6A  * 
42GRA6B  * 
42GRA6C  * 
42GRA6D  * 
42GRA7A  * 
42GRA7B  * 
42GRA7C  * 
42GRA7D  * 
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Appendix O in chapter VII 
Classification of two batches of grass vaccines at concentration of 45,000 SQ 
The second number in the sample names indicates batch number: 1—0000032135-40; 3—
0000050955-9. (SIMCA results at 95% confidence level). 
Samples Batch number  
 
00000 
32135-40 
00000 
50955-9 
31GRA1A *  
31GRA1B *  
31GRA1C *  
31GRA1D *  
31GRA2A *  
31GRA2B *  
31GRA2C *  
31GRA2D *  
31GRA3A *  
31GRA3B *  
31GRA3C *  
31GRA3D *  
31GRA4A *  
31GRA4B *  
31GRA4C *  
31GRA4D *  
31GRA5 *  
31GRA5A *  
31GRA5C *  
31GRA5D *  
31GRA6A *  
31GRA6B *  
31GRA6C *  
31GRA6D *  
31GRA7A *  
31GRA7B *  
31GRA7C *  
31GRA7D *  
31GRA8A *  
31GRA8B *  
31GRA8C *  
31GRA8D *  
31GRA9A *  
31GRA9B *  
31GRA9C *  
31GRA9D *  
31GRA10A *  
31GRA10B *  
31GRA10C *  
31GRA10D *  
32GRA1A  * 
32GRA1B  * 
32GRA1C  * 
32GRA1D  * 
32GRA2A  * 
32GRA2B  * 
32GRA2C  * 
32GRA2D  * 
32GRA3A  * 
32GRA3B  * 
32GRA3C  * 
32GRA3D  * 
32GRA4A  * 
32GRA4B  * 
32GRA4C  * 
32GRA4D  * 
32GRA5A  * 
32GRA5B  * 
32GRA5C  * 
32GRA5D  * 
32GRA6A  * 
32GRA6B  * 
32GRA6C  * 
32GRA6D  * 
32GRA7A  * 
32GRA7B  * 
32GRA7C  * 
32GRA7D  * 
32GRA8A  * 
32GRA8B  * 
32GRA8C  * 
32GRA8D  * 
32GRA9A  * 
32GRA9B  * 
32GRA9C  * 
32GRA9D  * 
32GRA10A  * 
32GRA10B  * 
32GRA10C  * 
32GRA10D  * 
31GRA11A *  
31GRA11B *  
31GRA11C *  
31GRA11D *  
32GRA11A  * 
32GRA11B  * 
32GRA11C  * 
32GRA11D  * 
32GRA12A  * 
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32GRA12B  * 
32GRA12C   
32GRA12D  * 
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Appendix P in chapter VII 
Classification of two batches of grass vaccines at concentration of 4,500 SQ 
The second number in the sample names indicates batch number: 1—0000032135-40; 3—
0000050955-9. (SIMCA results at 95% confidence level). 
Samples Batch numbers 
 
00000 
32135-40 
00000 
50955-9 
21GRA1A *  
21GRA1B *  
21GRA1C *  
21GRA1D *  
21GRA2A *  
21GRA2B *  
21GRA2C *  
21GRA2D *  
21GRA3A *  
21GRA3B *  
21GRA3C *  
21GRA3D *  
21GRA4A *  
21GRA4B *  
21GRA4C *  
21GRA4D *  
21GRA5A *  
21GRA5B *  
21GRA5C *  
21GRA5D *  
21GRA6A *  
21GRA6B *  
21GRA6C *  
21GRA6D *  
21GRA7A *  
21GRA7B *  
21GRA7C *  
21GRA7D * * 
21GRA8A * * 
21GRA8B * * 
21GRA8C * * 
21GRA8D * * 
21GRA9A *  
21GRA9B *  
21GRA9C *  
21GRA9D *  
21GRA10A *  
21GRA10B *  
21GRA10C *  
21GRA10D *  
21GRA11A *  
21GRA11B *  
21GRA11C *  
21GRA11D *  
21GRA12A *  
21GRA12B *  
21GRA12C *  
21GRA12D *  
22GRA1A  * 
22GRA1B  * 
22GRA1C  * 
22GRA1D  * 
22GRA2A   
22GRA2B   
22GRA2C   
22GRA2D   
22GRA3A  * 
22GRA3B  * 
22GRA3C  * 
22GRA3D  * 
22GRA4A  * 
22GRA4B  * 
22GRA4C  * 
22GRA4D  * 
22GRA5A  * 
22GRA5B  * 
22GRA5C  * 
22GRA5D  * 
22GRA6A  * 
22GRA6B  * 
22GRA6C   
22GRA6D  * 
22GRA7A  * 
22GRA7B  * 
22GRA7C  * 
22GRA7D  * 
22GRA8A  * 
22GRA8B  * 
22GRA8C  * 
22GRA8D  * 
22GRA9A  * 
22GRA9B  * 
22GRA9C  * 
22GRA9D * * 
22GRA10A  * 
22GRA10B  * 
22GRA10C  * 
22GRA10D  * 
21GRA13A *  
21GRA13B *  
21GRA13C *  
21GRA13D *  
21GRA14A *  
21GRA14B *  
21GRA14C *  
21GRA14D *  
21GRA15A *  
21GRA15B *  
21GRA15C *  
21GRA15D *  
22GRA12A  * 
22GRA12B  * 
22GRA12C  * 
22GRA12D  * 
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Appendix Q in chapter VII 
Classification of two batches of grass vaccines at concentration of 450 SQ 
The second number in the sample names indicates batch number: 1—0000032135-40; 3—
0000050955-9. (SIMCA results at 95% confidence level). 
Samples Batch numbers 
 
00000 
32135-40 
00000 
50955-9 
11GRA1A *  
11GRA1B *  
11GRA1C *  
11GRA1D *  
11GRA2A *  
11GRA2B *  
11GRA2C *  
11GRA2D *  
11GRA3A *  
11GRA3B *  
11GRA3C *  
11GRA3D *  
11GRA4A *  
11GRA4B *  
11GRA4C *  
11GRA4D *  
11GRA5A *  
11GRA5B *  
11GRA5C *  
11GRA5D *  
11GRA6A *  
11GRA6B *  
11GRA6C *  
11GRA6D *  
11GRA7A *  
11GRA7B *  
11GRA7C *  
11GRA7D *  
11GRA8A *  
11GRA8B *  
11GRA8C *  
11GRA8D *  
11GRA9A *  
11GRA9B *  
11GRA9C *  
11GRA9D *  
11GRA10A *  
11GRA10B *  
11GRA10C *  
11GRA10D *  
11GRA11A *  
11GRA11B *  
11GRA11C *  
11GRA11D *  
11GRA12A *  
11GRA12B *  
11GRA12C *  
11GRA12D *  
12GRA1A  * 
12GRA1B  * 
12GRA1C  * 
12GRA1D  * 
12GRA2A  * 
12GRA2B  * 
12GRA2C  * 
12GRA2D  * 
12GRA3A  * 
12GRA3B  * 
12GRA3C  * 
12GRA3D  * 
12GRA4A  * 
12GRA4B  * 
12GRA4C  * 
12GRA4D  * 
12GRA5A  * 
12GRA5B  * 
12GRA5C  * 
12GRA5D  * 
12GRA6A  * 
12GRA6B  * 
12GRA6C  * 
12GRA6D  * 
12GRA7A  * 
12GRA7B  * 
12GRA7C  * 
12GRA7D  * 
11GRA13A *  
11GRA13B *  
11GRA13C *  
11GRA13D *  
11GRA14A *  
11GRA14B *  
11GRA14C   
11GRA14D   
11GRA15A *  
11GRA15B *  
11GRA15C *  
11GRA15D *  
11GRA16A *  
11GRA16B *  
11GRA16C *  
11GRA16D *  
11GRA17A *  
11GRA17B *  
11GRA17C *  
11GRA17D *  
11GRA18A *  
11GRA18B *  
11GRA18C *  
11GRA18D *  
11GRA19A *  
11GRA19B *  
11GRA19C *  
11GRA19D *  
11VES13A  * 
11VES13B  * 
11VES13C  * 
11VES13D  * 
11VES14A  * 
11VES14B  * 
11VES14C  * 
11VES14D  * 
11VES15A   
11VES15B   
11VES15C   
11VES15D   
11VES16A   
11VES16B   
11VES16C   
11VES16D   
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Appendix R in chapter VII 
Classification of two batches of grass vaccines at concentration of 45 SQ 
The second number in the sample names indicates batch number: 1—0000032135-40; 3—
0000050955-9. (SIMCA results at 95% confidence level). 
 
Samples Batch numbers 
 
00000 
32135-40 
00000 
50955-9 
01GRA19D *  
01GRA19C *  
01GRA19B *  
01GRA19A *  
01GRA18D *  
01GRA18C *  
01GRA18B *  
01GRA18A *  
01GRA17D *  
01GRA17C *  
01GRA17B *  
01GRA17A *  
01GRA16D *  
01GRA16C *  
01GRA16B *  
01GRA16A *  
01GRA15D *  
01GRA15C *  
01GRA15B *  
01GRA15A *  
01GRA14D *  
01GRA14C *  
01GRA14B *  
01GRA14A *  
01GRA13D *  
01GRA13C *  
01GRA13B *  
01GRA13A *  
02GRA7D * * 
02GRA7C * * 
02GRA7B * * 
02GRA7A * * 
02GRA6D * * 
02GRA6C  * 
02GRA6B  * 
02GRA6A * * 
02GRA5D  * 
02GRA5C  * 
02GRA5B  * 
02GRA5A  * 
02GRA4D  * 
02GRA4C  * 
02GRA4B  * 
02GRA4A  * 
02GRA3D * * 
02GRA3C * * 
02GRA3B * * 
02GRA3A * * 
02GRA2D  * 
02GRA2C  * 
02GRA2B  * 
02GRA2A  * 
02GRA1D  * 
02GRA1C  * 
02GRA1B  * 
02GRA1A  * 
01GRA12D *  
01GRA12C *  
01GRA12B *  
01GRA12A *  
01GRA11D *  
01GRA11C *  
01GRA11B *  
01GRA11A *  
01GRA10D *  
01GRA10C *  
01GRA10B *  
01GRA10A *  
01GRA9D *  
01GRA9C *  
01GRA9B *  
01GRA9A *  
01GRA8D *  
01GRA8C *  
01GRA8B *  
01GRA8A *  
01GRA7D *  
01GRA7C *  
01GRA7B *  
01GRA7A *  
01GRA6D *  
01GRA6C *  
01GRA6B *  
01GRA6A *  
01GRA5D *  
01GRA5C *  
01GRA5B *  
01GRA5A *  
01GRA4D *  
01GRA4C *  
01GRA4B *  
01GRA4A *  
01GRA3D *  
01GRA3C *  
01GRA3B *  
01GRA3A *  
01GRA2D *  
01GRA2C *  
01GRA2B *  
01GRA2A *  
01GRA1D *  
01GRA1C *  
01GRA1B *  
01GRA1A *  
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